1a327e37的个人主页 - 老虎社区

1a327e37

暂无个人介绍

IP属地：未知

123关注

11粉丝

0主题

0勋章

2021-06-12

Help me make this become top comment please

AMC Bet by Hedge Fund Unravels Thanks to Meme-Stock Traders<blockquote>对冲基金对AMC的押注因模因股票交易员而瓦解</blockquote>

2021-06-07

Yeah[开心]

2021-12-15

K

Renewed Selling Pressure Likely For Singapore Stock Market<blockquote>新加坡股市可能面临新的抛售压力</blockquote>

2021-12-25

Ik

抱歉，原内容已删除

2021-06-08

$GameStop(GME)$all the way

2021-06-17

K

抱歉，原内容已删除

2021-12-27

K

Santa Claus Rally watch: What to know this week<blockquote>圣诞老人集会观察：本周需要了解什么</blockquote>

2021-06-22

I see

抱歉，原内容已删除

2021-12-28

K

Is Merck Stock A Buy Or Sell After FDA Authorizes Its Covid Pill?<blockquote>FDA批准默克公司的新冠药物后，默克公司的股票是买入还是卖出？</blockquote>

2021-12-24

Ok

Can Apple Stock Hit New Highs by Year's End?<blockquote>苹果股价能否在年底前创下新高？</blockquote>

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3586129577058331","uuid":"3586129577058331","gmtCreate":1623035694137,"gmtModify":1623036406974,"name":"1a327e37","pinyin":"1a327e37","introduction":"","introductionEn":"","signature":"","avatar":"https://static.laohu8.com/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":11,"headSize":123,"tweetSize":39,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":2,"name":"无畏虎","nameTw":"無畏虎","represent":"初生牛犊","factor":"发布3条非转发主帖,1条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.10.26","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"35ec162348d5460f88c959321e554969-2","templateUuid":"35ec162348d5460f88c959321e554969","name":"宗师交易员","description":"证券或期货账户累计交易次数达到100次","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"80.36%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":3,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":697119944,"gmtCreate":1642349260169,"gmtModify":1642349260369,"author":{"id":"3586129577058331","authorId":"3586129577058331","name":"1a327e37","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586129577058331","idStr":"3586129577058331"},"themes":[],"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/697119944","repostId":"2203201745","repostType":4,"isVote":1,"tweetType":1,"viewCount":2810,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":697081027,"gmtCreate":1642160906570,"gmtModify":1642160907122,"author":{"id":"3586129577058331","authorId":"3586129577058331","name":"1a327e37","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586129577058331","idStr":"3586129577058331"},"themes":[],"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/697081027","repostId":"1144666508","repostType":4,"repost":{"id":"1144666508","kind":"news","pubTimestamp":1642160056,"share":"https://www.laohu8.com/m/news/1144666508?lang=zh_CN&edition=full","pubTime":"2022-01-14 19:34","market":"us","language":"en","title":"3 Meme Stocks That Are Actually Solid Long-Term Picks<blockquote>3只实际上是可靠的长期选择的模因股票</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1144666508","media":"Motley Fool","summary":"The meme stock craze of 2021 was certainly a historically unique market environment. Many stocks, so","content":"<p><html><head></head><body>The meme stock craze of 2021 was certainly a historically unique market environment. Many stocks, some heavily shorted and some just interesting speculative growth plays, rocketed sharply higher -- often doubling, tripling, or more in a very short time. And many took investors on quite a roller coaster ride for months.</p><p><blockquote><html><head></head><body>2021年的模因股票热潮无疑是一个历史上独特的市场环境。许多股票，有些被严重做空，有些只是有趣的投机性增长股票，大幅上涨——通常在很短的时间内翻倍、三倍或更多。许多人让投资者经历了数月的过山车之旅。</body></html></blockquote></p><p>To be sure, most meme stocks aren&#39;t worth buying as long-term investments. For example, it&#39;s tough to make a long-term investment case for <b><a href=\"https://laohu8.com/S/AMC\">AMC Entertainment</a>.</b> On the other hand, there are some stocks that got caught up in the meme stock trade that looks like solid long-term investments. And this is especially true now that there&#39;s been a massive correction in many high-growth stocks.</p><p><blockquote>可以肯定的是，大多数模因股票不值得作为长期投资购买。例如，很难为<b><a href=\"https://laohu8.com/S/AMC\">AMC院线</a>.</b>另一方面，有一些股票陷入了看起来像是可靠的长期投资的模因股票交易。尤其是在许多高增长股票出现大幅调整的情况下。</blockquote></p><p><b>A massive opportunity and a great strategy</b></p><p><blockquote><b>巨大的机遇和伟大的战略</b></blockquote></p><p><b>Offerpad</b>(NYSE:OPAD) is a real estate company that is a so-called iBuyer, or instant buyer, of homes. Offerpad&#39;s core business involves buying homes directly from sellers, doing cosmetic repairs, and then selling them directly to buyers, hopefully earning a profit in the process.</p><p><blockquote><b>优惠垫</b>（纽约证券交易所股票代码：OPAD）是一家房地产公司，是所谓的房屋iBuyer或即时买家。Offerpad的核心业务包括直接从卖家那里购买房屋，进行表面维修，然后直接出售给买家，希望在此过程中赚取利润。</blockquote></p><p>However, there are a couple of things that set Offerpad apart from its peer group (which really only consists of two other companies). For <a href=\"https://laohu8.com/S/AONE.U\">one</a> thing, Offerpad is the only iBuyer that is more focused on efficiency than all-out growth. Its unit economics have been better than those of its peers, and while it won&#39;t be consistently profitable for some time, it isn&#39;t that far from it right now.</p><p><blockquote>然而，有几件事使Offerpad有别于其同行集团（实际上只由另外两家公司组成）。为了<a href=\"https://laohu8.com/S/AONE.U\">一</a>事实上，Offerpad是唯一一家更注重效率而不是全面增长的iBuyer。它的单位经济效益一直好于同行，虽然在一段时间内不会持续盈利，但现在离盈利也不远了。</blockquote></p><p>Second, Offerpad isn&#39;t necessarily trying to completely replace open-market home sales. Its Offerpad Flex product encourages customers to list their home on the open market (with an Offerpad partner agent) and gives them a cash offer to keep in their back pocket in the event they get tired of the traditional sale process.</p><p><blockquote>其次，Offerpad并不一定试图完全取代公开市场房屋销售。其Offerpad Flex产品鼓励客户在公开市场上列出他们的房屋（通过Offerpad合作伙伴代理），并为他们提供现金报价，以便在他们厌倦传统销售流程时放在口袋里。</blockquote></p><p>Offerpad went a bit meme-stockish after its late 2021 special purpose acquisition company (SPAC) merger was completed, at one point rocketing to nearly $21 from its $10 pre-SPAC valuation. Now that the SPAC boom has cooled, Offerpad has plunged to less than $6, in line with many other recent SPAC targets. But make no mistake -- this is a real business with a huge market opportunity.</p><p><blockquote>在2021年底完成与特殊目的收购公司(SPAC)的合并后，Offerpad变得有点疯狂，一度从SPAC之前的10美元估值飙升至近21美元。现在SPAC热潮已经降温，Offerpad已暴跌至6美元以下，与许多其他最近的SPAC目标一致。但毫无疑问，这是一个真正的行业，有着巨大的市场机会。</blockquote></p><p><b>Tons of disruptive potential</b></p><p><blockquote><b>巨大的颠覆性潜力</b></blockquote></p><p>One of the most discussed stocks in some of the most popular trader chat rooms in 2021, <a href=\"https://laohu8.com/S/SOFI\"><b>SoFi</b></a>, went public through a Chamath Palihapitiya-backed SPAC last year (this was &#34;IPOE&#34; for those who follow Palihapitiya). It started out as a private student loan company but has since evolved into a financial ecosystem, complete with a full lineup of lending products, a credit card, a bank account, a brokerage account, and more. The company also owns the Galileo financial services API and payments platform, which provides functionality for 89 million financial accounts operated by partners.</p><p><blockquote>2021年一些最受欢迎的交易者聊天室中讨论最多的股票之一，<a href=\"https://laohu8.com/S/SOFI\"><b>索菲</b></a>，去年通过Chamath Palihapitiya支持的SPAC上市（对于那些关注Palihapitiya的人来说，这是“IPOE”）。它最初是一家私人学生贷款公司，但后来发展成为一个金融生态系统，拥有全套贷款产品、信用卡、银行账户、经纪账户等。该公司还拥有伽利略金融服务API和支付平台，为合作伙伴运营的8900万个金融账户提供功能。</blockquote></p><p>To say SoFi&#39;s growth has been phenomenal would be an understatement. Thefintech&#39;suser base has nearly doubled over the past year to more than 2.9 million members, and these users account for roughly 4.3 million different financial products. And it&#39;s on the non-lending side of the business where the growth has been especially impressive, with a 179% year-over-year increase in products as of the third quarter of 2021.</p><p><blockquote>说SoFi的增长惊人是一种保守的说法。Thefintech的用户群在过去一年中几乎翻了一番，超过290万会员，这些用户约占430万种不同的金融产品。非贷款业务的增长尤其令人印象深刻，截至2021年第三季度，产品同比增长179%。</blockquote></p><p>SoFi has the capability to be a true disruptor of the traditional bank model and is making all the right moves to scale its business in a sustainable way. With shares down 36% in the last two months, now could be a great time to add it at a discount.</p><p><blockquote>SoFi有能力成为传统银行模式的真正颠覆者，并且正在采取所有正确的举措以可持续的方式扩大其业务规模。过去两个月股价下跌了36%，现在可能是打折增持的好时机。</blockquote></p><p><b>The most exciting growth is yet to come</b></p><p><blockquote><b>最激动人心的增长还在后头</b></blockquote></p><p>Last but certainly not least, insurance disruptor <a href=\"https://laohu8.com/S/LMND\"><b>Lemonade</b></a> has been a big victim of the recent growth stock headwinds, with shares down by about 35% in the past couple of months and a total of 80% off their all-time high.</p><p><blockquote>最后但并非最不重要的是，保险颠覆者<a href=\"https://laohu8.com/S/LMND\"><b>柠檬汽水</b></a>成为近期成长型股票逆风的一大受害者，过去几个月股价下跌约35%，较历史高点累计下跌80%。</blockquote></p><p>Lemonade is aninsurance technology company, aiming to provide a better way to get insurance quotes, buy policies, and submit claims. In the company&#39;s core business of renters and homeowners insurance, customer feedback has been incredibly strong.</p><p><blockquote>Lemonade是一家保险技术公司，旨在提供更好的方式来获取保险报价、购买保单和提交索赔。在该公司的租房者和房主保险核心业务中，客户反馈非常强烈。</blockquote></p><p>However, it&#39;s the rollout of Lemonade Car, the company&#39;s much-anticipated auto insurance product -- along with the pending acquisition of <b>Metromile</b>(NASDAQ:MILE)-- where Lemonade could accelerate the availability of the product and rapidly scale the business. If the company can replicate its early insurance success in the auto space, and can keep loss ratios in check, Lemonade could be a big winner for patient investors.</p><p><blockquote>然而，该公司备受期待的汽车保险产品Lemonade Car的推出，以及即将收购的<b>地铁里程</b>（纳斯达克：英里）-柠檬水可以加速产品的上市并迅速扩大业务规模。如果该公司能够复制其早期在汽车领域的保险成功，并能够控制损失率，那么Lemonade可能会成为耐心投资者的大赢家。</blockquote></p><p>Remember what you&#39;re buying</p><p><blockquote>记住你买的是什么</blockquote></p><p></p><p>To be sure, these three stocks are real businesses with great long-term growth opportunities. However, it&#39;s important to keep in mind that while the &#34;meme stock&#34; craze has died down, that doesn&#39;t mean it has permanently gone away. And if it comes back, all three of these stocks are likely to experience quite a roller coaster ride. Before you add any of these to your portfolio, it&#39;s important to be prepared for that possibility.</p><p><blockquote>可以肯定的是，这三只股票都是真正的企业，具有巨大的长期增长机会。然而，重要的是要记住，虽然“模因股票”热潮已经消退，但这并不意味着它已经永久消失。如果它卷土重来，这三只股票都可能经历一场过山车般的行情。在您将这些添加到您的投资组合之前，为这种可能性做好准备非常重要。</blockquote></p><p></body></html></p><p><blockquote></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Meme Stocks That Are Actually Solid Long-Term Picks<blockquote>3只实际上是可靠的长期选择的模因股票</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Meme Stocks That Are Actually Solid Long-Term Picks<blockquote>3只实际上是可靠的长期选择的模因股票</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Motley Fool</strong><span class=\"h-time small\">2022-01-14 19:34</span>\n</p>\n</h4>\n</header>\n<article>\n<p><html><head></head><body>The meme stock craze of 2021 was certainly a historically unique market environment. Many stocks, some heavily shorted and some just interesting speculative growth plays, rocketed sharply higher -- often doubling, tripling, or more in a very short time. And many took investors on quite a roller coaster ride for months.</p><p><blockquote><html><head></head><body>2021年的模因股票热潮无疑是一个历史上独特的市场环境。许多股票，有些被严重做空，有些只是有趣的投机性增长股票，大幅上涨——通常在很短的时间内翻倍、三倍或更多。许多人让投资者经历了数月的过山车之旅。</body></html></blockquote></p><p>To be sure, most meme stocks aren&#39;t worth buying as long-term investments. For example, it&#39;s tough to make a long-term investment case for <b><a href=\"https://laohu8.com/S/AMC\">AMC Entertainment</a>.</b> On the other hand, there are some stocks that got caught up in the meme stock trade that looks like solid long-term investments. And this is especially true now that there&#39;s been a massive correction in many high-growth stocks.</p><p><blockquote>可以肯定的是，大多数模因股票不值得作为长期投资购买。例如，很难为<b><a href=\"https://laohu8.com/S/AMC\">AMC院线</a>.</b>另一方面，有一些股票陷入了看起来像是可靠的长期投资的模因股票交易。尤其是在许多高增长股票出现大幅调整的情况下。</blockquote></p><p><b>A massive opportunity and a great strategy</b></p><p><blockquote><b>巨大的机遇和伟大的战略</b></blockquote></p><p><b>Offerpad</b>(NYSE:OPAD) is a real estate company that is a so-called iBuyer, or instant buyer, of homes. Offerpad&#39;s core business involves buying homes directly from sellers, doing cosmetic repairs, and then selling them directly to buyers, hopefully earning a profit in the process.</p><p><blockquote><b>优惠垫</b>（纽约证券交易所股票代码：OPAD）是一家房地产公司，是所谓的房屋iBuyer或即时买家。Offerpad的核心业务包括直接从卖家那里购买房屋，进行表面维修，然后直接出售给买家，希望在此过程中赚取利润。</blockquote></p><p>However, there are a couple of things that set Offerpad apart from its peer group (which really only consists of two other companies). For <a href=\"https://laohu8.com/S/AONE.U\">one</a> thing, Offerpad is the only iBuyer that is more focused on efficiency than all-out growth. Its unit economics have been better than those of its peers, and while it won&#39;t be consistently profitable for some time, it isn&#39;t that far from it right now.</p><p><blockquote>然而，有几件事使Offerpad有别于其同行集团（实际上只由另外两家公司组成）。为了<a href=\"https://laohu8.com/S/AONE.U\">一</a>事实上，Offerpad是唯一一家更注重效率而不是全面增长的iBuyer。它的单位经济效益一直好于同行，虽然在一段时间内不会持续盈利，但现在离盈利也不远了。</blockquote></p><p>Second, Offerpad isn&#39;t necessarily trying to completely replace open-market home sales. Its Offerpad Flex product encourages customers to list their home on the open market (with an Offerpad partner agent) and gives them a cash offer to keep in their back pocket in the event they get tired of the traditional sale process.</p><p><blockquote>其次，Offerpad并不一定试图完全取代公开市场房屋销售。其Offerpad Flex产品鼓励客户在公开市场上列出他们的房屋（通过Offerpad合作伙伴代理），并为他们提供现金报价，以便在他们厌倦传统销售流程时放在口袋里。</blockquote></p><p>Offerpad went a bit meme-stockish after its late 2021 special purpose acquisition company (SPAC) merger was completed, at one point rocketing to nearly $21 from its $10 pre-SPAC valuation. Now that the SPAC boom has cooled, Offerpad has plunged to less than $6, in line with many other recent SPAC targets. But make no mistake -- this is a real business with a huge market opportunity.</p><p><blockquote>在2021年底完成与特殊目的收购公司(SPAC)的合并后，Offerpad变得有点疯狂，一度从SPAC之前的10美元估值飙升至近21美元。现在SPAC热潮已经降温，Offerpad已暴跌至6美元以下，与许多其他最近的SPAC目标一致。但毫无疑问，这是一个真正的行业，有着巨大的市场机会。</blockquote></p><p><b>Tons of disruptive potential</b></p><p><blockquote><b>巨大的颠覆性潜力</b></blockquote></p><p>One of the most discussed stocks in some of the most popular trader chat rooms in 2021, <a href=\"https://laohu8.com/S/SOFI\"><b>SoFi</b></a>, went public through a Chamath Palihapitiya-backed SPAC last year (this was &#34;IPOE&#34; for those who follow Palihapitiya). It started out as a private student loan company but has since evolved into a financial ecosystem, complete with a full lineup of lending products, a credit card, a bank account, a brokerage account, and more. The company also owns the Galileo financial services API and payments platform, which provides functionality for 89 million financial accounts operated by partners.</p><p><blockquote>2021年一些最受欢迎的交易者聊天室中讨论最多的股票之一，<a href=\"https://laohu8.com/S/SOFI\"><b>索菲</b></a>，去年通过Chamath Palihapitiya支持的SPAC上市（对于那些关注Palihapitiya的人来说，这是“IPOE”）。它最初是一家私人学生贷款公司，但后来发展成为一个金融生态系统，拥有全套贷款产品、信用卡、银行账户、经纪账户等。该公司还拥有伽利略金融服务API和支付平台，为合作伙伴运营的8900万个金融账户提供功能。</blockquote></p><p>To say SoFi&#39;s growth has been phenomenal would be an understatement. Thefintech&#39;suser base has nearly doubled over the past year to more than 2.9 million members, and these users account for roughly 4.3 million different financial products. And it&#39;s on the non-lending side of the business where the growth has been especially impressive, with a 179% year-over-year increase in products as of the third quarter of 2021.</p><p><blockquote>说SoFi的增长惊人是一种保守的说法。Thefintech的用户群在过去一年中几乎翻了一番，超过290万会员，这些用户约占430万种不同的金融产品。非贷款业务的增长尤其令人印象深刻，截至2021年第三季度，产品同比增长179%。</blockquote></p><p>SoFi has the capability to be a true disruptor of the traditional bank model and is making all the right moves to scale its business in a sustainable way. With shares down 36% in the last two months, now could be a great time to add it at a discount.</p><p><blockquote>SoFi有能力成为传统银行模式的真正颠覆者，并且正在采取所有正确的举措以可持续的方式扩大其业务规模。过去两个月股价下跌了36%，现在可能是打折增持的好时机。</blockquote></p><p><b>The most exciting growth is yet to come</b></p><p><blockquote><b>最激动人心的增长还在后头</b></blockquote></p><p>Last but certainly not least, insurance disruptor <a href=\"https://laohu8.com/S/LMND\"><b>Lemonade</b></a> has been a big victim of the recent growth stock headwinds, with shares down by about 35% in the past couple of months and a total of 80% off their all-time high.</p><p><blockquote>最后但并非最不重要的是，保险颠覆者<a href=\"https://laohu8.com/S/LMND\"><b>柠檬汽水</b></a>成为近期成长型股票逆风的一大受害者，过去几个月股价下跌约35%，较历史高点累计下跌80%。</blockquote></p><p>Lemonade is aninsurance technology company, aiming to provide a better way to get insurance quotes, buy policies, and submit claims. In the company&#39;s core business of renters and homeowners insurance, customer feedback has been incredibly strong.</p><p><blockquote>Lemonade是一家保险技术公司，旨在提供更好的方式来获取保险报价、购买保单和提交索赔。在该公司的租房者和房主保险核心业务中，客户反馈非常强烈。</blockquote></p><p>However, it&#39;s the rollout of Lemonade Car, the company&#39;s much-anticipated auto insurance product -- along with the pending acquisition of <b>Metromile</b>(NASDAQ:MILE)-- where Lemonade could accelerate the availability of the product and rapidly scale the business. If the company can replicate its early insurance success in the auto space, and can keep loss ratios in check, Lemonade could be a big winner for patient investors.</p><p><blockquote>然而，该公司备受期待的汽车保险产品Lemonade Car的推出，以及即将收购的<b>地铁里程</b>（纳斯达克：英里）-柠檬水可以加速产品的上市并迅速扩大业务规模。如果该公司能够复制其早期在汽车领域的保险成功，并能够控制损失率，那么Lemonade可能会成为耐心投资者的大赢家。</blockquote></p><p>Remember what you&#39;re buying</p><p><blockquote>记住你买的是什么</blockquote></p><p></p><p>To be sure, these three stocks are real businesses with great long-term growth opportunities. However, it&#39;s important to keep in mind that while the &#34;meme stock&#34; craze has died down, that doesn&#39;t mean it has permanently gone away. And if it comes back, all three of these stocks are likely to experience quite a roller coaster ride. Before you add any of these to your portfolio, it&#39;s important to be prepared for that possibility.</p><p><blockquote>可以肯定的是，这三只股票都是真正的企业，具有巨大的长期增长机会。然而，重要的是要记住，虽然“模因股票”热潮已经消退，但这并不意味着它已经永久消失。如果它卷土重来，这三只股票都可能经历一场过山车般的行情。在您将这些添加到您的投资组合之前，为这种可能性做好准备非常重要。</blockquote></p><p></body></html></p><p><blockquote></blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.fool.com/investing/2022/01/14/3-meme-stocks-that-are-actually-solid-long-term-pi/\">Motley Fool</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SOFI":"SoFi Technologies Inc.","OPAD":"Offerpad Solutions","LMND":"Lemonade, Inc.","AMC":"AMC院线"},"source_url":"https://www.fool.com/investing/2022/01/14/3-meme-stocks-that-are-actually-solid-long-term-pi/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1144666508","content_text":"The meme stock craze of 2021 was certainly a historically unique market environment. Many stocks, some heavily shorted and some just interesting speculative growth plays, rocketed sharply higher -- often doubling, tripling, or more in a very short time. And many took investors on quite a roller coaster ride for months.To be sure, most meme stocks aren't worth buying as long-term investments. For example, it's tough to make a long-term investment case for AMC Entertainment. On the other hand, there are some stocks that got caught up in the meme stock trade that looks like solid long-term investments. And this is especially true now that there's been a massive correction in many high-growth stocks.A massive opportunity and a great strategyOfferpad(NYSE:OPAD) is a real estate company that is a so-called iBuyer, or instant buyer, of homes. Offerpad's core business involves buying homes directly from sellers, doing cosmetic repairs, and then selling them directly to buyers, hopefully earning a profit in the process.However, there are a couple of things that set Offerpad apart from its peer group (which really only consists of two other companies). For one thing, Offerpad is the only iBuyer that is more focused on efficiency than all-out growth. Its unit economics have been better than those of its peers, and while it won't be consistently profitable for some time, it isn't that far from it right now.Second, Offerpad isn't necessarily trying to completely replace open-market home sales. Its Offerpad Flex product encourages customers to list their home on the open market (with an Offerpad partner agent) and gives them a cash offer to keep in their back pocket in the event they get tired of the traditional sale process.Offerpad went a bit meme-stockish after its late 2021 special purpose acquisition company (SPAC) merger was completed, at one point rocketing to nearly $21 from its $10 pre-SPAC valuation. Now that the SPAC boom has cooled, Offerpad has plunged to less than $6, in line with many other recent SPAC targets. But make no mistake -- this is a real business with a huge market opportunity.Tons of disruptive potentialOne of the most discussed stocks in some of the most popular trader chat rooms in 2021, SoFi, went public through a Chamath Palihapitiya-backed SPAC last year (this was \"IPOE\" for those who follow Palihapitiya). It started out as a private student loan company but has since evolved into a financial ecosystem, complete with a full lineup of lending products, a credit card, a bank account, a brokerage account, and more. The company also owns the Galileo financial services API and payments platform, which provides functionality for 89 million financial accounts operated by partners.To say SoFi's growth has been phenomenal would be an understatement. Thefintech'suser base has nearly doubled over the past year to more than 2.9 million members, and these users account for roughly 4.3 million different financial products. And it's on the non-lending side of the business where the growth has been especially impressive, with a 179% year-over-year increase in products as of the third quarter of 2021.SoFi has the capability to be a true disruptor of the traditional bank model and is making all the right moves to scale its business in a sustainable way. With shares down 36% in the last two months, now could be a great time to add it at a discount.The most exciting growth is yet to comeLast but certainly not least, insurance disruptor Lemonade has been a big victim of the recent growth stock headwinds, with shares down by about 35% in the past couple of months and a total of 80% off their all-time high.Lemonade is aninsurance technology company, aiming to provide a better way to get insurance quotes, buy policies, and submit claims. In the company's core business of renters and homeowners insurance, customer feedback has been incredibly strong.However, it's the rollout of Lemonade Car, the company's much-anticipated auto insurance product -- along with the pending acquisition of Metromile(NASDAQ:MILE)-- where Lemonade could accelerate the availability of the product and rapidly scale the business. If the company can replicate its early insurance success in the auto space, and can keep loss ratios in check, Lemonade could be a big winner for patient investors.Remember what you're buyingTo be sure, these three stocks are real businesses with great long-term growth opportunities. However, it's important to keep in mind that while the \"meme stock\" craze has died down, that doesn't mean it has permanently gone away. And if it comes back, all three of these stocks are likely to experience quite a roller coaster ride. Before you add any of these to your portfolio, it's important to be prepared for that possibility.","news_type":1,"symbols_score_info":{"OPAD":0.9,"AMC":0.9,"LMND":0.9,"SOFI":0.9}},"isVote":1,"tweetType":1,"viewCount":3471,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":696174376,"gmtCreate":1640656213980,"gmtModify":1640656703694,"author":{"id":"3586129577058331","authorId":"3586129577058331","name":"1a327e37","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586129577058331","idStr":"3586129577058331"},"themes":[],"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/696174376","repostId":"1156481741","repostType":4,"repost":{"id":"1156481741","kind":"news","pubTimestamp":1640652473,"share":"https://www.laohu8.com/m/news/1156481741?lang=zh_CN&edition=full","pubTime":"2021-12-28 08:47","market":"us","language":"en","title":"Is Merck Stock A Buy Or Sell After FDA Authorizes Its Covid Pill?<blockquote>FDA批准默克公司的新冠药物后，默克公司的股票是买入还是卖出？</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1156481741","media":"Investors","summary":"The Food and Drug Administration authorized Merck's (MRK) antiviral Covid pill, molnupiravir. But Me","content":"<p>The Food and Drug Administration authorized&nbsp;<b>Merck</b>'s (MRK) antiviral Covid pill, molnupiravir. But Merck stock remains under pressure.</p><p><blockquote>食品药品监督管理局授权<b>默克</b>(MRK)的抗病毒新冠药物莫努匹拉韦。但默克股票仍面临压力。</blockquote></p><p> The FDA authorized the Ridgeback Biotherapeutics-partnered pill for emergency use when other options aren't available or appropriate.<b>Pfizer</b>(PFE) also gained authorization for its two-pill regimen, Paxlovid. Paxlovid proved more effective in clinical testing. Further, molnupiravir carries a cancer risk and could lead to birth defects in unborn children.</p><p><blockquote>FDA授权Ridgeback Biotherapeutics合作的药丸在其他选择不可用或不合适时紧急使用。<b>辉瑞</b>(PFE)的两片疗法Paxlovid也获得了授权。Paxlovid在临床测试中被证明更有效。此外，molnupiravir具有癌症风险，并可能导致未出生儿童的出生缺陷。</blockquote></p><p> Merck's molnupiravir cut the risk of Covid-related hospitalizations or death by 30% when patients began treatment within five days of symptoms appearing. Paxlovid reduced the same risk by 89% for patients who began treatment within three days of symptom onset.</p><p><blockquote>当患者在症状出现后五天内开始治疗时，默克公司的molnupiravir将与Covid相关的住院或死亡风险降低了30%。对于症状出现后三天内开始治疗的患者，Paxlovid将相同的风险降低了89%。</blockquote></p><p> Merck stock is well off highs it achieved in November. Bullishly, the company beat third-quarter expectations and offered an upbeat 2021 outlook that didn't include the potential impact of the antiviral pill. Molnupiravir is also allowed in the U.K. and Japan.</p><p><blockquote>默克股价远低于11月份达到的高点。乐观的是，该公司超出了第三季度的预期，并提供了乐观的2021年前景，其中不包括抗病毒药物的潜在影响。Molnupiravir在英国和日本也被允许。</blockquote></p><p> Merck expects to produce 10 million courses of molnupiravir this year and at least 20 million in 2022. It has supply agreements in place with more than 30 countries worldwide, including the U.S.</p><p><blockquote>默沙东预计今年将生产1000万个疗程的molnupiravir，2022年至少生产2000万个疗程。它与包括美国在内的全球30多个国家签订了供应协议。</blockquote></p><p> So, all in all, is Merck stock a buy or a sell right now?</p><p><blockquote>那么，总而言之，默克股票现在是买入还是卖出？</blockquote></p><p> <b>Merck Stock Fundamentals: Sales Top</b></p><p><blockquote><b>默克股票基本面：销售额最高</b></blockquote></p><p> During the third quarter, adjusted earnings climbed 28% to $1.75 per share and sales soared 20% to $13.15 billion. Both metrics beat forecasts.</p><p><blockquote>第三季度，调整后收益增长28%至每股1.75美元，销售额飙升20%至131.5亿美元。这两项指标都超出了预期。</blockquote></p><p> Merck also provided guidance following its&nbsp;<b>Organon</b>(OGN) spinoff. The pharma company boosted its full-year outlook to adjusted profit of $5.65-$5.70 per share on $47.4 billion to $47.9 billion in sales. Both measures topped expectations. And they don't include the potential for molnupiravir to gain authorizations in the U.S. or Europe.</p><p><blockquote>默克公司还提供了指导<b>欧加农</b>（OGN）分拆。该制药公司将全年调整后利润预期上调至每股5.65美元至5.70美元，销售额为474亿美元至479亿美元。两项指标均超出预期。而且它们不包括莫努匹拉韦在美国或欧洲获得授权的潜力。</blockquote></p><p> The company's biggest single drug remains cancer treatment Keytruda. Keytruda accounted for more than a third of total third-quarter sales. Keytruda sales increased 22% to $4.53 billion. Sales of its human papillomavirus vaccine, Gardasil, soared 68% to $1.99 billion.</p><p><blockquote>该公司最大的单一药物仍然是癌症治疗药物Keytruda。Keytruda占第三季度总销售额的三分之一以上。Keytruda销售额增长22%，达到45.3亿美元。其人乳头瘤病毒疫苗Gardasil的销售额飙升68%，达到19.9亿美元。</blockquote></p><p> But revenue from diabetes med Januvia fell 1% to $1.34 billion. And Merck reported a 26% decline for its pneumonia vaccine, Pneumovax 23, as Covid vaccines took priority in the U.S.</p><p><blockquote>但糖尿病药物Januvia的收入下降了1%，至13.4亿美元。默克公司报告称，由于新冠疫苗在美国占据优先地位，其肺炎疫苗Pneumovax 23的销量下降了26%。</blockquote></p><p> Overall, third-quarter metrics were in line withCAN SLIM rules for investing,which advise investors to look for companies with recent quarterly growth of 20%-25%, or better.</p><p><blockquote>总体而言，第三季度的指标符合CAN SLIM投资规则，该规则建议投资者寻找近期季度增长率为20%-25%或更高的公司。</blockquote></p><p> In the current quarter, analysts polled by FactSet expect Merck to earn $1.52 per share on $13.16 billion in sales. On a year-over-year basis, earnings would surge about 21% and sales would rise north of 5%.</p><p><blockquote>FactSet调查的分析师预计默克本季度每股收益为1.52美元，销售额为131.6亿美元。与去年同期相比，盈利将飙升约21%，销售额将增长5%以上。</blockquote></p><p> <b>What Do Annual Metrics Say About Merck?</b></p><p><blockquote><b>年度指标对默克有何影响？</b></blockquote></p><p> As Dec. 27, Merck stock was down slightly for the year. Shares recently hit at least a three-decade high, but have since tumbled.</p><p><blockquote>截至12月27日，默克股价年内小幅下跌。股价最近创下至少三年来的新高，但此后一直在下跌。</blockquote></p><p> Last year, Merck's sales grew 2.5% to $47.99 billion. That decelerated from 11% growth in 2019.</p><p><blockquote>去年，默克的销售额增长了2.5%，达到479.9亿美元。这一增长率较2019年11%的增长率有所放缓。</blockquote></p><p> For 2021, analysts expect sales to rise a fraction to $48.44 billion. Income is projected to inch 2.8% higher to $5.82 a share. That follows 14% growth in 2020.</p><p><blockquote>分析师预计2021年销售额将小幅增长至484.4亿美元。收入预计将增长2.8%，达到每股5.82美元。此前，2020年将增长14%。</blockquote></p><p> The stock ranks 6th by&nbsp;Composite Rating&nbsp;in the industry group of pharma companies. The 33-company Medical-Ethical Drugs group ranks No. 51 out of 197 groups tracked by Investor's Business Daily.</p><p><blockquote>该股在制药公司行业中的综合评级排名第六。由33家公司组成的医德药品集团在《投资者商报》追踪的197家集团中排名第51位。</blockquote></p><p> <b>Technical Analysis Of The Pharmaceutical Company</b></p><p><blockquote><b>制药公司的技术分析</b></blockquote></p><p> Merck stock has a&nbsp;Composite Rating&nbsp;of 81 out of a best-possible 99. The CR is a measure of a stock's key growth metrics over the past 12 months. This puts Merck stock within the top 19% of all stocks, regardless of industry group.</p><p><blockquote>默克股票的综合评级为81分（满分为99分）。CR是衡量股票过去12个月关键增长指标的指标。这使得默克股票在所有股票中排名前19%，无论行业类别如何。</blockquote></p><p> Shares also have a&nbsp;Relative Strength Rating&nbsp;of 57, reflecting the 12-month performance of Merck stock. This means the pharmaceutical stock ranks beneath the top one-third all stocks in terms of performance.</p><p><blockquote>股票的相对强度评级也为57，反映了默克股票12个月的表现。这意味着该医药股的业绩排名低于所有股票的前三分之一。</blockquote></p><p> It's also key to watch chart patterns. Merck stock broke out of a&nbsp;flat base&nbsp;with abuy point&nbsp;at 79.33 on Oct. 1, according to&nbsp;MarketSmith.com. But shares fell as much as 7% below their entry on Nov. 30. That triggered a sell signal. Investors are&nbsp;encouraged to sell&nbsp;when a stock is 7%-8% below its entry.</p><p><blockquote>观察图表模式也很关键。根据MarketSmith.com的数据，默克股价在10月1日突破了一个平盘，买入点为79.33点。但股价较11月30日入场时下跌了7%。这触发了卖出信号。当股票比进场价低7%-8%时，鼓励投资者卖出。</blockquote></p><p> Merck stock also recently undercut its&nbsp;50-day&nbsp;and&nbsp;200-day&nbsp;moving averages. Both are sell signals.</p><p><blockquote>默克股票最近也跌破了50日和200日移动平均线。两者都是卖出信号。</blockquote></p><p> <b>Merck Stock News: Merck Grabs Covid Deal</b></p><p><blockquote><b>默克股票新闻：默克获得新冠协议</b></blockquote></p><p> Merck's molnupiravir is now authorized in the U.S., U.K. and Japan.</p><p><blockquote>默克公司的molnupiravir现已在美国、英国和日本获得授权。</blockquote></p><p> In addition to Merck and Pfizer,<b>Atea Pharmaceuticals</b>(AVIR) and&nbsp;<b>Enanta Pharmaceuticals</b>(ENTA) working on oral Covid drugs.<b>Roche</b>(RHHBY) recently pulled out of its deal with Atea for the Covid antiviral.</p><p><blockquote>除了默沙东和辉瑞，<b>Atea制药公司</b>（AVIR）和<b>Enanta制药</b>(ENTA)正在研究口服新冠药物。<b>罗氏</b>(RHHBY)最近退出了与Atea的Covid抗病毒药物交易。</blockquote></p><p> Analysts say the pills could offer an easier route for non-hospitalized treatment of Covid than antibody drugs from&nbsp;<b>Regeneron Pharmaceuticals</b>(REGN),<b>Eli Lilly</b>(LLY) and&nbsp;<b>Vir Biotechnology</b>(VIR). Antibody drugs must be given by health care professionals.</p><p><blockquote>分析师表示，与抗体药物相比，这些药物可能为新冠病毒的非住院治疗提供更容易的途径<b>再生元制药</b>（REGN），<b>礼来公司</b>（LLY）及<b>维尔生物技术</b>（来）。抗体药物必须由卫生保健专业人员给予。</blockquote></p><p></p><p> But there is some concern that the way molnupiravir works could introduce mutations into the DNA of an unborn baby. So, FDA advisors waffled on whether to recommend its use for pregnant women.</p><p><blockquote>但有人担心莫努匹拉韦的作用方式可能会给未出生婴儿的DNA带来突变。因此，FDA顾问对是否推荐孕妇使用它犹豫不决。</blockquote></p><p> Bearishly, the FDA placed a study testing an HIV prevention drug, islatravir, on clinical hold. Several patients showed decreased in key immune cells. Merck and&nbsp;<b>Gilead Sciences</b>(GILD) also decided to stop testing a regimen of islatravir and Gilead's lenacapavir in HIV patients.</p><p><blockquote>悲观的是，FDA暂停了一项测试艾滋病毒预防药物islatravir的研究。一些患者显示关键免疫细胞减少。默克和<b>吉利德科学</b>（GILD）也决定停止在HIV患者中测试islatravir和吉利德的lenacapavir的一种方案。</blockquote></p><p> Merck also recently finished acquiring Acceleron.</p><p><blockquote>默克最近也完成了对Acceleron的收购。</blockquote></p><p> In early March, President Joe Biden announced Merck would help<b>Johnson &amp; Johnson</b>(JNJ) produce its Covid vaccine. Merck will receive $268.8 million from the Biomedical Advanced Research and Development Authority to help expand facility space to do so.</p><p><blockquote>三月初，乔·拜登总统宣布默克公司将提供帮助<b>强生公司</b>(JNJ)生产其新冠疫苗。默克公司将从生物医学高级研究与发展局获得2.688亿美元，以帮助扩大设施空间。</blockquote></p><p> <b>Is Merck Stock A Buy Now?</b></p><p><blockquote><b>默克股票现在值得买入吗？</b></blockquote></p><p> Based on CAN SLIM rules for investing, no, Merck stock is not a buy right now. Shares have round-tripped their earlier breakout and have triggered several sell signals.</p><p><blockquote>根据CAN SLIM投资规则，不，默克股票目前不值得买入。股价已经反复突破了之前的突破，并引发了多个卖出信号。</blockquote></p><p> There are further caveats. Both Merck's sales and earnings met CAN SLIM guidelines in the third quarter. Sales aren't expected to meet that mark in the current quarter.</p><p><blockquote>还有进一步的警告。默克公司第三季度的销售额和盈利都可能低于预期。预计本季度的销售额不会达到这一目标。</blockquote></p><p> Still, big stocks like Merck can add gains without hitting massive growth streaks.</p><p><blockquote>尽管如此，像默克这样的大型股票可以在不实现大幅增长的情况下增加涨幅。</blockquote></p><p></p>","source":"lsy1610449120050","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Is Merck Stock A Buy Or Sell After FDA Authorizes Its Covid Pill?<blockquote>FDA批准默克公司的新冠药物后，默克公司的股票是买入还是卖出？</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIs Merck Stock A Buy Or Sell After FDA Authorizes Its Covid Pill?<blockquote>FDA批准默克公司的新冠药物后，默克公司的股票是买入还是卖出？</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Investors</strong><span class=\"h-time small\">2021-12-28 08:47</span>\n</p>\n</h4>\n</header>\n<article>\n<p>The Food and Drug Administration authorized&nbsp;<b>Merck</b>'s (MRK) antiviral Covid pill, molnupiravir. But Merck stock remains under pressure.</p><p><blockquote>食品药品监督管理局授权<b>默克</b>(MRK)的抗病毒新冠药物莫努匹拉韦。但默克股票仍面临压力。</blockquote></p><p> The FDA authorized the Ridgeback Biotherapeutics-partnered pill for emergency use when other options aren't available or appropriate.<b>Pfizer</b>(PFE) also gained authorization for its two-pill regimen, Paxlovid. Paxlovid proved more effective in clinical testing. Further, molnupiravir carries a cancer risk and could lead to birth defects in unborn children.</p><p><blockquote>FDA授权Ridgeback Biotherapeutics合作的药丸在其他选择不可用或不合适时紧急使用。<b>辉瑞</b>(PFE)的两片疗法Paxlovid也获得了授权。Paxlovid在临床测试中被证明更有效。此外，molnupiravir具有癌症风险，并可能导致未出生儿童的出生缺陷。</blockquote></p><p> Merck's molnupiravir cut the risk of Covid-related hospitalizations or death by 30% when patients began treatment within five days of symptoms appearing. Paxlovid reduced the same risk by 89% for patients who began treatment within three days of symptom onset.</p><p><blockquote>当患者在症状出现后五天内开始治疗时，默克公司的molnupiravir将与Covid相关的住院或死亡风险降低了30%。对于症状出现后三天内开始治疗的患者，Paxlovid将相同的风险降低了89%。</blockquote></p><p> Merck stock is well off highs it achieved in November. Bullishly, the company beat third-quarter expectations and offered an upbeat 2021 outlook that didn't include the potential impact of the antiviral pill. Molnupiravir is also allowed in the U.K. and Japan.</p><p><blockquote>默克股价远低于11月份达到的高点。乐观的是，该公司超出了第三季度的预期，并提供了乐观的2021年前景，其中不包括抗病毒药物的潜在影响。Molnupiravir在英国和日本也被允许。</blockquote></p><p> Merck expects to produce 10 million courses of molnupiravir this year and at least 20 million in 2022. It has supply agreements in place with more than 30 countries worldwide, including the U.S.</p><p><blockquote>默沙东预计今年将生产1000万个疗程的molnupiravir，2022年至少生产2000万个疗程。它与包括美国在内的全球30多个国家签订了供应协议。</blockquote></p><p> So, all in all, is Merck stock a buy or a sell right now?</p><p><blockquote>那么，总而言之，默克股票现在是买入还是卖出？</blockquote></p><p> <b>Merck Stock Fundamentals: Sales Top</b></p><p><blockquote><b>默克股票基本面：销售额最高</b></blockquote></p><p> During the third quarter, adjusted earnings climbed 28% to $1.75 per share and sales soared 20% to $13.15 billion. Both metrics beat forecasts.</p><p><blockquote>第三季度，调整后收益增长28%至每股1.75美元，销售额飙升20%至131.5亿美元。这两项指标都超出了预期。</blockquote></p><p> Merck also provided guidance following its&nbsp;<b>Organon</b>(OGN) spinoff. The pharma company boosted its full-year outlook to adjusted profit of $5.65-$5.70 per share on $47.4 billion to $47.9 billion in sales. Both measures topped expectations. And they don't include the potential for molnupiravir to gain authorizations in the U.S. or Europe.</p><p><blockquote>默克公司还提供了指导<b>欧加农</b>（OGN）分拆。该制药公司将全年调整后利润预期上调至每股5.65美元至5.70美元，销售额为474亿美元至479亿美元。两项指标均超出预期。而且它们不包括莫努匹拉韦在美国或欧洲获得授权的潜力。</blockquote></p><p> The company's biggest single drug remains cancer treatment Keytruda. Keytruda accounted for more than a third of total third-quarter sales. Keytruda sales increased 22% to $4.53 billion. Sales of its human papillomavirus vaccine, Gardasil, soared 68% to $1.99 billion.</p><p><blockquote>该公司最大的单一药物仍然是癌症治疗药物Keytruda。Keytruda占第三季度总销售额的三分之一以上。Keytruda销售额增长22%，达到45.3亿美元。其人乳头瘤病毒疫苗Gardasil的销售额飙升68%，达到19.9亿美元。</blockquote></p><p> But revenue from diabetes med Januvia fell 1% to $1.34 billion. And Merck reported a 26% decline for its pneumonia vaccine, Pneumovax 23, as Covid vaccines took priority in the U.S.</p><p><blockquote>但糖尿病药物Januvia的收入下降了1%，至13.4亿美元。默克公司报告称，由于新冠疫苗在美国占据优先地位，其肺炎疫苗Pneumovax 23的销量下降了26%。</blockquote></p><p> Overall, third-quarter metrics were in line withCAN SLIM rules for investing,which advise investors to look for companies with recent quarterly growth of 20%-25%, or better.</p><p><blockquote>总体而言，第三季度的指标符合CAN SLIM投资规则，该规则建议投资者寻找近期季度增长率为20%-25%或更高的公司。</blockquote></p><p> In the current quarter, analysts polled by FactSet expect Merck to earn $1.52 per share on $13.16 billion in sales. On a year-over-year basis, earnings would surge about 21% and sales would rise north of 5%.</p><p><blockquote>FactSet调查的分析师预计默克本季度每股收益为1.52美元，销售额为131.6亿美元。与去年同期相比，盈利将飙升约21%，销售额将增长5%以上。</blockquote></p><p> <b>What Do Annual Metrics Say About Merck?</b></p><p><blockquote><b>年度指标对默克有何影响？</b></blockquote></p><p> As Dec. 27, Merck stock was down slightly for the year. Shares recently hit at least a three-decade high, but have since tumbled.</p><p><blockquote>截至12月27日，默克股价年内小幅下跌。股价最近创下至少三年来的新高，但此后一直在下跌。</blockquote></p><p> Last year, Merck's sales grew 2.5% to $47.99 billion. That decelerated from 11% growth in 2019.</p><p><blockquote>去年，默克的销售额增长了2.5%，达到479.9亿美元。这一增长率较2019年11%的增长率有所放缓。</blockquote></p><p> For 2021, analysts expect sales to rise a fraction to $48.44 billion. Income is projected to inch 2.8% higher to $5.82 a share. That follows 14% growth in 2020.</p><p><blockquote>分析师预计2021年销售额将小幅增长至484.4亿美元。收入预计将增长2.8%，达到每股5.82美元。此前，2020年将增长14%。</blockquote></p><p> The stock ranks 6th by&nbsp;Composite Rating&nbsp;in the industry group of pharma companies. The 33-company Medical-Ethical Drugs group ranks No. 51 out of 197 groups tracked by Investor's Business Daily.</p><p><blockquote>该股在制药公司行业中的综合评级排名第六。由33家公司组成的医德药品集团在《投资者商报》追踪的197家集团中排名第51位。</blockquote></p><p> <b>Technical Analysis Of The Pharmaceutical Company</b></p><p><blockquote><b>制药公司的技术分析</b></blockquote></p><p> Merck stock has a&nbsp;Composite Rating&nbsp;of 81 out of a best-possible 99. The CR is a measure of a stock's key growth metrics over the past 12 months. This puts Merck stock within the top 19% of all stocks, regardless of industry group.</p><p><blockquote>默克股票的综合评级为81分（满分为99分）。CR是衡量股票过去12个月关键增长指标的指标。这使得默克股票在所有股票中排名前19%，无论行业类别如何。</blockquote></p><p> Shares also have a&nbsp;Relative Strength Rating&nbsp;of 57, reflecting the 12-month performance of Merck stock. This means the pharmaceutical stock ranks beneath the top one-third all stocks in terms of performance.</p><p><blockquote>股票的相对强度评级也为57，反映了默克股票12个月的表现。这意味着该医药股的业绩排名低于所有股票的前三分之一。</blockquote></p><p> It's also key to watch chart patterns. Merck stock broke out of a&nbsp;flat base&nbsp;with abuy point&nbsp;at 79.33 on Oct. 1, according to&nbsp;MarketSmith.com. But shares fell as much as 7% below their entry on Nov. 30. That triggered a sell signal. Investors are&nbsp;encouraged to sell&nbsp;when a stock is 7%-8% below its entry.</p><p><blockquote>观察图表模式也很关键。根据MarketSmith.com的数据，默克股价在10月1日突破了一个平盘，买入点为79.33点。但股价较11月30日入场时下跌了7%。这触发了卖出信号。当股票比进场价低7%-8%时，鼓励投资者卖出。</blockquote></p><p> Merck stock also recently undercut its&nbsp;50-day&nbsp;and&nbsp;200-day&nbsp;moving averages. Both are sell signals.</p><p><blockquote>默克股票最近也跌破了50日和200日移动平均线。两者都是卖出信号。</blockquote></p><p> <b>Merck Stock News: Merck Grabs Covid Deal</b></p><p><blockquote><b>默克股票新闻：默克获得新冠协议</b></blockquote></p><p> Merck's molnupiravir is now authorized in the U.S., U.K. and Japan.</p><p><blockquote>默克公司的molnupiravir现已在美国、英国和日本获得授权。</blockquote></p><p> In addition to Merck and Pfizer,<b>Atea Pharmaceuticals</b>(AVIR) and&nbsp;<b>Enanta Pharmaceuticals</b>(ENTA) working on oral Covid drugs.<b>Roche</b>(RHHBY) recently pulled out of its deal with Atea for the Covid antiviral.</p><p><blockquote>除了默沙东和辉瑞，<b>Atea制药公司</b>（AVIR）和<b>Enanta制药</b>(ENTA)正在研究口服新冠药物。<b>罗氏</b>(RHHBY)最近退出了与Atea的Covid抗病毒药物交易。</blockquote></p><p> Analysts say the pills could offer an easier route for non-hospitalized treatment of Covid than antibody drugs from&nbsp;<b>Regeneron Pharmaceuticals</b>(REGN),<b>Eli Lilly</b>(LLY) and&nbsp;<b>Vir Biotechnology</b>(VIR). Antibody drugs must be given by health care professionals.</p><p><blockquote>分析师表示，与抗体药物相比，这些药物可能为新冠病毒的非住院治疗提供更容易的途径<b>再生元制药</b>（REGN），<b>礼来公司</b>（LLY）及<b>维尔生物技术</b>（来）。抗体药物必须由卫生保健专业人员给予。</blockquote></p><p></p><p> But there is some concern that the way molnupiravir works could introduce mutations into the DNA of an unborn baby. So, FDA advisors waffled on whether to recommend its use for pregnant women.</p><p><blockquote>但有人担心莫努匹拉韦的作用方式可能会给未出生婴儿的DNA带来突变。因此，FDA顾问对是否推荐孕妇使用它犹豫不决。</blockquote></p><p> Bearishly, the FDA placed a study testing an HIV prevention drug, islatravir, on clinical hold. Several patients showed decreased in key immune cells. Merck and&nbsp;<b>Gilead Sciences</b>(GILD) also decided to stop testing a regimen of islatravir and Gilead's lenacapavir in HIV patients.</p><p><blockquote>悲观的是，FDA暂停了一项测试艾滋病毒预防药物islatravir的研究。一些患者显示关键免疫细胞减少。默克和<b>吉利德科学</b>（GILD）也决定停止在HIV患者中测试islatravir和吉利德的lenacapavir的一种方案。</blockquote></p><p> Merck also recently finished acquiring Acceleron.</p><p><blockquote>默克最近也完成了对Acceleron的收购。</blockquote></p><p> In early March, President Joe Biden announced Merck would help<b>Johnson &amp; Johnson</b>(JNJ) produce its Covid vaccine. Merck will receive $268.8 million from the Biomedical Advanced Research and Development Authority to help expand facility space to do so.</p><p><blockquote>三月初，乔·拜登总统宣布默克公司将提供帮助<b>强生公司</b>(JNJ)生产其新冠疫苗。默克公司将从生物医学高级研究与发展局获得2.688亿美元，以帮助扩大设施空间。</blockquote></p><p> <b>Is Merck Stock A Buy Now?</b></p><p><blockquote><b>默克股票现在值得买入吗？</b></blockquote></p><p> Based on CAN SLIM rules for investing, no, Merck stock is not a buy right now. Shares have round-tripped their earlier breakout and have triggered several sell signals.</p><p><blockquote>根据CAN SLIM投资规则，不，默克股票目前不值得买入。股价已经反复突破了之前的突破，并引发了多个卖出信号。</blockquote></p><p> There are further caveats. Both Merck's sales and earnings met CAN SLIM guidelines in the third quarter. Sales aren't expected to meet that mark in the current quarter.</p><p><blockquote>还有进一步的警告。默克公司第三季度的销售额和盈利都可能低于预期。预计本季度的销售额不会达到这一目标。</blockquote></p><p> Still, big stocks like Merck can add gains without hitting massive growth streaks.</p><p><blockquote>尽管如此，像默克这样的大型股票可以在不实现大幅增长的情况下增加涨幅。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.investors.com/news/technology/merck-stock-buy-now/?src=A00220\">Investors</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRK":"默沙东"},"source_url":"https://www.investors.com/news/technology/merck-stock-buy-now/?src=A00220","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1156481741","content_text":"The Food and Drug Administration authorized Merck's (MRK) antiviral Covid pill, molnupiravir. But Merck stock remains under pressure.\nThe FDA authorized the Ridgeback Biotherapeutics-partnered pill for emergency use when other options aren't available or appropriate.Pfizer(PFE) also gained authorization for its two-pill regimen, Paxlovid. Paxlovid proved more effective in clinical testing. Further, molnupiravir carries a cancer risk and could lead to birth defects in unborn children.\nMerck's molnupiravir cut the risk of Covid-related hospitalizations or death by 30% when patients began treatment within five days of symptoms appearing. Paxlovid reduced the same risk by 89% for patients who began treatment within three days of symptom onset.\nMerck stock is well off highs it achieved in November. Bullishly, the company beat third-quarter expectations and offered an upbeat 2021 outlook that didn't include the potential impact of the antiviral pill. Molnupiravir is also allowed in the U.K. and Japan.\nMerck expects to produce 10 million courses of molnupiravir this year and at least 20 million in 2022. It has supply agreements in place with more than 30 countries worldwide, including the U.S.\nSo, all in all, is Merck stock a buy or a sell right now?\nMerck Stock Fundamentals: Sales Top\nDuring the third quarter, adjusted earnings climbed 28% to $1.75 per share and sales soared 20% to $13.15 billion. Both metrics beat forecasts.\nMerck also provided guidance following its Organon(OGN) spinoff. The pharma company boosted its full-year outlook to adjusted profit of $5.65-$5.70 per share on $47.4 billion to $47.9 billion in sales. Both measures topped expectations. And they don't include the potential for molnupiravir to gain authorizations in the U.S. or Europe.\nThe company's biggest single drug remains cancer treatment Keytruda. Keytruda accounted for more than a third of total third-quarter sales. Keytruda sales increased 22% to $4.53 billion. Sales of its human papillomavirus vaccine, Gardasil, soared 68% to $1.99 billion.\nBut revenue from diabetes med Januvia fell 1% to $1.34 billion. And Merck reported a 26% decline for its pneumonia vaccine, Pneumovax 23, as Covid vaccines took priority in the U.S.\nOverall, third-quarter metrics were in line withCAN SLIM rules for investing,which advise investors to look for companies with recent quarterly growth of 20%-25%, or better.\nIn the current quarter, analysts polled by FactSet expect Merck to earn $1.52 per share on $13.16 billion in sales. On a year-over-year basis, earnings would surge about 21% and sales would rise north of 5%.\nWhat Do Annual Metrics Say About Merck?\nAs Dec. 27, Merck stock was down slightly for the year. Shares recently hit at least a three-decade high, but have since tumbled.\nLast year, Merck's sales grew 2.5% to $47.99 billion. That decelerated from 11% growth in 2019.\nFor 2021, analysts expect sales to rise a fraction to $48.44 billion. Income is projected to inch 2.8% higher to $5.82 a share. That follows 14% growth in 2020.\nThe stock ranks 6th by Composite Rating in the industry group of pharma companies. The 33-company Medical-Ethical Drugs group ranks No. 51 out of 197 groups tracked by Investor's Business Daily.\nTechnical Analysis Of The Pharmaceutical Company\nMerck stock has a Composite Rating of 81 out of a best-possible 99. The CR is a measure of a stock's key growth metrics over the past 12 months. This puts Merck stock within the top 19% of all stocks, regardless of industry group.\nShares also have a Relative Strength Rating of 57, reflecting the 12-month performance of Merck stock. This means the pharmaceutical stock ranks beneath the top one-third all stocks in terms of performance.\nIt's also key to watch chart patterns. Merck stock broke out of a flat base with abuy point at 79.33 on Oct. 1, according to MarketSmith.com. But shares fell as much as 7% below their entry on Nov. 30. That triggered a sell signal. Investors are encouraged to sell when a stock is 7%-8% below its entry.\nMerck stock also recently undercut its 50-day and 200-day moving averages. Both are sell signals.\nMerck Stock News: Merck Grabs Covid Deal\nMerck's molnupiravir is now authorized in the U.S., U.K. and Japan.\nIn addition to Merck and Pfizer,Atea Pharmaceuticals(AVIR) and Enanta Pharmaceuticals(ENTA) working on oral Covid drugs.Roche(RHHBY) recently pulled out of its deal with Atea for the Covid antiviral.\nAnalysts say the pills could offer an easier route for non-hospitalized treatment of Covid than antibody drugs from Regeneron Pharmaceuticals(REGN),Eli Lilly(LLY) and Vir Biotechnology(VIR). Antibody drugs must be given by health care professionals.\nBut there is some concern that the way molnupiravir works could introduce mutations into the DNA of an unborn baby. So, FDA advisors waffled on whether to recommend its use for pregnant women.\nBearishly, the FDA placed a study testing an HIV prevention drug, islatravir, on clinical hold. Several patients showed decreased in key immune cells. Merck and Gilead Sciences(GILD) also decided to stop testing a regimen of islatravir and Gilead's lenacapavir in HIV patients.\nMerck also recently finished acquiring Acceleron.\nIn early March, President Joe Biden announced Merck would helpJohnson & Johnson(JNJ) produce its Covid vaccine. Merck will receive $268.8 million from the Biomedical Advanced Research and Development Authority to help expand facility space to do so.\nIs Merck Stock A Buy Now?\nBased on CAN SLIM rules for investing, no, Merck stock is not a buy right now. Shares have round-tripped their earlier breakout and have triggered several sell signals.\nThere are further caveats. Both Merck's sales and earnings met CAN SLIM guidelines in the third quarter. Sales aren't expected to meet that mark in the current quarter.\nStill, big stocks like Merck can add gains without hitting massive growth streaks.","news_type":1,"symbols_score_info":{"MRK":0.9}},"isVote":1,"tweetType":1,"viewCount":4064,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":696079293,"gmtCreate":1640585931325,"gmtModify":1640585931504,"author":{"id":"3586129577058331","authorId":"3586129577058331","name":"1a327e37","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586129577058331","idStr":"3586129577058331"},"themes":[],"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/696079293","repostId":"2194177239","repostType":4,"repost":{"id":"2194177239","kind":"news","pubTimestamp":1640559609,"share":"https://www.laohu8.com/m/news/2194177239?lang=zh_CN&edition=full","pubTime":"2021-12-27 07:00","market":"us","language":"en","title":"Santa Claus Rally watch: What to know this week<blockquote>圣诞老人集会观察：本周需要了解什么</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=2194177239","media":"Yahoo Finance","summary":"As traders return from the holiday-shortened week, the price action heading into the new year will be closely monitored — especially given the relatively light economic data and earnings calendar for the coming days.The S&P 500  is entering the period known for ushering in the so-called Santa Claus Rally, or seasonally strong timeframe for stocks at the end of each year.According to data from LPL Financial, the Santa Claus Rally period encapsulates the seven days most likely to be higher in any ","content":"<p><div> As traders return from the holiday-shortened week, the price action heading into the new year will be closely monitored — especially given the relatively light economic data and earnings calendar for ...</p><p><blockquote><div>随着交易员从假期缩短的一周中回归，进入新的一年的价格走势将受到密切关注——特别是考虑到相对清淡的经济数据和收益日历...</div></blockquote></p><p>  <a href=\"https://finance.yahoo.com/news/santa-claus-rally-watch-what-to-know-this-week-142909627.html\">网页链接</a>  </div> </p><p><blockquote><a href=\"https://finance.yahoo.com/news/santa-claus-rally-watch-what-to-know-this-week-142909627.html\">网页连接</a></blockquote></p><p></p>","source":"yahoofinance_au","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Santa Claus Rally watch: What to know this week<blockquote>圣诞老人集会观察：本周需要了解什么</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSanta Claus Rally watch: What to know this week<blockquote>圣诞老人集会观察：本周需要了解什么</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Yahoo Finance</strong><span class=\"h-time small\">2021-12-27 07:00</span>\n</p>\n</h4>\n</header>\n<article>\n<p><div> As traders return from the holiday-shortened week, the price action heading into the new year will be closely monitored — especially given the relatively light economic data and earnings calendar for ...</p><p><blockquote><div>随着交易员从假期缩短的一周中回归，进入新的一年的价格走势将受到密切关注——特别是考虑到相对清淡的经济数据和收益日历...</div></blockquote></p><p>  <a href=\"https://finance.yahoo.com/news/santa-claus-rally-watch-what-to-know-this-week-142909627.html\">网页链接</a>  </div> </p><p><blockquote><a href=\"https://finance.yahoo.com/news/santa-claus-rally-watch-what-to-know-this-week-142909627.html\">网页连接</a></blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://finance.yahoo.com/news/santa-claus-rally-watch-what-to-know-this-week-142909627.html\">Yahoo Finance</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4096":"电气部件与设备","FCEL":"燃料电池能源","BK4541":"氢能源","SPY.AU":"SPDR® S&P 500® ETF Trust"},"source_url":"https://finance.yahoo.com/news/santa-claus-rally-watch-what-to-know-this-week-142909627.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2194177239","content_text":"As traders return from the holiday-shortened week, the price action heading into the new year will be closely monitored — especially given the relatively light economic data and earnings calendar for the coming days.\nThe S&P 500 (^GSPC) is entering the period known for ushering in the so-called Santa Claus Rally, or seasonally strong timeframe for stocks at the end of each year.\nThe term, coined by Stock Trader's Almanac in the 1970s, encompasses the final five trading days of the year and first two sessions of the new year. This year, that Santa Claus Rally window is set to start on Monday, Dec. 27 — or the latest a Santa Claus rally has started in 11 years, due to the timing of the holidays this year.\nAccording to data from LPL Financial, the Santa Claus Rally period encapsulates the seven days most likely to be higher in any given year. Since 1950, the Santa Claus Rally period has produced a positive return for the S&P 500 78.9% of the time, with an average return of 1.33%.\n“Why are these seven days so strong?” wrote Ryan Detrick, LPL Financial chief market strategist, in a note. “Whether optimism over a coming new year, holiday spending, traders on vacation, institutions squaring up their books — or the holiday spirit — the bottom line is that bulls tend to believe in Santa.”\nAnd if history is any indication, the absence of a Santa Claus Rally has also typically served as a harbinger of lower near-term returns.\n\"Going back to the mid-1990s, there have been only six times Santa failed to show in December. January was lower five of those six times, and the full year had a solid gain only once (in 2016, but a mini-bear market early in the year),\" Detrick added.\n“Considering the bear markets of 2000 and 2008 both took place after one of the rare instances that Santa failed to show makes believers out of us,\" he said. A bear market typically refers to when stocks drop at least 20% from recent record highs. \"Should this seasonally strong period miss the mark, it could be a warning sign.\"\nAnd this year, investors do have considerable additional concerns to mull heading into the new year. Though stocks closed out Thursday's session at fresh record highs before the long holiday weekend, December still marked a volatile month to start, with renewed concerns over the Omicron variant and the potential for tighter monetary policy from the Federal Reserve weighing on risk assets. Plus, prospects for more near-term fiscal support via the Biden administration's Build Back Better bill have dwindled, and inflation concerns spiked further. Last week, the Bureau of Economic Analysis reported core personal consumption expenditures (PCE) — the Fed's preferred inflation gauge — rose at a 4.7% year-over-year clip, or the fastest since 1983.\n\"If the U.S. was not battling the Omicron variant, U.S. stocks would be dancing higher as the Santa Claus Rally would have kept the climb going into uncharted territory,\" Edward Moya, chief market strategist at OANDA, wrote in a note last week. \"It is too early to say for sure if we will get a Santa Claus Rally, but given all the short-term risks of Fed tightening, Chinese weakness, fiscal support uncertainty and COVID, Wall Street is not complaining.\"\nA man in a Santa Claus costume gestures on the floor at the closing bell of the Dow Industrial Average at the New York Stock Exchange on December 5, 2019 in New York. (Photo by Bryan R. Smith / AFP) (Photo by BRYAN R. SMITH/AFP via Getty Images)BRYAN R. SMITH via Getty Images\nEconomic calendar\n\nMonday: Dallas Federal Reserve Manufacturing Activity Index, Dec. (13.0 expected, 11.8 in November)\nTuesday: FHFA House Price Index, month-over-month, October (0.9% in September); S&P CoreLogic Case-Shiller 20 City Composite Index, month-over-month, October (0.9% expected, 0.96% in September); S&P CoreLogic Case-Shiller 20 City Composite Index, year-over-year, October (18.6%. expected, 19.05% in September); S&P CoreLogic Case-Shiller Home Price Index, year-over-year, November (19.51% in October); Richmond Fed Manufacturing Index, December (11 expected,11 in November)\nWednesday: Wholesale Inventories, month-over-month, November preliminary (1.7% expected, 2.3% in October); Advance Goods Trade Balance, November (-$89.0 billion expected, -$82.9 billion in October); Retail Inventories, month-over-month, November (0.5% expected, 0.1% in October); Pending Home Sales, month-over-month, November (0.5% expected, 7.5% in October)\nThursday: Initial jobless claims, week ended Dec. 25. (205,000 during prior week); Continuing claims, week ended Dec. 18 (1.859 million during prior week); MNI Chicago PMI, December (62.2 expected, 61.8 in November)\nFriday: No notable reports scheduled for release\n\nEarnings calendar\n\nMonday: No notable reports scheduled for release\nTuesday: No notable reports scheduled for release\nWednesday: FuelCell Energy Inc. (FCEL) before market open\nThursday: No notable reports scheduled for release\nFriday: No notable reports scheduled for release","news_type":1,"symbols_score_info":{"FCEL":0.9,"SPY.AU":0.9}},"isVote":1,"tweetType":1,"viewCount":3266,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698243183,"gmtCreate":1640420556660,"gmtModify":1640420556847,"author":{"id":"3586129577058331","authorId":"3586129577058331","name":"1a327e37","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586129577058331","idStr":"3586129577058331"},"themes":[],"htmlText":"Ik","listText":"Ik","text":"Ik","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/698243183","repostId":"2193917872","repostType":4,"isVote":1,"tweetType":1,"viewCount":3183,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698106756,"gmtCreate":1640312839363,"gmtModify":1640313787557,"author":{"id":"3586129577058331","authorId":"3586129577058331","name":"1a327e37","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586129577058331","idStr":"3586129577058331"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/698106756","repostId":"1168865278","repostType":4,"repost":{"id":"1168865278","kind":"news","pubTimestamp":1640311666,"share":"https://www.laohu8.com/m/news/1168865278?lang=zh_CN&edition=full","pubTime":"2021-12-24 10:07","market":"us","language":"en","title":"Can Apple Stock Hit New Highs by Year's End?<blockquote>苹果股价能否在年底前创下新高？</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1168865278","media":"TheStreet","summary":"Apple stock is higher on Thursday and could try to make a push to records before the end of the year","content":"<p>Apple stock is higher on Thursday and could try to make a push to records before the end of the year.</p><p><blockquote>苹果股价周四走高，并可能试图在年底前突破纪录。</blockquote></p><p> Apple&nbsp;shares earlier this month were a market leader, but over the past few trading sessions, they've wobbled.</p><p><blockquote>本月早些时候，苹果的股价是市场领导者，但在过去几个交易日中，它们出现了波动。</blockquote></p><p> As the overall market continued to sway with volatility, Apple was a beacon of strength.&nbsp;We were lucky with Apple stock. In fact, incredibly lucky.</p><p><blockquote>由于整体市场继续波动，苹果是力量的灯塔。我们对苹果股票很幸运。事实上，非常幸运。</blockquote></p><p> On Dec. 13 the Cupertino, Calif., tech giant was&nbsp;approaching a $3 trillion valuation. But I wrote about the potential sell-the-news&nbsp;bearish reversal that was in play. The stock then posted five daily losses in a six-session span.</p><p><blockquote>12月13日，这家位于加州库比蒂诺的科技巨头的估值接近3万亿美元。但我写了潜在的抛售新闻看跌逆转。随后，该股在六个交易日内连续五次下跌。</blockquote></p><p> Apple has now begun to find its footing.</p><p><blockquote>苹果现在已经开始站稳脚跟。</blockquote></p><p> It was recently reported that Apple was a massive buyer of its own stock last quarter — which is no surprise given its buyback commitment —as it led the S&amp;P 500.</p><p><blockquote>最近有报道称，苹果上个季度是自己股票的大量买家——考虑到其回购承诺，这并不奇怪——因为它引领了标普500。</blockquote></p><p> Now bulls are wondering if all that buying will eventually pay off. Let’s look at the charts.</p><p><blockquote>现在多头想知道所有的购买最终是否会得到回报。让我们看看图表。</blockquote></p><p> <b>Trading Apple Stock</b></p><p><blockquote><b>交易苹果股票</b></blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/6865ca6e0def05bb2a060b2af13be892\" tg-width=\"1139\" tg-height=\"866\" width=\"100%\" height=\"auto\"><span>Daily chart of Apple stock.</span></p><p><blockquote><p class=\"t-img-caption\"><span>苹果股票日线图。</span></p></blockquote></p><p> This morning&nbsp;I had Apple on my radar. Why? It’s simple.</p><p><blockquote>今天早上我注意到了苹果。为什么？很简单。</blockquote></p><p> Look at the way shares of Apple closed lower on Friday and Monday, but both times rallied from the open. We know that by the look of the candle.</p><p><blockquote>看看苹果股价周五和周一收盘走低，但两次开盘均上涨。我们从蜡烛的样子就知道了。</blockquote></p><p> Rather than a filled-in, deep-red candle (like Thursday, Dec. 16), we have two hollow&nbsp; red candles. That shows us a higher close from the open, even though the stock ended lower on the day. In other words, bulls were buying the opening dips.</p><p><blockquote>我们有两根空心的红色蜡烛，而不是一根填充的深红色蜡烛（就像12月16日星期四）。这向我们表明，尽管该股当天收盘走低，但收盘价较开盘走高。换句话说，多头在开盘时逢低买入。</blockquote></p><p> Further, Apple stock was holding the 21-day moving average.</p><p><blockquote>此外，苹果股价守住21日移动平均线。</blockquote></p><p> With yesterday’s bounce, Apple not only rallied off the 21-day moving average, it closed above the 10-day moving average.</p><p><blockquote>随着昨天的反弹，苹果不仅从21日移动均线反弹，收盘也高于10日移动均线。</blockquote></p><p> That had traders looking for a daily-up rotation over Tuesday’s high, at $173.20.</p><p><blockquote>这使得交易员希望在周二高点173.20美元的基础上每日上涨。</blockquote></p><p> From here I want to see whether Apple stock can continue to push higher. It’s above all its major daily moving averages.</p><p><blockquote>从这里我想看看苹果股票能否继续走高。它高于所有主要的每日移动平均线。</blockquote></p><p> If it does continue higher, downtrend resistance and the $179.50 area are in play. Twice, Apple has failed on its push over $180. So if it does make a run higher, we want to be cognizant of this zone.</p><p><blockquote>如果它确实继续走高，则下降趋势阻力和179.50美元区域正在发挥作用。苹果两次突破180美元的努力都失败了。因此，如果它确实走高，我们希望认识到这个区域。</blockquote></p><p> Above $180 opens the door to the all-time high, at $182.13. Above that and we can start talking about the $188 to $194 zone, where Apple&nbsp;finds a few upside extensions.</p><p><blockquote>高于180美元将为182.13美元的历史高点打开大门。在此之上，我们可以开始谈论188美元至194美元区域，苹果在该区域发现了一些上行延伸。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Can Apple Stock Hit New Highs by Year's End?<blockquote>苹果股价能否在年底前创下新高？</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCan Apple Stock Hit New Highs by Year's End?<blockquote>苹果股价能否在年底前创下新高？</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">TheStreet</strong><span class=\"h-time small\">2021-12-24 10:07</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Apple stock is higher on Thursday and could try to make a push to records before the end of the year.</p><p><blockquote>苹果股价周四走高，并可能试图在年底前突破纪录。</blockquote></p><p> Apple&nbsp;shares earlier this month were a market leader, but over the past few trading sessions, they've wobbled.</p><p><blockquote>本月早些时候，苹果的股价是市场领导者，但在过去几个交易日中，它们出现了波动。</blockquote></p><p> As the overall market continued to sway with volatility, Apple was a beacon of strength.&nbsp;We were lucky with Apple stock. In fact, incredibly lucky.</p><p><blockquote>由于整体市场继续波动，苹果是力量的灯塔。我们对苹果股票很幸运。事实上，非常幸运。</blockquote></p><p> On Dec. 13 the Cupertino, Calif., tech giant was&nbsp;approaching a $3 trillion valuation. But I wrote about the potential sell-the-news&nbsp;bearish reversal that was in play. The stock then posted five daily losses in a six-session span.</p><p><blockquote>12月13日，这家位于加州库比蒂诺的科技巨头的估值接近3万亿美元。但我写了潜在的抛售新闻看跌逆转。随后，该股在六个交易日内连续五次下跌。</blockquote></p><p> Apple has now begun to find its footing.</p><p><blockquote>苹果现在已经开始站稳脚跟。</blockquote></p><p> It was recently reported that Apple was a massive buyer of its own stock last quarter — which is no surprise given its buyback commitment —as it led the S&amp;P 500.</p><p><blockquote>最近有报道称，苹果上个季度是自己股票的大量买家——考虑到其回购承诺，这并不奇怪——因为它引领了标普500。</blockquote></p><p> Now bulls are wondering if all that buying will eventually pay off. Let’s look at the charts.</p><p><blockquote>现在多头想知道所有的购买最终是否会得到回报。让我们看看图表。</blockquote></p><p> <b>Trading Apple Stock</b></p><p><blockquote><b>交易苹果股票</b></blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/6865ca6e0def05bb2a060b2af13be892\" tg-width=\"1139\" tg-height=\"866\" width=\"100%\" height=\"auto\"><span>Daily chart of Apple stock.</span></p><p><blockquote><p class=\"t-img-caption\"><span>苹果股票日线图。</span></p></blockquote></p><p> This morning&nbsp;I had Apple on my radar. Why? It’s simple.</p><p><blockquote>今天早上我注意到了苹果。为什么？很简单。</blockquote></p><p> Look at the way shares of Apple closed lower on Friday and Monday, but both times rallied from the open. We know that by the look of the candle.</p><p><blockquote>看看苹果股价周五和周一收盘走低，但两次开盘均上涨。我们从蜡烛的样子就知道了。</blockquote></p><p> Rather than a filled-in, deep-red candle (like Thursday, Dec. 16), we have two hollow&nbsp; red candles. That shows us a higher close from the open, even though the stock ended lower on the day. In other words, bulls were buying the opening dips.</p><p><blockquote>我们有两根空心的红色蜡烛，而不是一根填充的深红色蜡烛（就像12月16日星期四）。这向我们表明，尽管该股当天收盘走低，但收盘价较开盘走高。换句话说，多头在开盘时逢低买入。</blockquote></p><p> Further, Apple stock was holding the 21-day moving average.</p><p><blockquote>此外，苹果股价守住21日移动平均线。</blockquote></p><p> With yesterday’s bounce, Apple not only rallied off the 21-day moving average, it closed above the 10-day moving average.</p><p><blockquote>随着昨天的反弹，苹果不仅从21日移动均线反弹，收盘也高于10日移动均线。</blockquote></p><p> That had traders looking for a daily-up rotation over Tuesday’s high, at $173.20.</p><p><blockquote>这使得交易员希望在周二高点173.20美元的基础上每日上涨。</blockquote></p><p> From here I want to see whether Apple stock can continue to push higher. It’s above all its major daily moving averages.</p><p><blockquote>从这里我想看看苹果股票能否继续走高。它高于所有主要的每日移动平均线。</blockquote></p><p> If it does continue higher, downtrend resistance and the $179.50 area are in play. Twice, Apple has failed on its push over $180. So if it does make a run higher, we want to be cognizant of this zone.</p><p><blockquote>如果它确实继续走高，则下降趋势阻力和179.50美元区域正在发挥作用。苹果两次突破180美元的努力都失败了。因此，如果它确实走高，我们希望认识到这个区域。</blockquote></p><p> Above $180 opens the door to the all-time high, at $182.13. Above that and we can start talking about the $188 to $194 zone, where Apple&nbsp;finds a few upside extensions.</p><p><blockquote>高于180美元将为182.13美元的历史高点打开大门。在此之上，我们可以开始谈论188美元至194美元区域，苹果在该区域发现了一些上行延伸。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.thestreet.com/investing/trading-apple-aapl-stock-new-highs-before-year-end-december-2021\">TheStreet</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"source_url":"https://www.thestreet.com/investing/trading-apple-aapl-stock-new-highs-before-year-end-december-2021","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1168865278","content_text":"Apple stock is higher on Thursday and could try to make a push to records before the end of the year.\nApple shares earlier this month were a market leader, but over the past few trading sessions, they've wobbled.\nAs the overall market continued to sway with volatility, Apple was a beacon of strength. We were lucky with Apple stock. In fact, incredibly lucky.\nOn Dec. 13 the Cupertino, Calif., tech giant was approaching a $3 trillion valuation. But I wrote about the potential sell-the-news bearish reversal that was in play. The stock then posted five daily losses in a six-session span.\nApple has now begun to find its footing.\nIt was recently reported that Apple was a massive buyer of its own stock last quarter — which is no surprise given its buyback commitment —as it led the S&P 500.\nNow bulls are wondering if all that buying will eventually pay off. Let’s look at the charts.\nTrading Apple Stock\nDaily chart of Apple stock.\nThis morning I had Apple on my radar. Why? It’s simple.\nLook at the way shares of Apple closed lower on Friday and Monday, but both times rallied from the open. We know that by the look of the candle.\nRather than a filled-in, deep-red candle (like Thursday, Dec. 16), we have two hollow  red candles. That shows us a higher close from the open, even though the stock ended lower on the day. In other words, bulls were buying the opening dips.\nFurther, Apple stock was holding the 21-day moving average.\nWith yesterday’s bounce, Apple not only rallied off the 21-day moving average, it closed above the 10-day moving average.\nThat had traders looking for a daily-up rotation over Tuesday’s high, at $173.20.\nFrom here I want to see whether Apple stock can continue to push higher. It’s above all its major daily moving averages.\nIf it does continue higher, downtrend resistance and the $179.50 area are in play. Twice, Apple has failed on its push over $180. So if it does make a run higher, we want to be cognizant of this zone.\nAbove $180 opens the door to the all-time high, at $182.13. Above that and we can start talking about the $188 to $194 zone, where Apple finds a few upside extensions.","news_type":1,"symbols_score_info":{"AAPL":0.9}},"isVote":1,"tweetType":1,"viewCount":3540,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":691598752,"gmtCreate":1640218291070,"gmtModify":1640218291222,"author":{"id":"3586129577058331","authorId":"3586129577058331","name":"1a327e37","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586129577058331","idStr":"3586129577058331"},"themes":[],"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/691598752","repostId":"2193511315","repostType":4,"isVote":1,"tweetType":1,"viewCount":3551,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":693947302,"gmtCreate":1639965038003,"gmtModify":1639965417989,"author":{"id":"3586129577058331","authorId":"3586129577058331","name":"1a327e37","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586129577058331","idStr":"3586129577058331"},"themes":[],"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/693947302","repostId":"2192096049","repostType":4,"isVote":1,"tweetType":1,"viewCount":4437,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":699757555,"gmtCreate":1639909859095,"gmtModify":1639909859267,"author":{"id":"3586129577058331","authorId":"3586129577058331","name":"1a327e37","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586129577058331","idStr":"3586129577058331"},"themes":[],"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/699757555","repostId":"2192976991","repostType":4,"isVote":1,"tweetType":1,"viewCount":3968,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":699518088,"gmtCreate":1639837572679,"gmtModify":1639837572876,"author":{"id":"3586129577058331","authorId":"3586129577058331","name":"1a327e37","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586129577058331","idStr":"3586129577058331"},"themes":[],"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/699518088","repostId":"1189235922","repostType":4,"repost":{"id":"1189235922","kind":"news","pubTimestamp":1639809269,"share":"https://www.laohu8.com/m/news/1189235922?lang=zh_CN&edition=full","pubTime":"2021-12-18 14:34","market":"us","language":"en","title":"DaVita authorizes additional $2B share repurchase<blockquote>DaVita授权额外回购20亿美元股票</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1189235922","media":"Seeking Alpha","summary":"DaVita  Board of Directors increased the authorization under the existing share repurchase program b","content":"<p><a href=\"https://laohu8.com/S/DVA\">DaVita </a> Board of Directors increased the authorization under the existing share repurchase program by $2B in additional repurchasing authority.</p><p><blockquote><a href=\"https://laohu8.com/S/DVA\">达维塔</a>董事会将现有股票回购计划下的授权增加了20亿美元的额外回购授权。</blockquote></p><p> The amount of shares authorized to be repurchased under the new authorization does not include the amount remaining under the company’s existing share repurchase program authorized on December 10, 2020 .</p><p><blockquote>根据新授权授权回购的股份金额不包括2020年12月10日授权的公司现有股份回购计划下剩余的金额。</blockquote></p><p> Some bearish commentary and rating on the stock by SA contributor who writes: 'The company appears to be overvalued, and there are several challenges facing the company in the future.'</p><p><blockquote>SA撰稿人对该股发表了一些看跌评论和评级，他写道：“该公司似乎被高估，该公司未来面临几项挑战。”</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>DaVita authorizes additional $2B share repurchase<blockquote>DaVita授权额外回购20亿美元股票</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDaVita authorizes additional $2B share repurchase<blockquote>DaVita授权额外回购20亿美元股票</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Seeking Alpha</strong><span class=\"h-time small\">2021-12-18 14:34</span>\n</p>\n</h4>\n</header>\n<article>\n<p><a href=\"https://laohu8.com/S/DVA\">DaVita </a> Board of Directors increased the authorization under the existing share repurchase program by $2B in additional repurchasing authority.</p><p><blockquote><a href=\"https://laohu8.com/S/DVA\">达维塔</a>董事会将现有股票回购计划下的授权增加了20亿美元的额外回购授权。</blockquote></p><p> The amount of shares authorized to be repurchased under the new authorization does not include the amount remaining under the company’s existing share repurchase program authorized on December 10, 2020 .</p><p><blockquote>根据新授权授权回购的股份金额不包括2020年12月10日授权的公司现有股份回购计划下剩余的金额。</blockquote></p><p> Some bearish commentary and rating on the stock by SA contributor who writes: 'The company appears to be overvalued, and there are several challenges facing the company in the future.'</p><p><blockquote>SA撰稿人对该股发表了一些看跌评论和评级，他写道：“该公司似乎被高估，该公司未来面临几项挑战。”</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://seekingalpha.com/news/3781473-davita-authorizes-additional-2b-share-repurchase\">Seeking Alpha</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"DVA":"达维塔保健"},"source_url":"https://seekingalpha.com/news/3781473-davita-authorizes-additional-2b-share-repurchase","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1189235922","content_text":"DaVita  Board of Directors increased the authorization under the existing share repurchase program by $2B in additional repurchasing authority.\nThe amount of shares authorized to be repurchased under the new authorization does not include the amount remaining under the company’s existing share repurchase program authorized on December 10, 2020 .\nSome bearish commentary and rating on the stock by SA contributor who writes: 'The company appears to be overvalued, and there are several challenges facing the company in the future.'","news_type":1,"symbols_score_info":{"DVA":0.9}},"isVote":1,"tweetType":1,"viewCount":3506,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":690525322,"gmtCreate":1639695992888,"gmtModify":1639695993033,"author":{"id":"3586129577058331","authorId":"3586129577058331","name":"1a327e37","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586129577058331","idStr":"3586129577058331"},"themes":[],"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/690525322","repostId":"1108384523","repostType":4,"repost":{"id":"1108384523","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639667369,"share":"https://www.laohu8.com/m/news/1108384523?lang=zh_CN&edition=full","pubTime":"2021-12-16 23:09","market":"us","language":"en","title":"Vir Biotechnology continued to gain over 7% in morning trading after showing neutralizing activity against omicron<blockquote>Vir Biotechnology在显示出对奥密克戎的中和活性后，早盘继续上涨超过7%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1108384523","media":"Tiger Newspress","summary":"Vir Biotechnology continued to gain over 7% in morning trading after showing neutralizing activity a","content":"<p>Vir Biotechnology continued to gain over 7% in morning trading after showing neutralizing activity against omicron.<img src=\"https://static.tigerbbs.com/07fe5a6b831322eef2c479861ad70527\" tg-width=\"766\" tg-height=\"563\" width=\"100%\" height=\"auto\">The company&nbsp;announced&nbsp;new preclinical data, published to the preprint server&nbsp;bioRxiv, demonstrating the impact of the significant antigenic shift of the new COVID-19 omicron variant (B.1.1.529).&nbsp;</p><p><blockquote>Vir Biotechnology在显示出对奥密克戎的中和活性后，在早盘交易中继续上涨超过7%。该公司宣布了新的临床前数据，发布到预印本服务器bioRxiv，证明了新的COVID-19奥密克戎变种（B.1.1.529）的显著抗原转变的影响。</blockquote></p><p> A significant reduction in plasma neutralizing activity was observed against omicron in sera from vaccinated and convalescent individuals.&nbsp;</p><p><blockquote>在接种疫苗和恢复期个体的血清中观察到针对奥密克戎的血浆中和活性显著降低。</blockquote></p><p> Researchers also tested the in vitro neutralizing activity of 44 monoclonal antibodies (mAbs) (eight of which are currently authorized or approved).&nbsp;</p><p><blockquote>研究人员还测试了44种单克隆抗体（mAb）的体外中和活性（其中8种目前已获得授权或批准）。</blockquote></p><p> Data demonstrate that sotrovimab and five other preclinical mAbs, developed by Vir in conjunction with&nbsp;GlaxoSmithKline plc&nbsp;(NYSE:&nbsp;GSK), retained their in vitro neutralizing activity against omicron.</p><p><blockquote>数据显示，由Vir与葛兰素史克公司（纽约证券交易所股票代码：GSK）联合开发的sotrovimab和其他五种临床前单克隆抗体保留了对奥密克戎病的体外中和活性。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Vir Biotechnology continued to gain over 7% in morning trading after showing neutralizing activity against omicron<blockquote>Vir Biotechnology在显示出对奥密克戎的中和活性后，早盘继续上涨超过7%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVir Biotechnology continued to gain over 7% in morning trading after showing neutralizing activity against omicron<blockquote>Vir Biotechnology在显示出对奥密克戎的中和活性后，早盘继续上涨超过7%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-12-16 23:09</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Vir Biotechnology continued to gain over 7% in morning trading after showing neutralizing activity against omicron.<img src=\"https://static.tigerbbs.com/07fe5a6b831322eef2c479861ad70527\" tg-width=\"766\" tg-height=\"563\" width=\"100%\" height=\"auto\">The company&nbsp;announced&nbsp;new preclinical data, published to the preprint server&nbsp;bioRxiv, demonstrating the impact of the significant antigenic shift of the new COVID-19 omicron variant (B.1.1.529).&nbsp;</p><p><blockquote>Vir Biotechnology在显示出对奥密克戎的中和活性后，在早盘交易中继续上涨超过7%。该公司宣布了新的临床前数据，发布到预印本服务器bioRxiv，证明了新的COVID-19奥密克戎变种（B.1.1.529）的显著抗原转变的影响。</blockquote></p><p> A significant reduction in plasma neutralizing activity was observed against omicron in sera from vaccinated and convalescent individuals.&nbsp;</p><p><blockquote>在接种疫苗和恢复期个体的血清中观察到针对奥密克戎的血浆中和活性显著降低。</blockquote></p><p> Researchers also tested the in vitro neutralizing activity of 44 monoclonal antibodies (mAbs) (eight of which are currently authorized or approved).&nbsp;</p><p><blockquote>研究人员还测试了44种单克隆抗体（mAb）的体外中和活性（其中8种目前已获得授权或批准）。</blockquote></p><p> Data demonstrate that sotrovimab and five other preclinical mAbs, developed by Vir in conjunction with&nbsp;GlaxoSmithKline plc&nbsp;(NYSE:&nbsp;GSK), retained their in vitro neutralizing activity against omicron.</p><p><blockquote>数据显示，由Vir与葛兰素史克公司（纽约证券交易所股票代码：GSK）联合开发的sotrovimab和其他五种临床前单克隆抗体保留了对奥密克戎病的体外中和活性。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VIR":"Vir Biotechnology, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1108384523","content_text":"Vir Biotechnology continued to gain over 7% in morning trading after showing neutralizing activity against omicron.The company announced new preclinical data, published to the preprint server bioRxiv, demonstrating the impact of the significant antigenic shift of the new COVID-19 omicron variant (B.1.1.529). \nA significant reduction in plasma neutralizing activity was observed against omicron in sera from vaccinated and convalescent individuals. \nResearchers also tested the in vitro neutralizing activity of 44 monoclonal antibodies (mAbs) (eight of which are currently authorized or approved). \nData demonstrate that sotrovimab and five other preclinical mAbs, developed by Vir in conjunction with GlaxoSmithKline plc (NYSE: GSK), retained their in vitro neutralizing activity against omicron.","news_type":1,"symbols_score_info":{"VIR":0.9}},"isVote":1,"tweetType":1,"viewCount":768,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607745114,"gmtCreate":1639609461527,"gmtModify":1639609461661,"author":{"id":"3586129577058331","authorId":"3586129577058331","name":"1a327e37","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586129577058331","idStr":"3586129577058331"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/607745114","repostId":"2191994940","repostType":4,"isVote":1,"tweetType":1,"viewCount":810,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607855252,"gmtCreate":1639527702313,"gmtModify":1639527702622,"author":{"id":"3586129577058331","authorId":"3586129577058331","name":"1a327e37","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586129577058331","idStr":"3586129577058331"},"themes":[],"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/607855252","repostId":"1197497046","repostType":4,"repost":{"id":"1197497046","kind":"news","pubTimestamp":1639526704,"share":"https://www.laohu8.com/m/news/1197497046?lang=zh_CN&edition=full","pubTime":"2021-12-15 08:05","market":"sg","language":"en","title":"Renewed Selling Pressure Likely For Singapore Stock Market<blockquote>新加坡股市可能面临新的抛售压力</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1197497046","media":"RTTNews","summary":"The Singapore stock market on Tuesday wrote a finish to the two-day slide in which it had fallen mor","content":"<p>The Singapore stock market on Tuesday wrote a finish to the two-day slide in which it had fallen more than 20 points or 0.7 percent. The Straits Times Index now sits just above the 3,120-point plateau although it figures to head south again on Wednesday.</p><p><blockquote>新加坡股市周二结束了连续两天的下跌，跌幅超过20点或0.7%。海峡时报指数目前略高于3,120点的高位，尽管预计周三将再次下跌。</blockquote></p><p> The global forecast for the Asian&nbsp;markets&nbsp;is soft on interest rate and COVID-19 concerns, with oil and technology stocks again expected to lead the way lower. The European and U.S. markets were down and the Asian markets figure to follow suit.</p><p><blockquote>由于利率和新冠肺炎担忧，全球对亚洲市场的预测疲软，石油和科技股预计将再次领跌。欧洲和美国市场下跌，亚洲市场预计也会效仿。</blockquote></p><p> The STI finished barely higher on Tuesday following gains from the properties and mixed performances from the financial shares.</p><p><blockquote>继房地产股上涨和金融股表现好坏参半后，海指周二收盘小幅走高。</blockquote></p><p> For the day, the index rose 1.14 points or 0.04 percent to finish at 3,121.09 after trading between 3,114.43 and 3,128.80. Volume was 1.15 billion shares worth 819.5 million Singapore dollars. There were 268 decliners and 176 gainers.</p><p><blockquote>当天，该指数在3,114.43至3,128.80之间交易后，上涨1.14点或0.04%，收于3,121.09点。成交量为11.5亿股，价值8.195亿新元。下跌股268家，上涨股176家。</blockquote></p><p> Among the actives, CapitaLand Integrated Commercial Trust jumped 0.90 percent, while City Developments climbed 0.85 percent, Comfort DelGro shed 0.72 percent, Dairy Farm International plummeted 2.03 percent, Genting Singapore lost 0.64 percent, Mapletree Commercial Trust added 0.49 percent, Oversea-Chinese Banking Corporation rose 0.18 percent, SATS tumbled 0.77 percent, Singapore Airlines fell 0.60 percent, Singapore Technologies Engineering slid 0.53 percent, Thai Beverage dropped 0.74 percent, United Overseas Bank collected 0.34 percent, Wilmar International added 0.24 percent, Yangzijiang Shipbuilding sank 0.76 percent and Mapletree Logistics Trust, Keppel Corp, DBS Group, Ascendas REIT, SembCorp Industries, Singapore Exchange, Singapore Press Holdings and SingTel were unchanged.</p><p><blockquote>活跃股中，凯德综合商业信托上涨0.90%，City Developments上涨0.85%，Comfort DelGro下跌0.72%，Dairy Farm International暴跌2.03%，云顶新加坡下跌0.64%，丰树商业信托上涨0.49%，华侨银行上涨0.18%，新航集团下跌0.77%，新加坡科技工程下跌0.53%，泰国饮料下跌0.74%，大华银行上涨0.34%，丰益国际上涨0.24%，扬子江造船下跌0.76%，丰树物流信托、吉宝企业、星展集团、腾飞房地产投资信托、胜科工业、新加坡交易所、新加坡报业控股和新加坡电信持平。</blockquote></p><p> The lead from Wall Street is negative as the major averages spent most of the day in the red, although they finished off session lows.</p><p><blockquote>华尔街的领先是负面的，因为主要股指全天大部分时间都处于亏损状态，尽管它们收盘于盘中低点。</blockquote></p><p> The Dow skidded 106.77 points or 0.30 percent to finish at 35,544.18, while the NASDAQ tumbled 175.64 points or 1.14 percent to end at 15,237.64 and the S&amp;P 500 sank 34.88 points or 0.75 percent to close at 4,634.09.</p><p><blockquote>道琼斯指数下跌106.77点或0.30%，收于35,544.18点；纳斯达克下跌175.64点或1.14%，收于15,237.64点；标普500下跌34.88点或0.75%，收于4,634.09点。</blockquote></p><p> Concerns about the outlook for monetary policy continued to weigh on the markets as the Federal Reserve's two-day meeting got underway. With inflation remaining at an elevated rate, the Fed is widely expected to accelerate its timetable for reducing bond purchases.</p><p><blockquote>随着美联储为期两天的会议开始，对货币政策前景的担忧继续打压市场。由于通胀仍处于高位，外界普遍预计美联储将加快缩减购债的时间表。</blockquote></p><p> Potentially adding to concerns about monetary policy, the Labor Department released a report showing producer prices increased by more than expected in November.</p><p><blockquote>美国劳工部发布的一份报告显示，11月份生产者价格涨幅超过预期，这可能会加剧人们对货币政策的担忧。</blockquote></p><p> Lingering worries about the new Omicron variant of the&nbsp;coronavirus&nbsp;may also have generated some selling pressure after the World Health Organization warned the new variant is spreading faster than previous strains.</p><p><blockquote>在世界卫生组织警告新变种病毒传播速度快于以前的毒株后，对新冠病毒奥密克戎变种挥之不去的担忧也可能产生了一些抛售压力。</blockquote></p><p> Crude oil futures dipped Tuesday on concerns about the outlook for energy demand due to renewed restrictions amid rising new cases of the Omicron variant of the coronavirus. West Texas Intermediate Crude oil futures for January ended down by $0.56 or 0.8 percent at $70.73 a barrel.</p><p><blockquote>由于奥密克戎变种冠状病毒新病例不断增加，新的限制措施导致人们对能源需求前景感到担忧，原油期货周二下跌。西德克萨斯中质原油1月期货收跌0.56美元或0.8%，报每桶70.73美元。</blockquote></p><p> Closer to home, Singapore will provide Q3 numbers for unemployment later today; in the three months prior, the jobless rate was 2.7 percent.</p><p><blockquote>言归正传，新加坡将于今天晚些时候提供第三季度失业数据；在此之前的三个月里，失业率为2.7%。</blockquote></p><p></p>","source":"lsy1626938412129","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Renewed Selling Pressure Likely For Singapore Stock Market<blockquote>新加坡股市可能面临新的抛售压力</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRenewed Selling Pressure Likely For Singapore Stock Market<blockquote>新加坡股市可能面临新的抛售压力</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">RTTNews</strong><span class=\"h-time small\">2021-12-15 08:05</span>\n</p>\n</h4>\n</header>\n<article>\n<p>The Singapore stock market on Tuesday wrote a finish to the two-day slide in which it had fallen more than 20 points or 0.7 percent. The Straits Times Index now sits just above the 3,120-point plateau although it figures to head south again on Wednesday.</p><p><blockquote>新加坡股市周二结束了连续两天的下跌，跌幅超过20点或0.7%。海峡时报指数目前略高于3,120点的高位，尽管预计周三将再次下跌。</blockquote></p><p> The global forecast for the Asian&nbsp;markets&nbsp;is soft on interest rate and COVID-19 concerns, with oil and technology stocks again expected to lead the way lower. The European and U.S. markets were down and the Asian markets figure to follow suit.</p><p><blockquote>由于利率和新冠肺炎担忧，全球对亚洲市场的预测疲软，石油和科技股预计将再次领跌。欧洲和美国市场下跌，亚洲市场预计也会效仿。</blockquote></p><p> The STI finished barely higher on Tuesday following gains from the properties and mixed performances from the financial shares.</p><p><blockquote>继房地产股上涨和金融股表现好坏参半后，海指周二收盘小幅走高。</blockquote></p><p> For the day, the index rose 1.14 points or 0.04 percent to finish at 3,121.09 after trading between 3,114.43 and 3,128.80. Volume was 1.15 billion shares worth 819.5 million Singapore dollars. There were 268 decliners and 176 gainers.</p><p><blockquote>当天，该指数在3,114.43至3,128.80之间交易后，上涨1.14点或0.04%，收于3,121.09点。成交量为11.5亿股，价值8.195亿新元。下跌股268家，上涨股176家。</blockquote></p><p> Among the actives, CapitaLand Integrated Commercial Trust jumped 0.90 percent, while City Developments climbed 0.85 percent, Comfort DelGro shed 0.72 percent, Dairy Farm International plummeted 2.03 percent, Genting Singapore lost 0.64 percent, Mapletree Commercial Trust added 0.49 percent, Oversea-Chinese Banking Corporation rose 0.18 percent, SATS tumbled 0.77 percent, Singapore Airlines fell 0.60 percent, Singapore Technologies Engineering slid 0.53 percent, Thai Beverage dropped 0.74 percent, United Overseas Bank collected 0.34 percent, Wilmar International added 0.24 percent, Yangzijiang Shipbuilding sank 0.76 percent and Mapletree Logistics Trust, Keppel Corp, DBS Group, Ascendas REIT, SembCorp Industries, Singapore Exchange, Singapore Press Holdings and SingTel were unchanged.</p><p><blockquote>活跃股中，凯德综合商业信托上涨0.90%，City Developments上涨0.85%，Comfort DelGro下跌0.72%，Dairy Farm International暴跌2.03%，云顶新加坡下跌0.64%，丰树商业信托上涨0.49%，华侨银行上涨0.18%，新航集团下跌0.77%，新加坡科技工程下跌0.53%，泰国饮料下跌0.74%，大华银行上涨0.34%，丰益国际上涨0.24%，扬子江造船下跌0.76%，丰树物流信托、吉宝企业、星展集团、腾飞房地产投资信托、胜科工业、新加坡交易所、新加坡报业控股和新加坡电信持平。</blockquote></p><p> The lead from Wall Street is negative as the major averages spent most of the day in the red, although they finished off session lows.</p><p><blockquote>华尔街的领先是负面的，因为主要股指全天大部分时间都处于亏损状态，尽管它们收盘于盘中低点。</blockquote></p><p> The Dow skidded 106.77 points or 0.30 percent to finish at 35,544.18, while the NASDAQ tumbled 175.64 points or 1.14 percent to end at 15,237.64 and the S&amp;P 500 sank 34.88 points or 0.75 percent to close at 4,634.09.</p><p><blockquote>道琼斯指数下跌106.77点或0.30%，收于35,544.18点；纳斯达克下跌175.64点或1.14%，收于15,237.64点；标普500下跌34.88点或0.75%，收于4,634.09点。</blockquote></p><p> Concerns about the outlook for monetary policy continued to weigh on the markets as the Federal Reserve's two-day meeting got underway. With inflation remaining at an elevated rate, the Fed is widely expected to accelerate its timetable for reducing bond purchases.</p><p><blockquote>随着美联储为期两天的会议开始，对货币政策前景的担忧继续打压市场。由于通胀仍处于高位，外界普遍预计美联储将加快缩减购债的时间表。</blockquote></p><p> Potentially adding to concerns about monetary policy, the Labor Department released a report showing producer prices increased by more than expected in November.</p><p><blockquote>美国劳工部发布的一份报告显示，11月份生产者价格涨幅超过预期，这可能会加剧人们对货币政策的担忧。</blockquote></p><p> Lingering worries about the new Omicron variant of the&nbsp;coronavirus&nbsp;may also have generated some selling pressure after the World Health Organization warned the new variant is spreading faster than previous strains.</p><p><blockquote>在世界卫生组织警告新变种病毒传播速度快于以前的毒株后，对新冠病毒奥密克戎变种挥之不去的担忧也可能产生了一些抛售压力。</blockquote></p><p> Crude oil futures dipped Tuesday on concerns about the outlook for energy demand due to renewed restrictions amid rising new cases of the Omicron variant of the coronavirus. West Texas Intermediate Crude oil futures for January ended down by $0.56 or 0.8 percent at $70.73 a barrel.</p><p><blockquote>由于奥密克戎变种冠状病毒新病例不断增加，新的限制措施导致人们对能源需求前景感到担忧，原油期货周二下跌。西德克萨斯中质原油1月期货收跌0.56美元或0.8%，报每桶70.73美元。</blockquote></p><p> Closer to home, Singapore will provide Q3 numbers for unemployment later today; in the three months prior, the jobless rate was 2.7 percent.</p><p><blockquote>言归正传，新加坡将于今天晚些时候提供第三季度失业数据；在此之前的三个月里，失业率为2.7%。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.rttnews.com/3249255/renewed-selling-pressure-likely-for-singapore-stock-market.aspx?type=acom\">RTTNews</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"STI.SI":"富时新加坡海峡指数"},"source_url":"https://www.rttnews.com/3249255/renewed-selling-pressure-likely-for-singapore-stock-market.aspx?type=acom","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1197497046","content_text":"The Singapore stock market on Tuesday wrote a finish to the two-day slide in which it had fallen more than 20 points or 0.7 percent. The Straits Times Index now sits just above the 3,120-point plateau although it figures to head south again on Wednesday.\nThe global forecast for the Asian markets is soft on interest rate and COVID-19 concerns, with oil and technology stocks again expected to lead the way lower. The European and U.S. markets were down and the Asian markets figure to follow suit.\nThe STI finished barely higher on Tuesday following gains from the properties and mixed performances from the financial shares.\nFor the day, the index rose 1.14 points or 0.04 percent to finish at 3,121.09 after trading between 3,114.43 and 3,128.80. Volume was 1.15 billion shares worth 819.5 million Singapore dollars. There were 268 decliners and 176 gainers.\nAmong the actives, CapitaLand Integrated Commercial Trust jumped 0.90 percent, while City Developments climbed 0.85 percent, Comfort DelGro shed 0.72 percent, Dairy Farm International plummeted 2.03 percent, Genting Singapore lost 0.64 percent, Mapletree Commercial Trust added 0.49 percent, Oversea-Chinese Banking Corporation rose 0.18 percent, SATS tumbled 0.77 percent, Singapore Airlines fell 0.60 percent, Singapore Technologies Engineering slid 0.53 percent, Thai Beverage dropped 0.74 percent, United Overseas Bank collected 0.34 percent, Wilmar International added 0.24 percent, Yangzijiang Shipbuilding sank 0.76 percent and Mapletree Logistics Trust, Keppel Corp, DBS Group, Ascendas REIT, SembCorp Industries, Singapore Exchange, Singapore Press Holdings and SingTel were unchanged.\nThe lead from Wall Street is negative as the major averages spent most of the day in the red, although they finished off session lows.\nThe Dow skidded 106.77 points or 0.30 percent to finish at 35,544.18, while the NASDAQ tumbled 175.64 points or 1.14 percent to end at 15,237.64 and the S&P 500 sank 34.88 points or 0.75 percent to close at 4,634.09.\nConcerns about the outlook for monetary policy continued to weigh on the markets as the Federal Reserve's two-day meeting got underway. With inflation remaining at an elevated rate, the Fed is widely expected to accelerate its timetable for reducing bond purchases.\nPotentially adding to concerns about monetary policy, the Labor Department released a report showing producer prices increased by more than expected in November.\nLingering worries about the new Omicron variant of the coronavirus may also have generated some selling pressure after the World Health Organization warned the new variant is spreading faster than previous strains.\nCrude oil futures dipped Tuesday on concerns about the outlook for energy demand due to renewed restrictions amid rising new cases of the Omicron variant of the coronavirus. West Texas Intermediate Crude oil futures for January ended down by $0.56 or 0.8 percent at $70.73 a barrel.\nCloser to home, Singapore will provide Q3 numbers for unemployment later today; in the three months prior, the jobless rate was 2.7 percent.","news_type":1,"symbols_score_info":{"STI.SI":0.9}},"isVote":1,"tweetType":1,"viewCount":967,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607004893,"gmtCreate":1639452342052,"gmtModify":1639452342206,"author":{"id":"3586129577058331","authorId":"3586129577058331","name":"1a327e37","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586129577058331","idStr":"3586129577058331"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/607004893","repostId":"1174096078","repostType":4,"isVote":1,"tweetType":1,"viewCount":890,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":605579897,"gmtCreate":1639199565211,"gmtModify":1639199565336,"author":{"id":"3586129577058331","authorId":"3586129577058331","name":"1a327e37","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586129577058331","idStr":"3586129577058331"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/605579897","repostId":"2190275356","repostType":4,"isVote":1,"tweetType":1,"viewCount":933,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":888705836,"gmtCreate":1631525217125,"gmtModify":1631891663371,"author":{"id":"3586129577058331","authorId":"3586129577058331","name":"1a327e37","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586129577058331","idStr":"3586129577058331"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/888705836","repostId":"2166303426","repostType":4,"isVote":1,"tweetType":1,"viewCount":841,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":120413056,"gmtCreate":1624331554475,"gmtModify":1631891663369,"author":{"id":"3586129577058331","authorId":"3586129577058331","name":"1a327e37","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586129577058331","idStr":"3586129577058331"},"themes":[],"htmlText":"I see","listText":"I see","text":"I see","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/120413056","repostId":"1191349655","repostType":4,"isVote":1,"tweetType":1,"viewCount":865,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":164497234,"gmtCreate":1624232650128,"gmtModify":1631891663376,"author":{"id":"3586129577058331","authorId":"3586129577058331","name":"1a327e37","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586129577058331","idStr":"3586129577058331"},"themes":[],"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/164497234","repostId":"1154249454","repostType":4,"isVote":1,"tweetType":1,"viewCount":806,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":163786590,"gmtCreate":1623893613110,"gmtModify":1631891663374,"author":{"id":"3586129577058331","authorId":"3586129577058331","name":"1a327e37","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586129577058331","idStr":"3586129577058331"},"themes":[],"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/163786590","repostId":"2143794095","repostType":4,"isVote":1,"tweetType":1,"viewCount":1086,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":160417362,"gmtCreate":1623804223156,"gmtModify":1631888826945,"author":{"id":"3586129577058331","authorId":"3586129577058331","name":"1a327e37","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3586129577058331","idStr":"3586129577058331"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/RF7.SI\">$AMOS GROUP LIMITED(RF7.SI)$</a>k","listText":"<a href=\"https://laohu8.com/S/RF7.SI\">$AMOS GROUP LIMITED(RF7.SI)$</a>k","text":"$AMOS GROUP LIMITED(RF7.SI)$k","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/160417362","isVote":1,"tweetType":1,"viewCount":941,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":186193373,"gmtCreate":1623476993792,"gmtModify":1631891663386,"author":{"id":"3586129577058331","authorId":"3586129577058331","name":"1a327e37","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586129577058331","authorIdStr":"3586129577058331"},"themes":[],"htmlText":"Help me make this become top comment please","listText":"Help me make this become top comment please","text":"Help me make this become top comment please","images":[],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":6,"commentSize":11,"repostSize":0,"link":"https://laohu8.com/post/186193373","repostId":"1104635261","repostType":4,"repost":{"id":"1104635261","kind":"news","pubTimestamp":1623470020,"share":"https://www.laohu8.com/m/news/1104635261?lang=zh_CN&edition=full","pubTime":"2021-06-12 11:53","market":"us","language":"en","title":"AMC Bet by Hedge Fund Unravels Thanks to Meme-Stock Traders<blockquote>对冲基金对AMC的押注因模因股票交易员而瓦解</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1104635261","media":"The Wall Street Journal","summary":"Losses by Mudrick Capital show the risks of exposure to meme stocks.\n\nA multipronged bet onAMC Enter","content":"<p>  <b>Losses by Mudrick Capital show the risks of exposure to meme stocks.</b>  A multipronged bet onAMC Entertainment HoldingsInc.AMC15.39%boomeranged this month on Mudrick Capital Management LP, the latest hedge fund to fall victim to swarming day traders.</p><p><blockquote><b>Mudrick Capital的亏损显示了投资模因股票的风险。</b>本月，对AMC Entertainment HoldingsINC.AMC 15.39%的多管齐下的押注在Mudrick Capital Management LP上适得其反，Mudrick Capital Management LP是最新一家成为大量日内交易者受害者的对冲基金。</blockquote></p><p> Mudrick’s flagship fund lost about 10% in just a few days as a jump in AMC’s stock price unexpectedly triggered changes in the value of derivatives the fund held as part of a complex trading strategy, people familiar with the matter said.</p><p><blockquote>知情人士称，穆德里克的旗舰基金在短短几天内损失了约10%，因为AMC股价的上涨意外引发了该基金作为复杂交易策略一部分持有的衍生品价值的变化。</blockquote></p><p> The setback comes months after a group of traders organizing on social media helped send the price ofGameStopCorp.GME5.88%and other stocks soaring in January, well beyond many investors’ views of underlying fundamentals.</p><p><blockquote>几个月前，一群在社交媒体上组织的交易员帮助GameStopCorp.GME5.88%和其他股票的价格在1月份飙升，远远超出了许多投资者对基本面的看法。</blockquote></p><p> The development prompted many hedge funds to slash their exposure to meme stocks. Mudrick Capital’s losses highlight how risky retaining significant exposure to such companies can be—even backfiring on a hedge-fund manager who was mostly in sync with the bullishness of individual investors.</p><p><blockquote>这一事态发展促使许多对冲基金削减了对模因股票的投资。Mudrick Capital的损失凸显了保留对此类公司的大量投资的风险有多大，甚至会对一位与个人投资者的看涨情绪基本同步的对冲基金经理产生适得其反的影响。</blockquote></p><p> Jason Mudrick, the firm’s founder, had been trading AMC stock, options and bonds for months, surfing a surge of enthusiasm for the theater chain among individual investors. But he also sold call options, derivative contracts meant to hedge the fund’s exposure to AMC should the stock price founder. Those derivative contracts, which gave its buyers the right to buy AMC stock from Mudrick at roughly $40 in the future, ballooned into liabilities when a resurgence ofReddit-fueled buyingrecently pushed AMC’s stock to new records, the people said.</p><p><blockquote>该公司创始人杰森·穆德里克(Jason Mudrick)几个月来一直在交易AMC股票、期权和债券，个人投资者对这家连锁影院的热情高涨。但他也出售了看涨期权期权，这是一种衍生品合约，旨在对冲该基金在股价下跌时对AMC的敞口。知情人士称，这些衍生品合约赋予买家未来以约40美元的价格从Mudrick购买AMC股票的权利，但当Reddit推动的购买热潮最近将AMC股票推至新纪录时，这些衍生品合约就变成了负债。</blockquote></p><p> As part of the broader AMC strategy, executives at Mudrick Capital were in talks with AMC to buy additional shares from the company in late May. On June 1, AMC disclosed that Mudrick Capital had agreed to buy $230.5 million of new stock directly from the company at $27.12 apiece, a premium over where it was then trading.</p><p><blockquote>作为更广泛的AMC战略的一部分，Mudrick Capital的高管正在与AMC就购买该公司的额外股票进行谈判。6月1日，AMC披露，Mudrick Capital已同意以每股27.12美元的价格直接从该公司购买2.305亿美元的新股，高于当时的交易价格。</blockquote></p><p> Mudrick immediately sold the stock at a profit, a quick flip that was reported by Bloomberg News and that sparked backlash on social media.</p><p><blockquote>穆德里克立即出售了该股票并获利，彭博新闻报道了这一快速抛售，并在社交媒体上引发了强烈反对。</blockquote></p><p> “Mudrick didn’t stab AMC in the back…They shot themselves in the foot,” read one post on Reddit’s Wall Street Bets forum on June 1. Other posts around that time referenced Mudrick as “losers,” “scum bags” and “a large waving pile of s—t with no future.” Members of the forum urged each other to buy and hold.</p><p><blockquote>6月1日，Reddit华尔街博彩论坛上的一篇帖子写道：“穆德里克没有在背后捅AMC一刀……他们是搬起石头砸自己的脚。”当时的其他帖子称穆德里克为“失败者”、“人渣”和“一大堆没有未来的挥舞着的S-T”。论坛成员互相催促买入并持有。</blockquote></p><p> Inside Mudrick, executives were growing apprehensive as the AMC rally gained steam. The firm’s risk committee met on the evening of June 1 after the stock closed at $32 and decided to exit all debt and derivative positions the following day.</p><p><blockquote>随着AMC反弹势头增强，穆德里克内部的高管们越来越感到担忧。该公司的风险委员会于6月1日晚在该股收于32美元后召开会议，并决定在第二天退出所有债务和衍生品头寸。</blockquote></p><p> It was a day too late.</p><p><blockquote>晚了一天。</blockquote></p><p> AMC’s stock price blew past $40in a matter of hours June 2, hitting an intraday high of $72.62.Call option prices soaredamid a frenzy of trading that Mudrick Capital contributed to and, by the end of the week, the winning trade had turned into a bust, costing the fund hundreds of millions of dollars in losses. Mudrick Capital made a roughly 5% return on the debt it sold but after accounting for its options trade, the fund took a net loss of about 5.4% on AMC.</p><p><blockquote>6月2日，AMC股价在几个小时内突破40美元，触及72.62美元的盘中高点。在穆德里克资本促成的疯狂交易中，看涨期权期权价格飙升，到本周末，获胜的交易变成了失败，使该基金损失了数亿美元。Mudrick Capital出售的债务回报率约为5%，但考虑到期权交易后，该基金在AMC上的净亏损约为5.4%。</blockquote></p><p> Mr. Mudrick’s fund is still up about 12% for the year, one of the people said. Meanwhile, investors who bought AMC stock at the start of the year and held on have gained about 2000%.</p><p><blockquote>其中一位知情人士表示，穆德里克的基金今年仍上涨了约12%。与此同时，年初购买AMC股票并持有的投资者已上涨约2000%。</blockquote></p><p> The impact of social media-fueled day traders has become a defining market development this year, costing top hedge funds billions of dollars in losses, sparking a congressional hearing anddrawing scrutinyfrom the U.S. Securities and Exchange Commission. More hedge funds now track individual investors’ sentiment on social media and pay greater attention to companies with smaller market values whose stock price may be more susceptible to the enthusiasms of individual investors.</p><p><blockquote>社交媒体推动的日内交易者的影响已成为今年市场的决定性发展，导致顶级对冲基金损失数十亿美元，引发国会听证会并受到美国证券交易委员会的审查。更多的对冲基金现在跟踪个人投资者在社交媒体上的情绪，更加关注市值较小的公司，这些公司的股价可能更容易受到个人投资者热情的影响。</blockquote></p><p> Mr. Mudrick specializes in distressed debt investing, often lending to troubled companies at high interest rates or swapping their existing debt for equity in bankruptcy court. Mudrick manages about $3.5 billion in investments firmwide and holds large, illiquid stakes in E-cigarette maker NJOY Holdings Inc. and satellite communications companyGlobalstarInc.from such exchanges. The flagship fund reported returns of about 17% annually from 2018 to 2020, according to data from HSBC Alternative Investment Group.</p><p><blockquote>穆德里克先生专门从事不良债务投资，经常以高利率向陷入困境的公司提供贷款，或者在破产法庭上将其现有债务换成股权。Mudrick管理着全公司约35亿美元的投资，并通过此类交易所持有电子烟制造商NJOY Holdings Inc.和卫星通信公司GlobalStarInc.的大量非流动性股份。汇丰另类投资集团的数据显示，2018年至2020年，该旗舰基金的年回报率约为17%。</blockquote></p><p> But distressed investing opportunities have grownharder to findas easy money from the Federal Reserve has given even struggling companies open access to debt markets. Mr. Mudrick has explored other strategies, launching several special-purpose acquisition companiesand, in the case of AMC, ultimately buying stock in block trades.</p><p><blockquote>但由于美联储的宽松资金甚至为陷入困境的公司提供了进入债务市场的机会，因此陷入困境的投资机会变得越来越难找到。穆德里克先生还探索了其他策略，成立了几家特殊目的收购公司，就AMC而言，最终通过大宗交易购买股票。</blockquote></p><p></p><p> Mr. Mudrick initially applied his typical playbook to AMC, buying bonds for as little as 20 cents on the dollar,lending the company $100 millionin December and swapping some bonds into new shares. Theater attendance, already under pressure, had disappeared almost entirely amid Covid-19 pandemic lockdowns, and AMC stock traded as low as $2. He reasoned that consumers would regain their appetite for big-screen entertainment this year as more Americans got vaccinated.</p><p><blockquote>穆德里克最初将他的典型策略应用于AMC，以低至20美分的价格购买债券，在12月向该公司借出1亿美元，并将部分债券换成新股。在Covid-19大流行封锁期间，已经面临压力的影院上座率几乎完全消失，AMC股票交易价格低至2美元。他推断，随着越来越多的美国人接种疫苗，消费者今年将恢复对大屏幕娱乐的兴趣。</blockquote></p><p> Day traders took theirfirst run at AMC in late January, urging each other on with the social-media rallying cry of #SaveAMC and briefly lifting the stock to around $20. AMC’s rising equity value boosted debt prices—one bond Mudrick Capital owned doubled within a week—quickly rewarding Mr. Mudrick’s bullishness. AMC capitalized on its surging stock priceto raise nearly $1 billion in new financingin late January, enabling it to ward off a previously expected bankruptcy filing.</p><p><blockquote>1月下旬，日内交易者首次在AMC进行了交易，在社交媒体上高呼#SaveAMC，并短暂将该股推升至20美元左右。AMC不断上涨的股票价值推高了债务价格——Mudrick Capital持有的一只债券在一周内翻了一番——很快就回报了Mudrick先生的看涨情绪。AMC利用其飙升的股价在1月底筹集了近10亿美元的新融资，使其能够避免此前预期的破产申请。</blockquote></p><p> Around that time, Mr. Mudrick sold call options on AMC stock, producing immediate income to offset potential losses if the theater chain did face problems. The derivatives gave buyers the option to buy AMC shares from Mudrick Capital for about $40—viewed as a seeming improbability when the stock was trading below $10.</p><p><blockquote>大约在那个时候，穆德里克先生出售了AMC股票的看涨期权期权，如果连锁影院确实面临问题，可以立即产生收入来抵消潜在的损失。这些衍生品让买家可以选择以约40美元的价格从Mudrick Capital购买AMC股票——当该股交易价格低于10美元时，这似乎不太可能。</blockquote></p><p> Mr. Mudrick remained in contact with AMC Chief Executive Adam Aron about providing additional funding, leading to his recent share purchase. But he kept the derivative contracts outstanding as an insurance policy, one of the people familiar with the matter said.</p><p><blockquote>穆德里克先生与AMC首席执行官亚当·阿伦(Adam Aron)就提供额外资金保持联系，导致他最近购买了股票。但一位知情人士表示，作为一项保险政策，他保留了衍生品合约。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>AMC Bet by Hedge Fund Unravels Thanks to Meme-Stock Traders<blockquote>对冲基金对AMC的押注因模因股票交易员而瓦解</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAMC Bet by Hedge Fund Unravels Thanks to Meme-Stock Traders<blockquote>对冲基金对AMC的押注因模因股票交易员而瓦解</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">The Wall Street Journal</strong><span class=\"h-time small\">2021-06-12 11:53</span>\n</p>\n</h4>\n</header>\n<article>\n<p>  <b>Losses by Mudrick Capital show the risks of exposure to meme stocks.</b>  A multipronged bet onAMC Entertainment HoldingsInc.AMC15.39%boomeranged this month on Mudrick Capital Management LP, the latest hedge fund to fall victim to swarming day traders.</p><p><blockquote><b>Mudrick Capital的亏损显示了投资模因股票的风险。</b>本月，对AMC Entertainment HoldingsINC.AMC 15.39%的多管齐下的押注在Mudrick Capital Management LP上适得其反，Mudrick Capital Management LP是最新一家成为大量日内交易者受害者的对冲基金。</blockquote></p><p> Mudrick’s flagship fund lost about 10% in just a few days as a jump in AMC’s stock price unexpectedly triggered changes in the value of derivatives the fund held as part of a complex trading strategy, people familiar with the matter said.</p><p><blockquote>知情人士称，穆德里克的旗舰基金在短短几天内损失了约10%，因为AMC股价的上涨意外引发了该基金作为复杂交易策略一部分持有的衍生品价值的变化。</blockquote></p><p> The setback comes months after a group of traders organizing on social media helped send the price ofGameStopCorp.GME5.88%and other stocks soaring in January, well beyond many investors’ views of underlying fundamentals.</p><p><blockquote>几个月前，一群在社交媒体上组织的交易员帮助GameStopCorp.GME5.88%和其他股票的价格在1月份飙升，远远超出了许多投资者对基本面的看法。</blockquote></p><p> The development prompted many hedge funds to slash their exposure to meme stocks. Mudrick Capital’s losses highlight how risky retaining significant exposure to such companies can be—even backfiring on a hedge-fund manager who was mostly in sync with the bullishness of individual investors.</p><p><blockquote>这一事态发展促使许多对冲基金削减了对模因股票的投资。Mudrick Capital的损失凸显了保留对此类公司的大量投资的风险有多大，甚至会对一位与个人投资者的看涨情绪基本同步的对冲基金经理产生适得其反的影响。</blockquote></p><p> Jason Mudrick, the firm’s founder, had been trading AMC stock, options and bonds for months, surfing a surge of enthusiasm for the theater chain among individual investors. But he also sold call options, derivative contracts meant to hedge the fund’s exposure to AMC should the stock price founder. Those derivative contracts, which gave its buyers the right to buy AMC stock from Mudrick at roughly $40 in the future, ballooned into liabilities when a resurgence ofReddit-fueled buyingrecently pushed AMC’s stock to new records, the people said.</p><p><blockquote>该公司创始人杰森·穆德里克(Jason Mudrick)几个月来一直在交易AMC股票、期权和债券，个人投资者对这家连锁影院的热情高涨。但他也出售了看涨期权期权，这是一种衍生品合约，旨在对冲该基金在股价下跌时对AMC的敞口。知情人士称，这些衍生品合约赋予买家未来以约40美元的价格从Mudrick购买AMC股票的权利，但当Reddit推动的购买热潮最近将AMC股票推至新纪录时，这些衍生品合约就变成了负债。</blockquote></p><p> As part of the broader AMC strategy, executives at Mudrick Capital were in talks with AMC to buy additional shares from the company in late May. On June 1, AMC disclosed that Mudrick Capital had agreed to buy $230.5 million of new stock directly from the company at $27.12 apiece, a premium over where it was then trading.</p><p><blockquote>作为更广泛的AMC战略的一部分，Mudrick Capital的高管正在与AMC就购买该公司的额外股票进行谈判。6月1日，AMC披露，Mudrick Capital已同意以每股27.12美元的价格直接从该公司购买2.305亿美元的新股，高于当时的交易价格。</blockquote></p><p> Mudrick immediately sold the stock at a profit, a quick flip that was reported by Bloomberg News and that sparked backlash on social media.</p><p><blockquote>穆德里克立即出售了该股票并获利，彭博新闻报道了这一快速抛售，并在社交媒体上引发了强烈反对。</blockquote></p><p> “Mudrick didn’t stab AMC in the back…They shot themselves in the foot,” read one post on Reddit’s Wall Street Bets forum on June 1. Other posts around that time referenced Mudrick as “losers,” “scum bags” and “a large waving pile of s—t with no future.” Members of the forum urged each other to buy and hold.</p><p><blockquote>6月1日，Reddit华尔街博彩论坛上的一篇帖子写道：“穆德里克没有在背后捅AMC一刀……他们是搬起石头砸自己的脚。”当时的其他帖子称穆德里克为“失败者”、“人渣”和“一大堆没有未来的挥舞着的S-T”。论坛成员互相催促买入并持有。</blockquote></p><p> Inside Mudrick, executives were growing apprehensive as the AMC rally gained steam. The firm’s risk committee met on the evening of June 1 after the stock closed at $32 and decided to exit all debt and derivative positions the following day.</p><p><blockquote>随着AMC反弹势头增强，穆德里克内部的高管们越来越感到担忧。该公司的风险委员会于6月1日晚在该股收于32美元后召开会议，并决定在第二天退出所有债务和衍生品头寸。</blockquote></p><p> It was a day too late.</p><p><blockquote>晚了一天。</blockquote></p><p> AMC’s stock price blew past $40in a matter of hours June 2, hitting an intraday high of $72.62.Call option prices soaredamid a frenzy of trading that Mudrick Capital contributed to and, by the end of the week, the winning trade had turned into a bust, costing the fund hundreds of millions of dollars in losses. Mudrick Capital made a roughly 5% return on the debt it sold but after accounting for its options trade, the fund took a net loss of about 5.4% on AMC.</p><p><blockquote>6月2日，AMC股价在几个小时内突破40美元，触及72.62美元的盘中高点。在穆德里克资本促成的疯狂交易中，看涨期权期权价格飙升，到本周末，获胜的交易变成了失败，使该基金损失了数亿美元。Mudrick Capital出售的债务回报率约为5%，但考虑到期权交易后，该基金在AMC上的净亏损约为5.4%。</blockquote></p><p> Mr. Mudrick’s fund is still up about 12% for the year, one of the people said. Meanwhile, investors who bought AMC stock at the start of the year and held on have gained about 2000%.</p><p><blockquote>其中一位知情人士表示，穆德里克的基金今年仍上涨了约12%。与此同时，年初购买AMC股票并持有的投资者已上涨约2000%。</blockquote></p><p> The impact of social media-fueled day traders has become a defining market development this year, costing top hedge funds billions of dollars in losses, sparking a congressional hearing anddrawing scrutinyfrom the U.S. Securities and Exchange Commission. More hedge funds now track individual investors’ sentiment on social media and pay greater attention to companies with smaller market values whose stock price may be more susceptible to the enthusiasms of individual investors.</p><p><blockquote>社交媒体推动的日内交易者的影响已成为今年市场的决定性发展，导致顶级对冲基金损失数十亿美元，引发国会听证会并受到美国证券交易委员会的审查。更多的对冲基金现在跟踪个人投资者在社交媒体上的情绪，更加关注市值较小的公司，这些公司的股价可能更容易受到个人投资者热情的影响。</blockquote></p><p> Mr. Mudrick specializes in distressed debt investing, often lending to troubled companies at high interest rates or swapping their existing debt for equity in bankruptcy court. Mudrick manages about $3.5 billion in investments firmwide and holds large, illiquid stakes in E-cigarette maker NJOY Holdings Inc. and satellite communications companyGlobalstarInc.from such exchanges. The flagship fund reported returns of about 17% annually from 2018 to 2020, according to data from HSBC Alternative Investment Group.</p><p><blockquote>穆德里克先生专门从事不良债务投资，经常以高利率向陷入困境的公司提供贷款，或者在破产法庭上将其现有债务换成股权。Mudrick管理着全公司约35亿美元的投资，并通过此类交易所持有电子烟制造商NJOY Holdings Inc.和卫星通信公司GlobalStarInc.的大量非流动性股份。汇丰另类投资集团的数据显示，2018年至2020年，该旗舰基金的年回报率约为17%。</blockquote></p><p> But distressed investing opportunities have grownharder to findas easy money from the Federal Reserve has given even struggling companies open access to debt markets. Mr. Mudrick has explored other strategies, launching several special-purpose acquisition companiesand, in the case of AMC, ultimately buying stock in block trades.</p><p><blockquote>但由于美联储的宽松资金甚至为陷入困境的公司提供了进入债务市场的机会，因此陷入困境的投资机会变得越来越难找到。穆德里克先生还探索了其他策略，成立了几家特殊目的收购公司，就AMC而言，最终通过大宗交易购买股票。</blockquote></p><p></p><p> Mr. Mudrick initially applied his typical playbook to AMC, buying bonds for as little as 20 cents on the dollar,lending the company $100 millionin December and swapping some bonds into new shares. Theater attendance, already under pressure, had disappeared almost entirely amid Covid-19 pandemic lockdowns, and AMC stock traded as low as $2. He reasoned that consumers would regain their appetite for big-screen entertainment this year as more Americans got vaccinated.</p><p><blockquote>穆德里克最初将他的典型策略应用于AMC，以低至20美分的价格购买债券，在12月向该公司借出1亿美元，并将部分债券换成新股。在Covid-19大流行封锁期间，已经面临压力的影院上座率几乎完全消失，AMC股票交易价格低至2美元。他推断，随着越来越多的美国人接种疫苗，消费者今年将恢复对大屏幕娱乐的兴趣。</blockquote></p><p> Day traders took theirfirst run at AMC in late January, urging each other on with the social-media rallying cry of #SaveAMC and briefly lifting the stock to around $20. AMC’s rising equity value boosted debt prices—one bond Mudrick Capital owned doubled within a week—quickly rewarding Mr. Mudrick’s bullishness. AMC capitalized on its surging stock priceto raise nearly $1 billion in new financingin late January, enabling it to ward off a previously expected bankruptcy filing.</p><p><blockquote>1月下旬，日内交易者首次在AMC进行了交易，在社交媒体上高呼#SaveAMC，并短暂将该股推升至20美元左右。AMC不断上涨的股票价值推高了债务价格——Mudrick Capital持有的一只债券在一周内翻了一番——很快就回报了Mudrick先生的看涨情绪。AMC利用其飙升的股价在1月底筹集了近10亿美元的新融资，使其能够避免此前预期的破产申请。</blockquote></p><p> Around that time, Mr. Mudrick sold call options on AMC stock, producing immediate income to offset potential losses if the theater chain did face problems. The derivatives gave buyers the option to buy AMC shares from Mudrick Capital for about $40—viewed as a seeming improbability when the stock was trading below $10.</p><p><blockquote>大约在那个时候，穆德里克先生出售了AMC股票的看涨期权期权，如果连锁影院确实面临问题，可以立即产生收入来抵消潜在的损失。这些衍生品让买家可以选择以约40美元的价格从Mudrick Capital购买AMC股票——当该股交易价格低于10美元时，这似乎不太可能。</blockquote></p><p> Mr. Mudrick remained in contact with AMC Chief Executive Adam Aron about providing additional funding, leading to his recent share purchase. But he kept the derivative contracts outstanding as an insurance policy, one of the people familiar with the matter said.</p><p><blockquote>穆德里克先生与AMC首席执行官亚当·阿伦(Adam Aron)就提供额外资金保持联系，导致他最近购买了股票。但一位知情人士表示，作为一项保险政策，他保留了衍生品合约。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.wsj.com/articles/amc-bet-by-hedge-fund-unravels-thanks-to-meme-stock-traders-11623431320?mod=markets_lead_pos2\">The Wall Street Journal</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMC":"AMC院线"},"source_url":"https://www.wsj.com/articles/amc-bet-by-hedge-fund-unravels-thanks-to-meme-stock-traders-11623431320?mod=markets_lead_pos2","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1104635261","content_text":"Losses by Mudrick Capital show the risks of exposure to meme stocks.\n\nA multipronged bet onAMC Entertainment HoldingsInc.AMC15.39%boomeranged this month on Mudrick Capital Management LP, the latest hedge fund to fall victim to swarming day traders.\nMudrick’s flagship fund lost about 10% in just a few days as a jump in AMC’s stock price unexpectedly triggered changes in the value of derivatives the fund held as part of a complex trading strategy, people familiar with the matter said.\nThe setback comes months after a group of traders organizing on social media helped send the price ofGameStopCorp.GME5.88%and other stocks soaring in January, well beyond many investors’ views of underlying fundamentals.\nThe development prompted many hedge funds to slash their exposure to meme stocks. Mudrick Capital’s losses highlight how risky retaining significant exposure to such companies can be—even backfiring on a hedge-fund manager who was mostly in sync with the bullishness of individual investors.\nJason Mudrick, the firm’s founder, had been trading AMC stock, options and bonds for months, surfing a surge of enthusiasm for the theater chain among individual investors. But he also sold call options, derivative contracts meant to hedge the fund’s exposure to AMC should the stock price founder. Those derivative contracts, which gave its buyers the right to buy AMC stock from Mudrick at roughly $40 in the future, ballooned into liabilities when a resurgence ofReddit-fueled buyingrecently pushed AMC’s stock to new records, the people said.\nAs part of the broader AMC strategy, executives at Mudrick Capital were in talks with AMC to buy additional shares from the company in late May. On June 1, AMC disclosed that Mudrick Capital had agreed to buy $230.5 million of new stock directly from the company at $27.12 apiece, a premium over where it was then trading.\nMudrick immediately sold the stock at a profit, a quick flip that was reported by Bloomberg News and that sparked backlash on social media.\n“Mudrick didn’t stab AMC in the back…They shot themselves in the foot,” read one post on Reddit’s Wall Street Bets forum on June 1. Other posts around that time referenced Mudrick as “losers,” “scum bags” and “a large waving pile of s—t with no future.” Members of the forum urged each other to buy and hold.\nInside Mudrick, executives were growing apprehensive as the AMC rally gained steam. The firm’s risk committee met on the evening of June 1 after the stock closed at $32 and decided to exit all debt and derivative positions the following day.\nIt was a day too late.\nAMC’s stock price blew past $40in a matter of hours June 2, hitting an intraday high of $72.62.Call option prices soaredamid a frenzy of trading that Mudrick Capital contributed to and, by the end of the week, the winning trade had turned into a bust, costing the fund hundreds of millions of dollars in losses. Mudrick Capital made a roughly 5% return on the debt it sold but after accounting for its options trade, the fund took a net loss of about 5.4% on AMC.\nMr. Mudrick’s fund is still up about 12% for the year, one of the people said. Meanwhile, investors who bought AMC stock at the start of the year and held on have gained about 2000%.\nThe impact of social media-fueled day traders has become a defining market development this year, costing top hedge funds billions of dollars in losses, sparking a congressional hearing anddrawing scrutinyfrom the U.S. Securities and Exchange Commission. More hedge funds now track individual investors’ sentiment on social media and pay greater attention to companies with smaller market values whose stock price may be more susceptible to the enthusiasms of individual investors.\nMr. Mudrick specializes in distressed debt investing, often lending to troubled companies at high interest rates or swapping their existing debt for equity in bankruptcy court. Mudrick manages about $3.5 billion in investments firmwide and holds large, illiquid stakes in E-cigarette maker NJOY Holdings Inc. and satellite communications companyGlobalstarInc.from such exchanges. The flagship fund reported returns of about 17% annually from 2018 to 2020, according to data from HSBC Alternative Investment Group.\nBut distressed investing opportunities have grownharder to findas easy money from the Federal Reserve has given even struggling companies open access to debt markets. Mr. Mudrick has explored other strategies, launching several special-purpose acquisition companiesand, in the case of AMC, ultimately buying stock in block trades.\nMr. Mudrick initially applied his typical playbook to AMC, buying bonds for as little as 20 cents on the dollar,lending the company $100 millionin December and swapping some bonds into new shares. Theater attendance, already under pressure, had disappeared almost entirely amid Covid-19 pandemic lockdowns, and AMC stock traded as low as $2. He reasoned that consumers would regain their appetite for big-screen entertainment this year as more Americans got vaccinated.\nDay traders took theirfirst run at AMC in late January, urging each other on with the social-media rallying cry of #SaveAMC and briefly lifting the stock to around $20. AMC’s rising equity value boosted debt prices—one bond Mudrick Capital owned doubled within a week—quickly rewarding Mr. Mudrick’s bullishness. AMC capitalized on its surging stock priceto raise nearly $1 billion in new financingin late January, enabling it to ward off a previously expected bankruptcy filing.\nAround that time, Mr. Mudrick sold call options on AMC stock, producing immediate income to offset potential losses if the theater chain did face problems. The derivatives gave buyers the option to buy AMC shares from Mudrick Capital for about $40—viewed as a seeming improbability when the stock was trading below $10.\nMr. Mudrick remained in contact with AMC Chief Executive Adam Aron about providing additional funding, leading to his recent share purchase. But he kept the derivative contracts outstanding as an insurance policy, one of the people familiar with the matter said.","news_type":1,"symbols_score_info":{"AMC":0.9}},"isVote":1,"tweetType":1,"viewCount":607,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":114089567,"gmtCreate":1623035858859,"gmtModify":1634095998641,"author":{"id":"3586129577058331","authorId":"3586129577058331","name":"1a327e37","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586129577058331","authorIdStr":"3586129577058331"},"themes":[],"htmlText":"Yeah[开心]&nbsp;","listText":"Yeah[开心]&nbsp;","text":"Yeah[开心]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":7,"repostSize":0,"link":"https://laohu8.com/post/114089567","isVote":1,"tweetType":1,"viewCount":1145,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607855252,"gmtCreate":1639527702313,"gmtModify":1639527702622,"author":{"id":"3586129577058331","authorId":"3586129577058331","name":"1a327e37","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586129577058331","authorIdStr":"3586129577058331"},"themes":[],"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/607855252","repostId":"1197497046","repostType":4,"repost":{"id":"1197497046","kind":"news","pubTimestamp":1639526704,"share":"https://www.laohu8.com/m/news/1197497046?lang=zh_CN&edition=full","pubTime":"2021-12-15 08:05","market":"sg","language":"en","title":"Renewed Selling Pressure Likely For Singapore Stock Market<blockquote>新加坡股市可能面临新的抛售压力</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1197497046","media":"RTTNews","summary":"The Singapore stock market on Tuesday wrote a finish to the two-day slide in which it had fallen mor","content":"<p>The Singapore stock market on Tuesday wrote a finish to the two-day slide in which it had fallen more than 20 points or 0.7 percent. The Straits Times Index now sits just above the 3,120-point plateau although it figures to head south again on Wednesday.</p><p><blockquote>新加坡股市周二结束了连续两天的下跌，跌幅超过20点或0.7%。海峡时报指数目前略高于3,120点的高位，尽管预计周三将再次下跌。</blockquote></p><p> The global forecast for the Asian&nbsp;markets&nbsp;is soft on interest rate and COVID-19 concerns, with oil and technology stocks again expected to lead the way lower. The European and U.S. markets were down and the Asian markets figure to follow suit.</p><p><blockquote>由于利率和新冠肺炎担忧，全球对亚洲市场的预测疲软，石油和科技股预计将再次领跌。欧洲和美国市场下跌，亚洲市场预计也会效仿。</blockquote></p><p> The STI finished barely higher on Tuesday following gains from the properties and mixed performances from the financial shares.</p><p><blockquote>继房地产股上涨和金融股表现好坏参半后，海指周二收盘小幅走高。</blockquote></p><p> For the day, the index rose 1.14 points or 0.04 percent to finish at 3,121.09 after trading between 3,114.43 and 3,128.80. Volume was 1.15 billion shares worth 819.5 million Singapore dollars. There were 268 decliners and 176 gainers.</p><p><blockquote>当天，该指数在3,114.43至3,128.80之间交易后，上涨1.14点或0.04%，收于3,121.09点。成交量为11.5亿股，价值8.195亿新元。下跌股268家，上涨股176家。</blockquote></p><p> Among the actives, CapitaLand Integrated Commercial Trust jumped 0.90 percent, while City Developments climbed 0.85 percent, Comfort DelGro shed 0.72 percent, Dairy Farm International plummeted 2.03 percent, Genting Singapore lost 0.64 percent, Mapletree Commercial Trust added 0.49 percent, Oversea-Chinese Banking Corporation rose 0.18 percent, SATS tumbled 0.77 percent, Singapore Airlines fell 0.60 percent, Singapore Technologies Engineering slid 0.53 percent, Thai Beverage dropped 0.74 percent, United Overseas Bank collected 0.34 percent, Wilmar International added 0.24 percent, Yangzijiang Shipbuilding sank 0.76 percent and Mapletree Logistics Trust, Keppel Corp, DBS Group, Ascendas REIT, SembCorp Industries, Singapore Exchange, Singapore Press Holdings and SingTel were unchanged.</p><p><blockquote>活跃股中，凯德综合商业信托上涨0.90%，City Developments上涨0.85%，Comfort DelGro下跌0.72%，Dairy Farm International暴跌2.03%，云顶新加坡下跌0.64%，丰树商业信托上涨0.49%，华侨银行上涨0.18%，新航集团下跌0.77%，新加坡科技工程下跌0.53%，泰国饮料下跌0.74%，大华银行上涨0.34%，丰益国际上涨0.24%，扬子江造船下跌0.76%，丰树物流信托、吉宝企业、星展集团、腾飞房地产投资信托、胜科工业、新加坡交易所、新加坡报业控股和新加坡电信持平。</blockquote></p><p> The lead from Wall Street is negative as the major averages spent most of the day in the red, although they finished off session lows.</p><p><blockquote>华尔街的领先是负面的，因为主要股指全天大部分时间都处于亏损状态，尽管它们收盘于盘中低点。</blockquote></p><p> The Dow skidded 106.77 points or 0.30 percent to finish at 35,544.18, while the NASDAQ tumbled 175.64 points or 1.14 percent to end at 15,237.64 and the S&amp;P 500 sank 34.88 points or 0.75 percent to close at 4,634.09.</p><p><blockquote>道琼斯指数下跌106.77点或0.30%，收于35,544.18点；纳斯达克下跌175.64点或1.14%，收于15,237.64点；标普500下跌34.88点或0.75%，收于4,634.09点。</blockquote></p><p> Concerns about the outlook for monetary policy continued to weigh on the markets as the Federal Reserve's two-day meeting got underway. With inflation remaining at an elevated rate, the Fed is widely expected to accelerate its timetable for reducing bond purchases.</p><p><blockquote>随着美联储为期两天的会议开始，对货币政策前景的担忧继续打压市场。由于通胀仍处于高位，外界普遍预计美联储将加快缩减购债的时间表。</blockquote></p><p> Potentially adding to concerns about monetary policy, the Labor Department released a report showing producer prices increased by more than expected in November.</p><p><blockquote>美国劳工部发布的一份报告显示，11月份生产者价格涨幅超过预期，这可能会加剧人们对货币政策的担忧。</blockquote></p><p> Lingering worries about the new Omicron variant of the&nbsp;coronavirus&nbsp;may also have generated some selling pressure after the World Health Organization warned the new variant is spreading faster than previous strains.</p><p><blockquote>在世界卫生组织警告新变种病毒传播速度快于以前的毒株后，对新冠病毒奥密克戎变种挥之不去的担忧也可能产生了一些抛售压力。</blockquote></p><p> Crude oil futures dipped Tuesday on concerns about the outlook for energy demand due to renewed restrictions amid rising new cases of the Omicron variant of the coronavirus. West Texas Intermediate Crude oil futures for January ended down by $0.56 or 0.8 percent at $70.73 a barrel.</p><p><blockquote>由于奥密克戎变种冠状病毒新病例不断增加，新的限制措施导致人们对能源需求前景感到担忧，原油期货周二下跌。西德克萨斯中质原油1月期货收跌0.56美元或0.8%，报每桶70.73美元。</blockquote></p><p> Closer to home, Singapore will provide Q3 numbers for unemployment later today; in the three months prior, the jobless rate was 2.7 percent.</p><p><blockquote>言归正传，新加坡将于今天晚些时候提供第三季度失业数据；在此之前的三个月里，失业率为2.7%。</blockquote></p><p></p>","source":"lsy1626938412129","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Renewed Selling Pressure Likely For Singapore Stock Market<blockquote>新加坡股市可能面临新的抛售压力</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRenewed Selling Pressure Likely For Singapore Stock Market<blockquote>新加坡股市可能面临新的抛售压力</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">RTTNews</strong><span class=\"h-time small\">2021-12-15 08:05</span>\n</p>\n</h4>\n</header>\n<article>\n<p>The Singapore stock market on Tuesday wrote a finish to the two-day slide in which it had fallen more than 20 points or 0.7 percent. The Straits Times Index now sits just above the 3,120-point plateau although it figures to head south again on Wednesday.</p><p><blockquote>新加坡股市周二结束了连续两天的下跌，跌幅超过20点或0.7%。海峡时报指数目前略高于3,120点的高位，尽管预计周三将再次下跌。</blockquote></p><p> The global forecast for the Asian&nbsp;markets&nbsp;is soft on interest rate and COVID-19 concerns, with oil and technology stocks again expected to lead the way lower. The European and U.S. markets were down and the Asian markets figure to follow suit.</p><p><blockquote>由于利率和新冠肺炎担忧，全球对亚洲市场的预测疲软，石油和科技股预计将再次领跌。欧洲和美国市场下跌，亚洲市场预计也会效仿。</blockquote></p><p> The STI finished barely higher on Tuesday following gains from the properties and mixed performances from the financial shares.</p><p><blockquote>继房地产股上涨和金融股表现好坏参半后，海指周二收盘小幅走高。</blockquote></p><p> For the day, the index rose 1.14 points or 0.04 percent to finish at 3,121.09 after trading between 3,114.43 and 3,128.80. Volume was 1.15 billion shares worth 819.5 million Singapore dollars. There were 268 decliners and 176 gainers.</p><p><blockquote>当天，该指数在3,114.43至3,128.80之间交易后，上涨1.14点或0.04%，收于3,121.09点。成交量为11.5亿股，价值8.195亿新元。下跌股268家，上涨股176家。</blockquote></p><p> Among the actives, CapitaLand Integrated Commercial Trust jumped 0.90 percent, while City Developments climbed 0.85 percent, Comfort DelGro shed 0.72 percent, Dairy Farm International plummeted 2.03 percent, Genting Singapore lost 0.64 percent, Mapletree Commercial Trust added 0.49 percent, Oversea-Chinese Banking Corporation rose 0.18 percent, SATS tumbled 0.77 percent, Singapore Airlines fell 0.60 percent, Singapore Technologies Engineering slid 0.53 percent, Thai Beverage dropped 0.74 percent, United Overseas Bank collected 0.34 percent, Wilmar International added 0.24 percent, Yangzijiang Shipbuilding sank 0.76 percent and Mapletree Logistics Trust, Keppel Corp, DBS Group, Ascendas REIT, SembCorp Industries, Singapore Exchange, Singapore Press Holdings and SingTel were unchanged.</p><p><blockquote>活跃股中，凯德综合商业信托上涨0.90%，City Developments上涨0.85%，Comfort DelGro下跌0.72%，Dairy Farm International暴跌2.03%，云顶新加坡下跌0.64%，丰树商业信托上涨0.49%，华侨银行上涨0.18%，新航集团下跌0.77%，新加坡科技工程下跌0.53%，泰国饮料下跌0.74%，大华银行上涨0.34%，丰益国际上涨0.24%，扬子江造船下跌0.76%，丰树物流信托、吉宝企业、星展集团、腾飞房地产投资信托、胜科工业、新加坡交易所、新加坡报业控股和新加坡电信持平。</blockquote></p><p> The lead from Wall Street is negative as the major averages spent most of the day in the red, although they finished off session lows.</p><p><blockquote>华尔街的领先是负面的，因为主要股指全天大部分时间都处于亏损状态，尽管它们收盘于盘中低点。</blockquote></p><p> The Dow skidded 106.77 points or 0.30 percent to finish at 35,544.18, while the NASDAQ tumbled 175.64 points or 1.14 percent to end at 15,237.64 and the S&amp;P 500 sank 34.88 points or 0.75 percent to close at 4,634.09.</p><p><blockquote>道琼斯指数下跌106.77点或0.30%，收于35,544.18点；纳斯达克下跌175.64点或1.14%，收于15,237.64点；标普500下跌34.88点或0.75%，收于4,634.09点。</blockquote></p><p> Concerns about the outlook for monetary policy continued to weigh on the markets as the Federal Reserve's two-day meeting got underway. With inflation remaining at an elevated rate, the Fed is widely expected to accelerate its timetable for reducing bond purchases.</p><p><blockquote>随着美联储为期两天的会议开始，对货币政策前景的担忧继续打压市场。由于通胀仍处于高位，外界普遍预计美联储将加快缩减购债的时间表。</blockquote></p><p> Potentially adding to concerns about monetary policy, the Labor Department released a report showing producer prices increased by more than expected in November.</p><p><blockquote>美国劳工部发布的一份报告显示，11月份生产者价格涨幅超过预期，这可能会加剧人们对货币政策的担忧。</blockquote></p><p> Lingering worries about the new Omicron variant of the&nbsp;coronavirus&nbsp;may also have generated some selling pressure after the World Health Organization warned the new variant is spreading faster than previous strains.</p><p><blockquote>在世界卫生组织警告新变种病毒传播速度快于以前的毒株后，对新冠病毒奥密克戎变种挥之不去的担忧也可能产生了一些抛售压力。</blockquote></p><p> Crude oil futures dipped Tuesday on concerns about the outlook for energy demand due to renewed restrictions amid rising new cases of the Omicron variant of the coronavirus. West Texas Intermediate Crude oil futures for January ended down by $0.56 or 0.8 percent at $70.73 a barrel.</p><p><blockquote>由于奥密克戎变种冠状病毒新病例不断增加，新的限制措施导致人们对能源需求前景感到担忧，原油期货周二下跌。西德克萨斯中质原油1月期货收跌0.56美元或0.8%，报每桶70.73美元。</blockquote></p><p> Closer to home, Singapore will provide Q3 numbers for unemployment later today; in the three months prior, the jobless rate was 2.7 percent.</p><p><blockquote>言归正传，新加坡将于今天晚些时候提供第三季度失业数据；在此之前的三个月里，失业率为2.7%。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.rttnews.com/3249255/renewed-selling-pressure-likely-for-singapore-stock-market.aspx?type=acom\">RTTNews</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"STI.SI":"富时新加坡海峡指数"},"source_url":"https://www.rttnews.com/3249255/renewed-selling-pressure-likely-for-singapore-stock-market.aspx?type=acom","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1197497046","content_text":"The Singapore stock market on Tuesday wrote a finish to the two-day slide in which it had fallen more than 20 points or 0.7 percent. The Straits Times Index now sits just above the 3,120-point plateau although it figures to head south again on Wednesday.\nThe global forecast for the Asian markets is soft on interest rate and COVID-19 concerns, with oil and technology stocks again expected to lead the way lower. The European and U.S. markets were down and the Asian markets figure to follow suit.\nThe STI finished barely higher on Tuesday following gains from the properties and mixed performances from the financial shares.\nFor the day, the index rose 1.14 points or 0.04 percent to finish at 3,121.09 after trading between 3,114.43 and 3,128.80. Volume was 1.15 billion shares worth 819.5 million Singapore dollars. There were 268 decliners and 176 gainers.\nAmong the actives, CapitaLand Integrated Commercial Trust jumped 0.90 percent, while City Developments climbed 0.85 percent, Comfort DelGro shed 0.72 percent, Dairy Farm International plummeted 2.03 percent, Genting Singapore lost 0.64 percent, Mapletree Commercial Trust added 0.49 percent, Oversea-Chinese Banking Corporation rose 0.18 percent, SATS tumbled 0.77 percent, Singapore Airlines fell 0.60 percent, Singapore Technologies Engineering slid 0.53 percent, Thai Beverage dropped 0.74 percent, United Overseas Bank collected 0.34 percent, Wilmar International added 0.24 percent, Yangzijiang Shipbuilding sank 0.76 percent and Mapletree Logistics Trust, Keppel Corp, DBS Group, Ascendas REIT, SembCorp Industries, Singapore Exchange, Singapore Press Holdings and SingTel were unchanged.\nThe lead from Wall Street is negative as the major averages spent most of the day in the red, although they finished off session lows.\nThe Dow skidded 106.77 points or 0.30 percent to finish at 35,544.18, while the NASDAQ tumbled 175.64 points or 1.14 percent to end at 15,237.64 and the S&P 500 sank 34.88 points or 0.75 percent to close at 4,634.09.\nConcerns about the outlook for monetary policy continued to weigh on the markets as the Federal Reserve's two-day meeting got underway. With inflation remaining at an elevated rate, the Fed is widely expected to accelerate its timetable for reducing bond purchases.\nPotentially adding to concerns about monetary policy, the Labor Department released a report showing producer prices increased by more than expected in November.\nLingering worries about the new Omicron variant of the coronavirus may also have generated some selling pressure after the World Health Organization warned the new variant is spreading faster than previous strains.\nCrude oil futures dipped Tuesday on concerns about the outlook for energy demand due to renewed restrictions amid rising new cases of the Omicron variant of the coronavirus. West Texas Intermediate Crude oil futures for January ended down by $0.56 or 0.8 percent at $70.73 a barrel.\nCloser to home, Singapore will provide Q3 numbers for unemployment later today; in the three months prior, the jobless rate was 2.7 percent.","news_type":1,"symbols_score_info":{"STI.SI":0.9}},"isVote":1,"tweetType":1,"viewCount":967,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698243183,"gmtCreate":1640420556660,"gmtModify":1640420556847,"author":{"id":"3586129577058331","authorId":"3586129577058331","name":"1a327e37","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586129577058331","authorIdStr":"3586129577058331"},"themes":[],"htmlText":"Ik","listText":"Ik","text":"Ik","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/698243183","repostId":"2193917872","repostType":4,"isVote":1,"tweetType":1,"viewCount":3183,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":117367042,"gmtCreate":1623117770286,"gmtModify":1634036751744,"author":{"id":"3586129577058331","authorId":"3586129577058331","name":"1a327e37","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586129577058331","authorIdStr":"3586129577058331"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/GME\">$GameStop(GME)$</a>all the way","listText":"<a href=\"https://laohu8.com/S/GME\">$GameStop(GME)$</a>all the way","text":"$GameStop(GME)$all the way","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":5,"repostSize":0,"link":"https://laohu8.com/post/117367042","isVote":1,"tweetType":1,"viewCount":511,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":163786590,"gmtCreate":1623893613110,"gmtModify":1631891663374,"author":{"id":"3586129577058331","authorId":"3586129577058331","name":"1a327e37","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586129577058331","authorIdStr":"3586129577058331"},"themes":[],"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/163786590","repostId":"2143794095","repostType":4,"isVote":1,"tweetType":1,"viewCount":1086,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":696079293,"gmtCreate":1640585931325,"gmtModify":1640585931504,"author":{"id":"3586129577058331","authorId":"3586129577058331","name":"1a327e37","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586129577058331","authorIdStr":"3586129577058331"},"themes":[],"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/696079293","repostId":"2194177239","repostType":4,"repost":{"id":"2194177239","kind":"news","pubTimestamp":1640559609,"share":"https://www.laohu8.com/m/news/2194177239?lang=zh_CN&edition=full","pubTime":"2021-12-27 07:00","market":"us","language":"en","title":"Santa Claus Rally watch: What to know this week<blockquote>圣诞老人集会观察：本周需要了解什么</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=2194177239","media":"Yahoo Finance","summary":"As traders return from the holiday-shortened week, the price action heading into the new year will be closely monitored — especially given the relatively light economic data and earnings calendar for the coming days.The S&P 500  is entering the period known for ushering in the so-called Santa Claus Rally, or seasonally strong timeframe for stocks at the end of each year.According to data from LPL Financial, the Santa Claus Rally period encapsulates the seven days most likely to be higher in any ","content":"<p><div> As traders return from the holiday-shortened week, the price action heading into the new year will be closely monitored — especially given the relatively light economic data and earnings calendar for ...</p><p><blockquote><div>随着交易员从假期缩短的一周中回归，进入新的一年的价格走势将受到密切关注——特别是考虑到相对清淡的经济数据和收益日历...</div></blockquote></p><p>  <a href=\"https://finance.yahoo.com/news/santa-claus-rally-watch-what-to-know-this-week-142909627.html\">网页链接</a>  </div> </p><p><blockquote><a href=\"https://finance.yahoo.com/news/santa-claus-rally-watch-what-to-know-this-week-142909627.html\">网页连接</a></blockquote></p><p></p>","source":"yahoofinance_au","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Santa Claus Rally watch: What to know this week<blockquote>圣诞老人集会观察：本周需要了解什么</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSanta Claus Rally watch: What to know this week<blockquote>圣诞老人集会观察：本周需要了解什么</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Yahoo Finance</strong><span class=\"h-time small\">2021-12-27 07:00</span>\n</p>\n</h4>\n</header>\n<article>\n<p><div> As traders return from the holiday-shortened week, the price action heading into the new year will be closely monitored — especially given the relatively light economic data and earnings calendar for ...</p><p><blockquote><div>随着交易员从假期缩短的一周中回归，进入新的一年的价格走势将受到密切关注——特别是考虑到相对清淡的经济数据和收益日历...</div></blockquote></p><p>  <a href=\"https://finance.yahoo.com/news/santa-claus-rally-watch-what-to-know-this-week-142909627.html\">网页链接</a>  </div> </p><p><blockquote><a href=\"https://finance.yahoo.com/news/santa-claus-rally-watch-what-to-know-this-week-142909627.html\">网页连接</a></blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://finance.yahoo.com/news/santa-claus-rally-watch-what-to-know-this-week-142909627.html\">Yahoo Finance</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4096":"电气部件与设备","FCEL":"燃料电池能源","BK4541":"氢能源","SPY.AU":"SPDR® S&P 500® ETF Trust"},"source_url":"https://finance.yahoo.com/news/santa-claus-rally-watch-what-to-know-this-week-142909627.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2194177239","content_text":"As traders return from the holiday-shortened week, the price action heading into the new year will be closely monitored — especially given the relatively light economic data and earnings calendar for the coming days.\nThe S&P 500 (^GSPC) is entering the period known for ushering in the so-called Santa Claus Rally, or seasonally strong timeframe for stocks at the end of each year.\nThe term, coined by Stock Trader's Almanac in the 1970s, encompasses the final five trading days of the year and first two sessions of the new year. This year, that Santa Claus Rally window is set to start on Monday, Dec. 27 — or the latest a Santa Claus rally has started in 11 years, due to the timing of the holidays this year.\nAccording to data from LPL Financial, the Santa Claus Rally period encapsulates the seven days most likely to be higher in any given year. Since 1950, the Santa Claus Rally period has produced a positive return for the S&P 500 78.9% of the time, with an average return of 1.33%.\n“Why are these seven days so strong?” wrote Ryan Detrick, LPL Financial chief market strategist, in a note. “Whether optimism over a coming new year, holiday spending, traders on vacation, institutions squaring up their books — or the holiday spirit — the bottom line is that bulls tend to believe in Santa.”\nAnd if history is any indication, the absence of a Santa Claus Rally has also typically served as a harbinger of lower near-term returns.\n\"Going back to the mid-1990s, there have been only six times Santa failed to show in December. January was lower five of those six times, and the full year had a solid gain only once (in 2016, but a mini-bear market early in the year),\" Detrick added.\n“Considering the bear markets of 2000 and 2008 both took place after one of the rare instances that Santa failed to show makes believers out of us,\" he said. A bear market typically refers to when stocks drop at least 20% from recent record highs. \"Should this seasonally strong period miss the mark, it could be a warning sign.\"\nAnd this year, investors do have considerable additional concerns to mull heading into the new year. Though stocks closed out Thursday's session at fresh record highs before the long holiday weekend, December still marked a volatile month to start, with renewed concerns over the Omicron variant and the potential for tighter monetary policy from the Federal Reserve weighing on risk assets. Plus, prospects for more near-term fiscal support via the Biden administration's Build Back Better bill have dwindled, and inflation concerns spiked further. Last week, the Bureau of Economic Analysis reported core personal consumption expenditures (PCE) — the Fed's preferred inflation gauge — rose at a 4.7% year-over-year clip, or the fastest since 1983.\n\"If the U.S. was not battling the Omicron variant, U.S. stocks would be dancing higher as the Santa Claus Rally would have kept the climb going into uncharted territory,\" Edward Moya, chief market strategist at OANDA, wrote in a note last week. \"It is too early to say for sure if we will get a Santa Claus Rally, but given all the short-term risks of Fed tightening, Chinese weakness, fiscal support uncertainty and COVID, Wall Street is not complaining.\"\nA man in a Santa Claus costume gestures on the floor at the closing bell of the Dow Industrial Average at the New York Stock Exchange on December 5, 2019 in New York. (Photo by Bryan R. Smith / AFP) (Photo by BRYAN R. SMITH/AFP via Getty Images)BRYAN R. SMITH via Getty Images\nEconomic calendar\n\nMonday: Dallas Federal Reserve Manufacturing Activity Index, Dec. (13.0 expected, 11.8 in November)\nTuesday: FHFA House Price Index, month-over-month, October (0.9% in September); S&P CoreLogic Case-Shiller 20 City Composite Index, month-over-month, October (0.9% expected, 0.96% in September); S&P CoreLogic Case-Shiller 20 City Composite Index, year-over-year, October (18.6%. expected, 19.05% in September); S&P CoreLogic Case-Shiller Home Price Index, year-over-year, November (19.51% in October); Richmond Fed Manufacturing Index, December (11 expected,11 in November)\nWednesday: Wholesale Inventories, month-over-month, November preliminary (1.7% expected, 2.3% in October); Advance Goods Trade Balance, November (-$89.0 billion expected, -$82.9 billion in October); Retail Inventories, month-over-month, November (0.5% expected, 0.1% in October); Pending Home Sales, month-over-month, November (0.5% expected, 7.5% in October)\nThursday: Initial jobless claims, week ended Dec. 25. (205,000 during prior week); Continuing claims, week ended Dec. 18 (1.859 million during prior week); MNI Chicago PMI, December (62.2 expected, 61.8 in November)\nFriday: No notable reports scheduled for release\n\nEarnings calendar\n\nMonday: No notable reports scheduled for release\nTuesday: No notable reports scheduled for release\nWednesday: FuelCell Energy Inc. (FCEL) before market open\nThursday: No notable reports scheduled for release\nFriday: No notable reports scheduled for release","news_type":1,"symbols_score_info":{"FCEL":0.9,"SPY.AU":0.9}},"isVote":1,"tweetType":1,"viewCount":3266,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":120413056,"gmtCreate":1624331554475,"gmtModify":1631891663369,"author":{"id":"3586129577058331","authorId":"3586129577058331","name":"1a327e37","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586129577058331","authorIdStr":"3586129577058331"},"themes":[],"htmlText":"I see","listText":"I see","text":"I see","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/120413056","repostId":"1191349655","repostType":4,"isVote":1,"tweetType":1,"viewCount":865,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":696174376,"gmtCreate":1640656213980,"gmtModify":1640656703694,"author":{"id":"3586129577058331","authorId":"3586129577058331","name":"1a327e37","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586129577058331","authorIdStr":"3586129577058331"},"themes":[],"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/696174376","repostId":"1156481741","repostType":4,"repost":{"id":"1156481741","kind":"news","pubTimestamp":1640652473,"share":"https://www.laohu8.com/m/news/1156481741?lang=zh_CN&edition=full","pubTime":"2021-12-28 08:47","market":"us","language":"en","title":"Is Merck Stock A Buy Or Sell After FDA Authorizes Its Covid Pill?<blockquote>FDA批准默克公司的新冠药物后，默克公司的股票是买入还是卖出？</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1156481741","media":"Investors","summary":"The Food and Drug Administration authorized Merck's (MRK) antiviral Covid pill, molnupiravir. But Me","content":"<p>The Food and Drug Administration authorized&nbsp;<b>Merck</b>'s (MRK) antiviral Covid pill, molnupiravir. But Merck stock remains under pressure.</p><p><blockquote>食品药品监督管理局授权<b>默克</b>(MRK)的抗病毒新冠药物莫努匹拉韦。但默克股票仍面临压力。</blockquote></p><p> The FDA authorized the Ridgeback Biotherapeutics-partnered pill for emergency use when other options aren't available or appropriate.<b>Pfizer</b>(PFE) also gained authorization for its two-pill regimen, Paxlovid. Paxlovid proved more effective in clinical testing. Further, molnupiravir carries a cancer risk and could lead to birth defects in unborn children.</p><p><blockquote>FDA授权Ridgeback Biotherapeutics合作的药丸在其他选择不可用或不合适时紧急使用。<b>辉瑞</b>(PFE)的两片疗法Paxlovid也获得了授权。Paxlovid在临床测试中被证明更有效。此外，molnupiravir具有癌症风险，并可能导致未出生儿童的出生缺陷。</blockquote></p><p> Merck's molnupiravir cut the risk of Covid-related hospitalizations or death by 30% when patients began treatment within five days of symptoms appearing. Paxlovid reduced the same risk by 89% for patients who began treatment within three days of symptom onset.</p><p><blockquote>当患者在症状出现后五天内开始治疗时，默克公司的molnupiravir将与Covid相关的住院或死亡风险降低了30%。对于症状出现后三天内开始治疗的患者，Paxlovid将相同的风险降低了89%。</blockquote></p><p> Merck stock is well off highs it achieved in November. Bullishly, the company beat third-quarter expectations and offered an upbeat 2021 outlook that didn't include the potential impact of the antiviral pill. Molnupiravir is also allowed in the U.K. and Japan.</p><p><blockquote>默克股价远低于11月份达到的高点。乐观的是，该公司超出了第三季度的预期，并提供了乐观的2021年前景，其中不包括抗病毒药物的潜在影响。Molnupiravir在英国和日本也被允许。</blockquote></p><p> Merck expects to produce 10 million courses of molnupiravir this year and at least 20 million in 2022. It has supply agreements in place with more than 30 countries worldwide, including the U.S.</p><p><blockquote>默沙东预计今年将生产1000万个疗程的molnupiravir，2022年至少生产2000万个疗程。它与包括美国在内的全球30多个国家签订了供应协议。</blockquote></p><p> So, all in all, is Merck stock a buy or a sell right now?</p><p><blockquote>那么，总而言之，默克股票现在是买入还是卖出？</blockquote></p><p> <b>Merck Stock Fundamentals: Sales Top</b></p><p><blockquote><b>默克股票基本面：销售额最高</b></blockquote></p><p> During the third quarter, adjusted earnings climbed 28% to $1.75 per share and sales soared 20% to $13.15 billion. Both metrics beat forecasts.</p><p><blockquote>第三季度，调整后收益增长28%至每股1.75美元，销售额飙升20%至131.5亿美元。这两项指标都超出了预期。</blockquote></p><p> Merck also provided guidance following its&nbsp;<b>Organon</b>(OGN) spinoff. The pharma company boosted its full-year outlook to adjusted profit of $5.65-$5.70 per share on $47.4 billion to $47.9 billion in sales. Both measures topped expectations. And they don't include the potential for molnupiravir to gain authorizations in the U.S. or Europe.</p><p><blockquote>默克公司还提供了指导<b>欧加农</b>（OGN）分拆。该制药公司将全年调整后利润预期上调至每股5.65美元至5.70美元，销售额为474亿美元至479亿美元。两项指标均超出预期。而且它们不包括莫努匹拉韦在美国或欧洲获得授权的潜力。</blockquote></p><p> The company's biggest single drug remains cancer treatment Keytruda. Keytruda accounted for more than a third of total third-quarter sales. Keytruda sales increased 22% to $4.53 billion. Sales of its human papillomavirus vaccine, Gardasil, soared 68% to $1.99 billion.</p><p><blockquote>该公司最大的单一药物仍然是癌症治疗药物Keytruda。Keytruda占第三季度总销售额的三分之一以上。Keytruda销售额增长22%，达到45.3亿美元。其人乳头瘤病毒疫苗Gardasil的销售额飙升68%，达到19.9亿美元。</blockquote></p><p> But revenue from diabetes med Januvia fell 1% to $1.34 billion. And Merck reported a 26% decline for its pneumonia vaccine, Pneumovax 23, as Covid vaccines took priority in the U.S.</p><p><blockquote>但糖尿病药物Januvia的收入下降了1%，至13.4亿美元。默克公司报告称，由于新冠疫苗在美国占据优先地位，其肺炎疫苗Pneumovax 23的销量下降了26%。</blockquote></p><p> Overall, third-quarter metrics were in line withCAN SLIM rules for investing,which advise investors to look for companies with recent quarterly growth of 20%-25%, or better.</p><p><blockquote>总体而言，第三季度的指标符合CAN SLIM投资规则，该规则建议投资者寻找近期季度增长率为20%-25%或更高的公司。</blockquote></p><p> In the current quarter, analysts polled by FactSet expect Merck to earn $1.52 per share on $13.16 billion in sales. On a year-over-year basis, earnings would surge about 21% and sales would rise north of 5%.</p><p><blockquote>FactSet调查的分析师预计默克本季度每股收益为1.52美元，销售额为131.6亿美元。与去年同期相比，盈利将飙升约21%，销售额将增长5%以上。</blockquote></p><p> <b>What Do Annual Metrics Say About Merck?</b></p><p><blockquote><b>年度指标对默克有何影响？</b></blockquote></p><p> As Dec. 27, Merck stock was down slightly for the year. Shares recently hit at least a three-decade high, but have since tumbled.</p><p><blockquote>截至12月27日，默克股价年内小幅下跌。股价最近创下至少三年来的新高，但此后一直在下跌。</blockquote></p><p> Last year, Merck's sales grew 2.5% to $47.99 billion. That decelerated from 11% growth in 2019.</p><p><blockquote>去年，默克的销售额增长了2.5%，达到479.9亿美元。这一增长率较2019年11%的增长率有所放缓。</blockquote></p><p> For 2021, analysts expect sales to rise a fraction to $48.44 billion. Income is projected to inch 2.8% higher to $5.82 a share. That follows 14% growth in 2020.</p><p><blockquote>分析师预计2021年销售额将小幅增长至484.4亿美元。收入预计将增长2.8%，达到每股5.82美元。此前，2020年将增长14%。</blockquote></p><p> The stock ranks 6th by&nbsp;Composite Rating&nbsp;in the industry group of pharma companies. The 33-company Medical-Ethical Drugs group ranks No. 51 out of 197 groups tracked by Investor's Business Daily.</p><p><blockquote>该股在制药公司行业中的综合评级排名第六。由33家公司组成的医德药品集团在《投资者商报》追踪的197家集团中排名第51位。</blockquote></p><p> <b>Technical Analysis Of The Pharmaceutical Company</b></p><p><blockquote><b>制药公司的技术分析</b></blockquote></p><p> Merck stock has a&nbsp;Composite Rating&nbsp;of 81 out of a best-possible 99. The CR is a measure of a stock's key growth metrics over the past 12 months. This puts Merck stock within the top 19% of all stocks, regardless of industry group.</p><p><blockquote>默克股票的综合评级为81分（满分为99分）。CR是衡量股票过去12个月关键增长指标的指标。这使得默克股票在所有股票中排名前19%，无论行业类别如何。</blockquote></p><p> Shares also have a&nbsp;Relative Strength Rating&nbsp;of 57, reflecting the 12-month performance of Merck stock. This means the pharmaceutical stock ranks beneath the top one-third all stocks in terms of performance.</p><p><blockquote>股票的相对强度评级也为57，反映了默克股票12个月的表现。这意味着该医药股的业绩排名低于所有股票的前三分之一。</blockquote></p><p> It's also key to watch chart patterns. Merck stock broke out of a&nbsp;flat base&nbsp;with abuy point&nbsp;at 79.33 on Oct. 1, according to&nbsp;MarketSmith.com. But shares fell as much as 7% below their entry on Nov. 30. That triggered a sell signal. Investors are&nbsp;encouraged to sell&nbsp;when a stock is 7%-8% below its entry.</p><p><blockquote>观察图表模式也很关键。根据MarketSmith.com的数据，默克股价在10月1日突破了一个平盘，买入点为79.33点。但股价较11月30日入场时下跌了7%。这触发了卖出信号。当股票比进场价低7%-8%时，鼓励投资者卖出。</blockquote></p><p> Merck stock also recently undercut its&nbsp;50-day&nbsp;and&nbsp;200-day&nbsp;moving averages. Both are sell signals.</p><p><blockquote>默克股票最近也跌破了50日和200日移动平均线。两者都是卖出信号。</blockquote></p><p> <b>Merck Stock News: Merck Grabs Covid Deal</b></p><p><blockquote><b>默克股票新闻：默克获得新冠协议</b></blockquote></p><p> Merck's molnupiravir is now authorized in the U.S., U.K. and Japan.</p><p><blockquote>默克公司的molnupiravir现已在美国、英国和日本获得授权。</blockquote></p><p> In addition to Merck and Pfizer,<b>Atea Pharmaceuticals</b>(AVIR) and&nbsp;<b>Enanta Pharmaceuticals</b>(ENTA) working on oral Covid drugs.<b>Roche</b>(RHHBY) recently pulled out of its deal with Atea for the Covid antiviral.</p><p><blockquote>除了默沙东和辉瑞，<b>Atea制药公司</b>（AVIR）和<b>Enanta制药</b>(ENTA)正在研究口服新冠药物。<b>罗氏</b>(RHHBY)最近退出了与Atea的Covid抗病毒药物交易。</blockquote></p><p> Analysts say the pills could offer an easier route for non-hospitalized treatment of Covid than antibody drugs from&nbsp;<b>Regeneron Pharmaceuticals</b>(REGN),<b>Eli Lilly</b>(LLY) and&nbsp;<b>Vir Biotechnology</b>(VIR). Antibody drugs must be given by health care professionals.</p><p><blockquote>分析师表示，与抗体药物相比，这些药物可能为新冠病毒的非住院治疗提供更容易的途径<b>再生元制药</b>（REGN），<b>礼来公司</b>（LLY）及<b>维尔生物技术</b>（来）。抗体药物必须由卫生保健专业人员给予。</blockquote></p><p></p><p> But there is some concern that the way molnupiravir works could introduce mutations into the DNA of an unborn baby. So, FDA advisors waffled on whether to recommend its use for pregnant women.</p><p><blockquote>但有人担心莫努匹拉韦的作用方式可能会给未出生婴儿的DNA带来突变。因此，FDA顾问对是否推荐孕妇使用它犹豫不决。</blockquote></p><p> Bearishly, the FDA placed a study testing an HIV prevention drug, islatravir, on clinical hold. Several patients showed decreased in key immune cells. Merck and&nbsp;<b>Gilead Sciences</b>(GILD) also decided to stop testing a regimen of islatravir and Gilead's lenacapavir in HIV patients.</p><p><blockquote>悲观的是，FDA暂停了一项测试艾滋病毒预防药物islatravir的研究。一些患者显示关键免疫细胞减少。默克和<b>吉利德科学</b>（GILD）也决定停止在HIV患者中测试islatravir和吉利德的lenacapavir的一种方案。</blockquote></p><p> Merck also recently finished acquiring Acceleron.</p><p><blockquote>默克最近也完成了对Acceleron的收购。</blockquote></p><p> In early March, President Joe Biden announced Merck would help<b>Johnson &amp; Johnson</b>(JNJ) produce its Covid vaccine. Merck will receive $268.8 million from the Biomedical Advanced Research and Development Authority to help expand facility space to do so.</p><p><blockquote>三月初，乔·拜登总统宣布默克公司将提供帮助<b>强生公司</b>(JNJ)生产其新冠疫苗。默克公司将从生物医学高级研究与发展局获得2.688亿美元，以帮助扩大设施空间。</blockquote></p><p> <b>Is Merck Stock A Buy Now?</b></p><p><blockquote><b>默克股票现在值得买入吗？</b></blockquote></p><p> Based on CAN SLIM rules for investing, no, Merck stock is not a buy right now. Shares have round-tripped their earlier breakout and have triggered several sell signals.</p><p><blockquote>根据CAN SLIM投资规则，不，默克股票目前不值得买入。股价已经反复突破了之前的突破，并引发了多个卖出信号。</blockquote></p><p> There are further caveats. Both Merck's sales and earnings met CAN SLIM guidelines in the third quarter. Sales aren't expected to meet that mark in the current quarter.</p><p><blockquote>还有进一步的警告。默克公司第三季度的销售额和盈利都可能低于预期。预计本季度的销售额不会达到这一目标。</blockquote></p><p> Still, big stocks like Merck can add gains without hitting massive growth streaks.</p><p><blockquote>尽管如此，像默克这样的大型股票可以在不实现大幅增长的情况下增加涨幅。</blockquote></p><p></p>","source":"lsy1610449120050","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Is Merck Stock A Buy Or Sell After FDA Authorizes Its Covid Pill?<blockquote>FDA批准默克公司的新冠药物后，默克公司的股票是买入还是卖出？</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIs Merck Stock A Buy Or Sell After FDA Authorizes Its Covid Pill?<blockquote>FDA批准默克公司的新冠药物后，默克公司的股票是买入还是卖出？</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Investors</strong><span class=\"h-time small\">2021-12-28 08:47</span>\n</p>\n</h4>\n</header>\n<article>\n<p>The Food and Drug Administration authorized&nbsp;<b>Merck</b>'s (MRK) antiviral Covid pill, molnupiravir. But Merck stock remains under pressure.</p><p><blockquote>食品药品监督管理局授权<b>默克</b>(MRK)的抗病毒新冠药物莫努匹拉韦。但默克股票仍面临压力。</blockquote></p><p> The FDA authorized the Ridgeback Biotherapeutics-partnered pill for emergency use when other options aren't available or appropriate.<b>Pfizer</b>(PFE) also gained authorization for its two-pill regimen, Paxlovid. Paxlovid proved more effective in clinical testing. Further, molnupiravir carries a cancer risk and could lead to birth defects in unborn children.</p><p><blockquote>FDA授权Ridgeback Biotherapeutics合作的药丸在其他选择不可用或不合适时紧急使用。<b>辉瑞</b>(PFE)的两片疗法Paxlovid也获得了授权。Paxlovid在临床测试中被证明更有效。此外，molnupiravir具有癌症风险，并可能导致未出生儿童的出生缺陷。</blockquote></p><p> Merck's molnupiravir cut the risk of Covid-related hospitalizations or death by 30% when patients began treatment within five days of symptoms appearing. Paxlovid reduced the same risk by 89% for patients who began treatment within three days of symptom onset.</p><p><blockquote>当患者在症状出现后五天内开始治疗时，默克公司的molnupiravir将与Covid相关的住院或死亡风险降低了30%。对于症状出现后三天内开始治疗的患者，Paxlovid将相同的风险降低了89%。</blockquote></p><p> Merck stock is well off highs it achieved in November. Bullishly, the company beat third-quarter expectations and offered an upbeat 2021 outlook that didn't include the potential impact of the antiviral pill. Molnupiravir is also allowed in the U.K. and Japan.</p><p><blockquote>默克股价远低于11月份达到的高点。乐观的是，该公司超出了第三季度的预期，并提供了乐观的2021年前景，其中不包括抗病毒药物的潜在影响。Molnupiravir在英国和日本也被允许。</blockquote></p><p> Merck expects to produce 10 million courses of molnupiravir this year and at least 20 million in 2022. It has supply agreements in place with more than 30 countries worldwide, including the U.S.</p><p><blockquote>默沙东预计今年将生产1000万个疗程的molnupiravir，2022年至少生产2000万个疗程。它与包括美国在内的全球30多个国家签订了供应协议。</blockquote></p><p> So, all in all, is Merck stock a buy or a sell right now?</p><p><blockquote>那么，总而言之，默克股票现在是买入还是卖出？</blockquote></p><p> <b>Merck Stock Fundamentals: Sales Top</b></p><p><blockquote><b>默克股票基本面：销售额最高</b></blockquote></p><p> During the third quarter, adjusted earnings climbed 28% to $1.75 per share and sales soared 20% to $13.15 billion. Both metrics beat forecasts.</p><p><blockquote>第三季度，调整后收益增长28%至每股1.75美元，销售额飙升20%至131.5亿美元。这两项指标都超出了预期。</blockquote></p><p> Merck also provided guidance following its&nbsp;<b>Organon</b>(OGN) spinoff. The pharma company boosted its full-year outlook to adjusted profit of $5.65-$5.70 per share on $47.4 billion to $47.9 billion in sales. Both measures topped expectations. And they don't include the potential for molnupiravir to gain authorizations in the U.S. or Europe.</p><p><blockquote>默克公司还提供了指导<b>欧加农</b>（OGN）分拆。该制药公司将全年调整后利润预期上调至每股5.65美元至5.70美元，销售额为474亿美元至479亿美元。两项指标均超出预期。而且它们不包括莫努匹拉韦在美国或欧洲获得授权的潜力。</blockquote></p><p> The company's biggest single drug remains cancer treatment Keytruda. Keytruda accounted for more than a third of total third-quarter sales. Keytruda sales increased 22% to $4.53 billion. Sales of its human papillomavirus vaccine, Gardasil, soared 68% to $1.99 billion.</p><p><blockquote>该公司最大的单一药物仍然是癌症治疗药物Keytruda。Keytruda占第三季度总销售额的三分之一以上。Keytruda销售额增长22%，达到45.3亿美元。其人乳头瘤病毒疫苗Gardasil的销售额飙升68%，达到19.9亿美元。</blockquote></p><p> But revenue from diabetes med Januvia fell 1% to $1.34 billion. And Merck reported a 26% decline for its pneumonia vaccine, Pneumovax 23, as Covid vaccines took priority in the U.S.</p><p><blockquote>但糖尿病药物Januvia的收入下降了1%，至13.4亿美元。默克公司报告称，由于新冠疫苗在美国占据优先地位，其肺炎疫苗Pneumovax 23的销量下降了26%。</blockquote></p><p> Overall, third-quarter metrics were in line withCAN SLIM rules for investing,which advise investors to look for companies with recent quarterly growth of 20%-25%, or better.</p><p><blockquote>总体而言，第三季度的指标符合CAN SLIM投资规则，该规则建议投资者寻找近期季度增长率为20%-25%或更高的公司。</blockquote></p><p> In the current quarter, analysts polled by FactSet expect Merck to earn $1.52 per share on $13.16 billion in sales. On a year-over-year basis, earnings would surge about 21% and sales would rise north of 5%.</p><p><blockquote>FactSet调查的分析师预计默克本季度每股收益为1.52美元，销售额为131.6亿美元。与去年同期相比，盈利将飙升约21%，销售额将增长5%以上。</blockquote></p><p> <b>What Do Annual Metrics Say About Merck?</b></p><p><blockquote><b>年度指标对默克有何影响？</b></blockquote></p><p> As Dec. 27, Merck stock was down slightly for the year. Shares recently hit at least a three-decade high, but have since tumbled.</p><p><blockquote>截至12月27日，默克股价年内小幅下跌。股价最近创下至少三年来的新高，但此后一直在下跌。</blockquote></p><p> Last year, Merck's sales grew 2.5% to $47.99 billion. That decelerated from 11% growth in 2019.</p><p><blockquote>去年，默克的销售额增长了2.5%，达到479.9亿美元。这一增长率较2019年11%的增长率有所放缓。</blockquote></p><p> For 2021, analysts expect sales to rise a fraction to $48.44 billion. Income is projected to inch 2.8% higher to $5.82 a share. That follows 14% growth in 2020.</p><p><blockquote>分析师预计2021年销售额将小幅增长至484.4亿美元。收入预计将增长2.8%，达到每股5.82美元。此前，2020年将增长14%。</blockquote></p><p> The stock ranks 6th by&nbsp;Composite Rating&nbsp;in the industry group of pharma companies. The 33-company Medical-Ethical Drugs group ranks No. 51 out of 197 groups tracked by Investor's Business Daily.</p><p><blockquote>该股在制药公司行业中的综合评级排名第六。由33家公司组成的医德药品集团在《投资者商报》追踪的197家集团中排名第51位。</blockquote></p><p> <b>Technical Analysis Of The Pharmaceutical Company</b></p><p><blockquote><b>制药公司的技术分析</b></blockquote></p><p> Merck stock has a&nbsp;Composite Rating&nbsp;of 81 out of a best-possible 99. The CR is a measure of a stock's key growth metrics over the past 12 months. This puts Merck stock within the top 19% of all stocks, regardless of industry group.</p><p><blockquote>默克股票的综合评级为81分（满分为99分）。CR是衡量股票过去12个月关键增长指标的指标。这使得默克股票在所有股票中排名前19%，无论行业类别如何。</blockquote></p><p> Shares also have a&nbsp;Relative Strength Rating&nbsp;of 57, reflecting the 12-month performance of Merck stock. This means the pharmaceutical stock ranks beneath the top one-third all stocks in terms of performance.</p><p><blockquote>股票的相对强度评级也为57，反映了默克股票12个月的表现。这意味着该医药股的业绩排名低于所有股票的前三分之一。</blockquote></p><p> It's also key to watch chart patterns. Merck stock broke out of a&nbsp;flat base&nbsp;with abuy point&nbsp;at 79.33 on Oct. 1, according to&nbsp;MarketSmith.com. But shares fell as much as 7% below their entry on Nov. 30. That triggered a sell signal. Investors are&nbsp;encouraged to sell&nbsp;when a stock is 7%-8% below its entry.</p><p><blockquote>观察图表模式也很关键。根据MarketSmith.com的数据，默克股价在10月1日突破了一个平盘，买入点为79.33点。但股价较11月30日入场时下跌了7%。这触发了卖出信号。当股票比进场价低7%-8%时，鼓励投资者卖出。</blockquote></p><p> Merck stock also recently undercut its&nbsp;50-day&nbsp;and&nbsp;200-day&nbsp;moving averages. Both are sell signals.</p><p><blockquote>默克股票最近也跌破了50日和200日移动平均线。两者都是卖出信号。</blockquote></p><p> <b>Merck Stock News: Merck Grabs Covid Deal</b></p><p><blockquote><b>默克股票新闻：默克获得新冠协议</b></blockquote></p><p> Merck's molnupiravir is now authorized in the U.S., U.K. and Japan.</p><p><blockquote>默克公司的molnupiravir现已在美国、英国和日本获得授权。</blockquote></p><p> In addition to Merck and Pfizer,<b>Atea Pharmaceuticals</b>(AVIR) and&nbsp;<b>Enanta Pharmaceuticals</b>(ENTA) working on oral Covid drugs.<b>Roche</b>(RHHBY) recently pulled out of its deal with Atea for the Covid antiviral.</p><p><blockquote>除了默沙东和辉瑞，<b>Atea制药公司</b>（AVIR）和<b>Enanta制药</b>(ENTA)正在研究口服新冠药物。<b>罗氏</b>(RHHBY)最近退出了与Atea的Covid抗病毒药物交易。</blockquote></p><p> Analysts say the pills could offer an easier route for non-hospitalized treatment of Covid than antibody drugs from&nbsp;<b>Regeneron Pharmaceuticals</b>(REGN),<b>Eli Lilly</b>(LLY) and&nbsp;<b>Vir Biotechnology</b>(VIR). Antibody drugs must be given by health care professionals.</p><p><blockquote>分析师表示，与抗体药物相比，这些药物可能为新冠病毒的非住院治疗提供更容易的途径<b>再生元制药</b>（REGN），<b>礼来公司</b>（LLY）及<b>维尔生物技术</b>（来）。抗体药物必须由卫生保健专业人员给予。</blockquote></p><p></p><p> But there is some concern that the way molnupiravir works could introduce mutations into the DNA of an unborn baby. So, FDA advisors waffled on whether to recommend its use for pregnant women.</p><p><blockquote>但有人担心莫努匹拉韦的作用方式可能会给未出生婴儿的DNA带来突变。因此，FDA顾问对是否推荐孕妇使用它犹豫不决。</blockquote></p><p> Bearishly, the FDA placed a study testing an HIV prevention drug, islatravir, on clinical hold. Several patients showed decreased in key immune cells. Merck and&nbsp;<b>Gilead Sciences</b>(GILD) also decided to stop testing a regimen of islatravir and Gilead's lenacapavir in HIV patients.</p><p><blockquote>悲观的是，FDA暂停了一项测试艾滋病毒预防药物islatravir的研究。一些患者显示关键免疫细胞减少。默克和<b>吉利德科学</b>（GILD）也决定停止在HIV患者中测试islatravir和吉利德的lenacapavir的一种方案。</blockquote></p><p> Merck also recently finished acquiring Acceleron.</p><p><blockquote>默克最近也完成了对Acceleron的收购。</blockquote></p><p> In early March, President Joe Biden announced Merck would help<b>Johnson &amp; Johnson</b>(JNJ) produce its Covid vaccine. Merck will receive $268.8 million from the Biomedical Advanced Research and Development Authority to help expand facility space to do so.</p><p><blockquote>三月初，乔·拜登总统宣布默克公司将提供帮助<b>强生公司</b>(JNJ)生产其新冠疫苗。默克公司将从生物医学高级研究与发展局获得2.688亿美元，以帮助扩大设施空间。</blockquote></p><p> <b>Is Merck Stock A Buy Now?</b></p><p><blockquote><b>默克股票现在值得买入吗？</b></blockquote></p><p> Based on CAN SLIM rules for investing, no, Merck stock is not a buy right now. Shares have round-tripped their earlier breakout and have triggered several sell signals.</p><p><blockquote>根据CAN SLIM投资规则，不，默克股票目前不值得买入。股价已经反复突破了之前的突破，并引发了多个卖出信号。</blockquote></p><p> There are further caveats. Both Merck's sales and earnings met CAN SLIM guidelines in the third quarter. Sales aren't expected to meet that mark in the current quarter.</p><p><blockquote>还有进一步的警告。默克公司第三季度的销售额和盈利都可能低于预期。预计本季度的销售额不会达到这一目标。</blockquote></p><p> Still, big stocks like Merck can add gains without hitting massive growth streaks.</p><p><blockquote>尽管如此，像默克这样的大型股票可以在不实现大幅增长的情况下增加涨幅。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.investors.com/news/technology/merck-stock-buy-now/?src=A00220\">Investors</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRK":"默沙东"},"source_url":"https://www.investors.com/news/technology/merck-stock-buy-now/?src=A00220","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1156481741","content_text":"The Food and Drug Administration authorized Merck's (MRK) antiviral Covid pill, molnupiravir. But Merck stock remains under pressure.\nThe FDA authorized the Ridgeback Biotherapeutics-partnered pill for emergency use when other options aren't available or appropriate.Pfizer(PFE) also gained authorization for its two-pill regimen, Paxlovid. Paxlovid proved more effective in clinical testing. Further, molnupiravir carries a cancer risk and could lead to birth defects in unborn children.\nMerck's molnupiravir cut the risk of Covid-related hospitalizations or death by 30% when patients began treatment within five days of symptoms appearing. Paxlovid reduced the same risk by 89% for patients who began treatment within three days of symptom onset.\nMerck stock is well off highs it achieved in November. Bullishly, the company beat third-quarter expectations and offered an upbeat 2021 outlook that didn't include the potential impact of the antiviral pill. Molnupiravir is also allowed in the U.K. and Japan.\nMerck expects to produce 10 million courses of molnupiravir this year and at least 20 million in 2022. It has supply agreements in place with more than 30 countries worldwide, including the U.S.\nSo, all in all, is Merck stock a buy or a sell right now?\nMerck Stock Fundamentals: Sales Top\nDuring the third quarter, adjusted earnings climbed 28% to $1.75 per share and sales soared 20% to $13.15 billion. Both metrics beat forecasts.\nMerck also provided guidance following its Organon(OGN) spinoff. The pharma company boosted its full-year outlook to adjusted profit of $5.65-$5.70 per share on $47.4 billion to $47.9 billion in sales. Both measures topped expectations. And they don't include the potential for molnupiravir to gain authorizations in the U.S. or Europe.\nThe company's biggest single drug remains cancer treatment Keytruda. Keytruda accounted for more than a third of total third-quarter sales. Keytruda sales increased 22% to $4.53 billion. Sales of its human papillomavirus vaccine, Gardasil, soared 68% to $1.99 billion.\nBut revenue from diabetes med Januvia fell 1% to $1.34 billion. And Merck reported a 26% decline for its pneumonia vaccine, Pneumovax 23, as Covid vaccines took priority in the U.S.\nOverall, third-quarter metrics were in line withCAN SLIM rules for investing,which advise investors to look for companies with recent quarterly growth of 20%-25%, or better.\nIn the current quarter, analysts polled by FactSet expect Merck to earn $1.52 per share on $13.16 billion in sales. On a year-over-year basis, earnings would surge about 21% and sales would rise north of 5%.\nWhat Do Annual Metrics Say About Merck?\nAs Dec. 27, Merck stock was down slightly for the year. Shares recently hit at least a three-decade high, but have since tumbled.\nLast year, Merck's sales grew 2.5% to $47.99 billion. That decelerated from 11% growth in 2019.\nFor 2021, analysts expect sales to rise a fraction to $48.44 billion. Income is projected to inch 2.8% higher to $5.82 a share. That follows 14% growth in 2020.\nThe stock ranks 6th by Composite Rating in the industry group of pharma companies. The 33-company Medical-Ethical Drugs group ranks No. 51 out of 197 groups tracked by Investor's Business Daily.\nTechnical Analysis Of The Pharmaceutical Company\nMerck stock has a Composite Rating of 81 out of a best-possible 99. The CR is a measure of a stock's key growth metrics over the past 12 months. This puts Merck stock within the top 19% of all stocks, regardless of industry group.\nShares also have a Relative Strength Rating of 57, reflecting the 12-month performance of Merck stock. This means the pharmaceutical stock ranks beneath the top one-third all stocks in terms of performance.\nIt's also key to watch chart patterns. Merck stock broke out of a flat base with abuy point at 79.33 on Oct. 1, according to MarketSmith.com. But shares fell as much as 7% below their entry on Nov. 30. That triggered a sell signal. Investors are encouraged to sell when a stock is 7%-8% below its entry.\nMerck stock also recently undercut its 50-day and 200-day moving averages. Both are sell signals.\nMerck Stock News: Merck Grabs Covid Deal\nMerck's molnupiravir is now authorized in the U.S., U.K. and Japan.\nIn addition to Merck and Pfizer,Atea Pharmaceuticals(AVIR) and Enanta Pharmaceuticals(ENTA) working on oral Covid drugs.Roche(RHHBY) recently pulled out of its deal with Atea for the Covid antiviral.\nAnalysts say the pills could offer an easier route for non-hospitalized treatment of Covid than antibody drugs from Regeneron Pharmaceuticals(REGN),Eli Lilly(LLY) and Vir Biotechnology(VIR). Antibody drugs must be given by health care professionals.\nBut there is some concern that the way molnupiravir works could introduce mutations into the DNA of an unborn baby. So, FDA advisors waffled on whether to recommend its use for pregnant women.\nBearishly, the FDA placed a study testing an HIV prevention drug, islatravir, on clinical hold. Several patients showed decreased in key immune cells. Merck and Gilead Sciences(GILD) also decided to stop testing a regimen of islatravir and Gilead's lenacapavir in HIV patients.\nMerck also recently finished acquiring Acceleron.\nIn early March, President Joe Biden announced Merck would helpJohnson & Johnson(JNJ) produce its Covid vaccine. Merck will receive $268.8 million from the Biomedical Advanced Research and Development Authority to help expand facility space to do so.\nIs Merck Stock A Buy Now?\nBased on CAN SLIM rules for investing, no, Merck stock is not a buy right now. Shares have round-tripped their earlier breakout and have triggered several sell signals.\nThere are further caveats. Both Merck's sales and earnings met CAN SLIM guidelines in the third quarter. Sales aren't expected to meet that mark in the current quarter.\nStill, big stocks like Merck can add gains without hitting massive growth streaks.","news_type":1,"symbols_score_info":{"MRK":0.9}},"isVote":1,"tweetType":1,"viewCount":4064,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698106756,"gmtCreate":1640312839363,"gmtModify":1640313787557,"author":{"id":"3586129577058331","authorId":"3586129577058331","name":"1a327e37","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586129577058331","authorIdStr":"3586129577058331"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/698106756","repostId":"1168865278","repostType":4,"repost":{"id":"1168865278","kind":"news","pubTimestamp":1640311666,"share":"https://www.laohu8.com/m/news/1168865278?lang=zh_CN&edition=full","pubTime":"2021-12-24 10:07","market":"us","language":"en","title":"Can Apple Stock Hit New Highs by Year's End?<blockquote>苹果股价能否在年底前创下新高？</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1168865278","media":"TheStreet","summary":"Apple stock is higher on Thursday and could try to make a push to records before the end of the year","content":"<p>Apple stock is higher on Thursday and could try to make a push to records before the end of the year.</p><p><blockquote>苹果股价周四走高，并可能试图在年底前突破纪录。</blockquote></p><p> Apple&nbsp;shares earlier this month were a market leader, but over the past few trading sessions, they've wobbled.</p><p><blockquote>本月早些时候，苹果的股价是市场领导者，但在过去几个交易日中，它们出现了波动。</blockquote></p><p> As the overall market continued to sway with volatility, Apple was a beacon of strength.&nbsp;We were lucky with Apple stock. In fact, incredibly lucky.</p><p><blockquote>由于整体市场继续波动，苹果是力量的灯塔。我们对苹果股票很幸运。事实上，非常幸运。</blockquote></p><p> On Dec. 13 the Cupertino, Calif., tech giant was&nbsp;approaching a $3 trillion valuation. But I wrote about the potential sell-the-news&nbsp;bearish reversal that was in play. The stock then posted five daily losses in a six-session span.</p><p><blockquote>12月13日，这家位于加州库比蒂诺的科技巨头的估值接近3万亿美元。但我写了潜在的抛售新闻看跌逆转。随后，该股在六个交易日内连续五次下跌。</blockquote></p><p> Apple has now begun to find its footing.</p><p><blockquote>苹果现在已经开始站稳脚跟。</blockquote></p><p> It was recently reported that Apple was a massive buyer of its own stock last quarter — which is no surprise given its buyback commitment —as it led the S&amp;P 500.</p><p><blockquote>最近有报道称，苹果上个季度是自己股票的大量买家——考虑到其回购承诺，这并不奇怪——因为它引领了标普500。</blockquote></p><p> Now bulls are wondering if all that buying will eventually pay off. Let’s look at the charts.</p><p><blockquote>现在多头想知道所有的购买最终是否会得到回报。让我们看看图表。</blockquote></p><p> <b>Trading Apple Stock</b></p><p><blockquote><b>交易苹果股票</b></blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/6865ca6e0def05bb2a060b2af13be892\" tg-width=\"1139\" tg-height=\"866\" width=\"100%\" height=\"auto\"><span>Daily chart of Apple stock.</span></p><p><blockquote><p class=\"t-img-caption\"><span>苹果股票日线图。</span></p></blockquote></p><p> This morning&nbsp;I had Apple on my radar. Why? It’s simple.</p><p><blockquote>今天早上我注意到了苹果。为什么？很简单。</blockquote></p><p> Look at the way shares of Apple closed lower on Friday and Monday, but both times rallied from the open. We know that by the look of the candle.</p><p><blockquote>看看苹果股价周五和周一收盘走低，但两次开盘均上涨。我们从蜡烛的样子就知道了。</blockquote></p><p> Rather than a filled-in, deep-red candle (like Thursday, Dec. 16), we have two hollow&nbsp; red candles. That shows us a higher close from the open, even though the stock ended lower on the day. In other words, bulls were buying the opening dips.</p><p><blockquote>我们有两根空心的红色蜡烛，而不是一根填充的深红色蜡烛（就像12月16日星期四）。这向我们表明，尽管该股当天收盘走低，但收盘价较开盘走高。换句话说，多头在开盘时逢低买入。</blockquote></p><p> Further, Apple stock was holding the 21-day moving average.</p><p><blockquote>此外，苹果股价守住21日移动平均线。</blockquote></p><p> With yesterday’s bounce, Apple not only rallied off the 21-day moving average, it closed above the 10-day moving average.</p><p><blockquote>随着昨天的反弹，苹果不仅从21日移动均线反弹，收盘也高于10日移动均线。</blockquote></p><p> That had traders looking for a daily-up rotation over Tuesday’s high, at $173.20.</p><p><blockquote>这使得交易员希望在周二高点173.20美元的基础上每日上涨。</blockquote></p><p> From here I want to see whether Apple stock can continue to push higher. It’s above all its major daily moving averages.</p><p><blockquote>从这里我想看看苹果股票能否继续走高。它高于所有主要的每日移动平均线。</blockquote></p><p> If it does continue higher, downtrend resistance and the $179.50 area are in play. Twice, Apple has failed on its push over $180. So if it does make a run higher, we want to be cognizant of this zone.</p><p><blockquote>如果它确实继续走高，则下降趋势阻力和179.50美元区域正在发挥作用。苹果两次突破180美元的努力都失败了。因此，如果它确实走高，我们希望认识到这个区域。</blockquote></p><p> Above $180 opens the door to the all-time high, at $182.13. Above that and we can start talking about the $188 to $194 zone, where Apple&nbsp;finds a few upside extensions.</p><p><blockquote>高于180美元将为182.13美元的历史高点打开大门。在此之上，我们可以开始谈论188美元至194美元区域，苹果在该区域发现了一些上行延伸。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Can Apple Stock Hit New Highs by Year's End?<blockquote>苹果股价能否在年底前创下新高？</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCan Apple Stock Hit New Highs by Year's End?<blockquote>苹果股价能否在年底前创下新高？</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">TheStreet</strong><span class=\"h-time small\">2021-12-24 10:07</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Apple stock is higher on Thursday and could try to make a push to records before the end of the year.</p><p><blockquote>苹果股价周四走高，并可能试图在年底前突破纪录。</blockquote></p><p> Apple&nbsp;shares earlier this month were a market leader, but over the past few trading sessions, they've wobbled.</p><p><blockquote>本月早些时候，苹果的股价是市场领导者，但在过去几个交易日中，它们出现了波动。</blockquote></p><p> As the overall market continued to sway with volatility, Apple was a beacon of strength.&nbsp;We were lucky with Apple stock. In fact, incredibly lucky.</p><p><blockquote>由于整体市场继续波动，苹果是力量的灯塔。我们对苹果股票很幸运。事实上，非常幸运。</blockquote></p><p> On Dec. 13 the Cupertino, Calif., tech giant was&nbsp;approaching a $3 trillion valuation. But I wrote about the potential sell-the-news&nbsp;bearish reversal that was in play. The stock then posted five daily losses in a six-session span.</p><p><blockquote>12月13日，这家位于加州库比蒂诺的科技巨头的估值接近3万亿美元。但我写了潜在的抛售新闻看跌逆转。随后，该股在六个交易日内连续五次下跌。</blockquote></p><p> Apple has now begun to find its footing.</p><p><blockquote>苹果现在已经开始站稳脚跟。</blockquote></p><p> It was recently reported that Apple was a massive buyer of its own stock last quarter — which is no surprise given its buyback commitment —as it led the S&amp;P 500.</p><p><blockquote>最近有报道称，苹果上个季度是自己股票的大量买家——考虑到其回购承诺，这并不奇怪——因为它引领了标普500。</blockquote></p><p> Now bulls are wondering if all that buying will eventually pay off. Let’s look at the charts.</p><p><blockquote>现在多头想知道所有的购买最终是否会得到回报。让我们看看图表。</blockquote></p><p> <b>Trading Apple Stock</b></p><p><blockquote><b>交易苹果股票</b></blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/6865ca6e0def05bb2a060b2af13be892\" tg-width=\"1139\" tg-height=\"866\" width=\"100%\" height=\"auto\"><span>Daily chart of Apple stock.</span></p><p><blockquote><p class=\"t-img-caption\"><span>苹果股票日线图。</span></p></blockquote></p><p> This morning&nbsp;I had Apple on my radar. Why? It’s simple.</p><p><blockquote>今天早上我注意到了苹果。为什么？很简单。</blockquote></p><p> Look at the way shares of Apple closed lower on Friday and Monday, but both times rallied from the open. We know that by the look of the candle.</p><p><blockquote>看看苹果股价周五和周一收盘走低，但两次开盘均上涨。我们从蜡烛的样子就知道了。</blockquote></p><p> Rather than a filled-in, deep-red candle (like Thursday, Dec. 16), we have two hollow&nbsp; red candles. That shows us a higher close from the open, even though the stock ended lower on the day. In other words, bulls were buying the opening dips.</p><p><blockquote>我们有两根空心的红色蜡烛，而不是一根填充的深红色蜡烛（就像12月16日星期四）。这向我们表明，尽管该股当天收盘走低，但收盘价较开盘走高。换句话说，多头在开盘时逢低买入。</blockquote></p><p> Further, Apple stock was holding the 21-day moving average.</p><p><blockquote>此外，苹果股价守住21日移动平均线。</blockquote></p><p> With yesterday’s bounce, Apple not only rallied off the 21-day moving average, it closed above the 10-day moving average.</p><p><blockquote>随着昨天的反弹，苹果不仅从21日移动均线反弹，收盘也高于10日移动均线。</blockquote></p><p> That had traders looking for a daily-up rotation over Tuesday’s high, at $173.20.</p><p><blockquote>这使得交易员希望在周二高点173.20美元的基础上每日上涨。</blockquote></p><p> From here I want to see whether Apple stock can continue to push higher. It’s above all its major daily moving averages.</p><p><blockquote>从这里我想看看苹果股票能否继续走高。它高于所有主要的每日移动平均线。</blockquote></p><p> If it does continue higher, downtrend resistance and the $179.50 area are in play. Twice, Apple has failed on its push over $180. So if it does make a run higher, we want to be cognizant of this zone.</p><p><blockquote>如果它确实继续走高，则下降趋势阻力和179.50美元区域正在发挥作用。苹果两次突破180美元的努力都失败了。因此，如果它确实走高，我们希望认识到这个区域。</blockquote></p><p> Above $180 opens the door to the all-time high, at $182.13. Above that and we can start talking about the $188 to $194 zone, where Apple&nbsp;finds a few upside extensions.</p><p><blockquote>高于180美元将为182.13美元的历史高点打开大门。在此之上，我们可以开始谈论188美元至194美元区域，苹果在该区域发现了一些上行延伸。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.thestreet.com/investing/trading-apple-aapl-stock-new-highs-before-year-end-december-2021\">TheStreet</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"source_url":"https://www.thestreet.com/investing/trading-apple-aapl-stock-new-highs-before-year-end-december-2021","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1168865278","content_text":"Apple stock is higher on Thursday and could try to make a push to records before the end of the year.\nApple shares earlier this month were a market leader, but over the past few trading sessions, they've wobbled.\nAs the overall market continued to sway with volatility, Apple was a beacon of strength. We were lucky with Apple stock. In fact, incredibly lucky.\nOn Dec. 13 the Cupertino, Calif., tech giant was approaching a $3 trillion valuation. But I wrote about the potential sell-the-news bearish reversal that was in play. The stock then posted five daily losses in a six-session span.\nApple has now begun to find its footing.\nIt was recently reported that Apple was a massive buyer of its own stock last quarter — which is no surprise given its buyback commitment —as it led the S&P 500.\nNow bulls are wondering if all that buying will eventually pay off. Let’s look at the charts.\nTrading Apple Stock\nDaily chart of Apple stock.\nThis morning I had Apple on my radar. Why? It’s simple.\nLook at the way shares of Apple closed lower on Friday and Monday, but both times rallied from the open. We know that by the look of the candle.\nRather than a filled-in, deep-red candle (like Thursday, Dec. 16), we have two hollow  red candles. That shows us a higher close from the open, even though the stock ended lower on the day. In other words, bulls were buying the opening dips.\nFurther, Apple stock was holding the 21-day moving average.\nWith yesterday’s bounce, Apple not only rallied off the 21-day moving average, it closed above the 10-day moving average.\nThat had traders looking for a daily-up rotation over Tuesday’s high, at $173.20.\nFrom here I want to see whether Apple stock can continue to push higher. It’s above all its major daily moving averages.\nIf it does continue higher, downtrend resistance and the $179.50 area are in play. Twice, Apple has failed on its push over $180. So if it does make a run higher, we want to be cognizant of this zone.\nAbove $180 opens the door to the all-time high, at $182.13. Above that and we can start talking about the $188 to $194 zone, where Apple finds a few upside extensions.","news_type":1,"symbols_score_info":{"AAPL":0.9}},"isVote":1,"tweetType":1,"viewCount":3540,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}